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ABSTRACT 
Transition metals play essential roles in biological systems, but Fe can also be 
toxic to cells. In order to maintain this balance between necessity and toxicity 
mechanisms are employed for regulating and storing intracellular Fe. In Saccharomyces 
cerevisiae, vacuoles are responsible for sequestering, storing, and supplying Fe to the 
cytosol. Many of the proteins and regulatory pathways involved in Fe trafficking and 
storage in S. cerevisiae have been identified, but the forms of Fe which are involved in 
these processes have not been fully characterized.  
In these studies, biophysical and bioanalytical techniques were used to study 
intracellular Fe distributions in S. cerevisiae cells and organelles. Ultimately, Fe-
containing species were biophysically characterized and absolute Fe concentrations in 
cells and organelles were quantified. The motivation for these studies stemmed from 
previous studies which revealed that the majority of the whole-cell Fe is a non-heme, 
high-spin (NHHS) form of Fe
3+
. This Fe is not localized to the mitochondria. The 
purpose of these studies was to determine if the vacuoles contained this NHHS Fe
3+
. 
A large-scale isolation procedure was developed to obtain purified vacuoles from 
S. cerevisiae and to investigate the Fe in these organelles. Mössbauer and EPR analysis 
revealed that the primary form of Fe in vacuoles is a mononuclear, NHHS Fe
3+
 species. 
A second form of Fe was also observed as superparamagnetic ferric phosphate 
nanoparticles (NP). By investigating model compounds of Fe and polyphosphate we 
determined that a shift in vacuolar pH induces the conversion between NHHS Fe
3+
 and 
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NP. These results showed that there are at least two forms of Fe in vacuoles, and that the 
ratio of these two forms is dependent upon the pH of these organelles. 
Biophysical analyses of whole cells also revealed the presence of low 
concentrations of a non-heme, high-spin Fe
2+
 species. The goal of these next projects 
was to determine if this NHHS Fe
2+
 species was localized to the cytosol. Genetic strains 
lacking or over-expressing the vacuolar Fe import protein Ccc1p were studied by 
Mössbauer spectroscopy (∆CCC1 and CCC1-up, respectively). ∆CCC1 cells showed 
low vacuolar Fe (NHHS Fe
3+
 and NP), and increased NHHS Fe
2+
. We hypothesize that 
this NHHS Fe
2+
 is cytosolic Fe. We also propose that this NHHS Fe
2+
 is involved in the 
regulating intracellular Fe levels. 
CCC1-up cells accumulated more Fe than wild-type (WT) cells, and showed 
elevated levels of vacuolar Fe (NHHS Fe
3+
 and NP). These cells also accumulated high 
levels of NHHS Fe
2+
. The CCC1-up cells exhibited an adenine deficient phenotype, 
where the cells developed a red color during growth. With excess adenine the levels of 
NHHS Fe
2+
 declined, which indicated that this Fe accumulation was related to adenine 
deficiency. We conclude that adenine deficiency leads to the accumulation of a 
sequestered (possibly vacuolar) form of NHHS Fe
2+
. Overall, we have identified two 
separate pools of NHHS Fe
2+
 in ∆CCC1 and CCC1-up cells. In ∆CCC1 cells the NHHS 
Fe
2+
 pool is localized to the cytosol and is sensed by the cell. In CCC1-up cells the 
NHHS Fe
2+
 is sequestered from the Fe regulatory mechanism- possibly in the vacuoles. 
These data have helped us better understand the roles of vacuoles in Fe trafficking and 
the dynamics of vacuolar Fe trafficking. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
Transition metals are essential components in every biological system, from 
plants to humans (1).  These metals are extremely useful for cells because they are stable 
in multiple redox states, which allow enzymes to efficiently catalyze reactions such as 
those involving electron transfer (2-4), respiration (5-7), and DNA replication and repair 
(8-11).   
One of the most widely-used transition metals in biology is iron (Fe) (12). Iron 
can exist in many oxidation states, with the two most common being ferrous (Fe
2+
) and 
ferric (Fe
3+
).  In cellular systems, iron is utilized as heme centers, in iron-sulfur (Fe/S) 
clusters, and others (12).  Iron can also be detrimental to cells due to its ability to do 
Fenton chemistry [Fe
2+
 + H2O2  Fe
3+
 + 
-
OH + 
•
OH], which leads to the formation of 
reactive oxygen species (ROS) (13).  ROS can damage lipids (14), proteins (15), and 
DNA (16) which can eventually lead to cell death (17, 18).  The need for iron in cells is 
well established, but the route for iron incorporation into different centers and proteins is 
poorly understood.  The objective of the studies presented in this dissertation was to 
investigate the ways Fe distributions change under various conditions.  The conclusions 
shown have provided insight for Fe regulation and trafficking within cells. 
 
Iron Uptake in Yeast Cells 
Iron trafficking- the way iron moves within cells- has been studied extensively 
for decades, and while many pathways have been identified, others remain elusive.  
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Many studies have been conducted in higher organisms (i.e., mammals), but much of 
iron trafficking knowledge has been ascertained by studying single-celled eukaryotic 
organisms like Saccharomyces cerevisiae.  This organism is a good model system for 
iron trafficking because many of the proteins in yeast are homologous to those in 
humans.  Yeast is also easy to grow in large cultures, and doing so is cost effective.  
Iron is brought into the yeast cell through two primary pathways (19-21).  The 
first pathway utilizes siderophores, or small molecules which chelate metals (21).  While 
Saccharomyces cerevisiae does not produce its own siderophores, yeast are able to 
import Fe
3+
- binding siderophores through Arn and Sit proteins on the plasma membrane 
(21, 22).  In the absence of siderophore-bound iron these proteins are localized to 
intracellular vesicles (22). When siderophores are present or extracellular iron 
concentrations are low, these proteins are trafficked to the plasma membrane (22).  This 
complex is endocytosed upon the iron-containing substrate binding to its receptor (22).  
Once the siderophore-binding proteins are endocytosed, the endocytotic vesicle is 
acidified and the iron-bound siderophore is released into the cytosol (22).  The 
siderophore can accumulate in intracellular vesicles or be degraded (23).  In the cytosol, 
iron is chelated by an unknown trafficking compound.  The cytosolic iron pool is 
hypothesized to exist as Fe
2+
, rather than Fe
3+
, which would imply that some reducing 
agent is involved in the metal ion transfer process (24).   
The second pathway of iron import to the yeast cell is a reductive uptake 
mechanism.  Fre1p and Fre2p are ferric reductase proteins on the plasma membrane 
which are responsible for reducing Fe
3+
 to Fe
2+
.  These reductases contain binding sites 
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for NADH, FAD, and hemes, which accommodate electron transfer from NADH to Fe
3+
 
(25, 26).  The reductive-uptake mechanism is active when iron is available as ferric 
citrate and ferric chelates (27).  Without Fre1p, iron will not be transported through the 
reductive uptake system, as Fre1p is responsible for >90% of iron reduction on the 
plasma membrane (26, 28).  The ferrous iron resulting from this step can then be 
transported to a high-affinity or low-affinity transport system (26).   
The high-affinity uptake system is composed of Fet3p and Ftr1p and has a high 
binding affinity for Fe
2+
 (Km = 0.2μM) (29).  When ferric iron is available in the 
extracellular environment it is necessary for Fet3p/Ftr1p to acquire ferrous iron from 
Fre1p; however, when ferrous iron is available to cells it can be transported through 
Fet3p/Ftr1p without Fre1p (30).  This high affinity system is active under low iron 
concentrations (i.e., <1uM) (31) while high iron conditions lead to degradation of the 
complex (32).  The first step of high-affinity iron transport involves the oxidation of Fe
2+
 
to Fe
3+
 by Fet3p, a multi-copper oxidase (26, 28, 33).  Ftr1 is a ferric permease (33, 34).  
The Fet3/Ftr1 complex forms in the Golgi before the proteins are trafficked to the plama 
membrane (20, 28, 34).  If one of these proteins is deleted the other will be degraded in 
the vacuoles (35), and if this complex is not formed copper will not be inserted into 
Fet3p (20, 28, 34, 35).  The mechanism of iron transfer between these proteins remains 
to be elucidated.  
The low-affinity pathway (Smf1p, Smf2p, and Fet4p) directly transports Fe
2+
 
from Fre1p into the cytosol (36-38).  Saccharomyces cerevisiae expresses three Smf 
proteins- Smf1p, Smf2p, and Smf3p (38-40). Smf1p and Smf2p increase cellular iron 
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levels when they are over-expressed, but Smf3p does not (39).  Smf1p and Smf2p are 
located on the plasma membrane, and they also transport the divalent metals including 
Mn
2+
, Zn
2+
, Co
2+
 and Cu
2+
 (38, 39).  Smf3p is localized to the vacuoles and will be 
discussed later in this chapter.  While Smf1p and Smf2p increase intracellular iron 
levels, they are regulated on a protein level by Mn
2+
 (41-43).  Under high Mn
2+
 
conditions Smf1p and Smf2p are degraded in the vacuoles, and when Mn
2+
 levels are 
low these proteins localize to the plasma membrane (43).  It is unclear how Mn
2+
 levels 
control this protein localization (43). 
Fet4p is also part of the low-affinity Fe
2+
 transport system and it can also 
transport other metals including Zn
2+
, Cu
2+
, Mn
2+
, and Cd
2+
 (36).  This protein is 
regulated by Rox1p and Aft1p, although the two regulatory mechanisms are independent 
of one another (37).  Rox1p is an oxygen-sensitive transcription factor (44). In aerobic 
conditions, Rox1p binds to the promoter region of FET4 and represses gene expression 
(37). This oxygen-responsive regulation mechanism allows cells to acquire Fe under 
anaerobic growth conditions (45). This is advantageous to the cell because the 
Fet3p/Ftr1p pathway requires oxygen for activity (Fet3p is a multi-copper oxidase) (20). 
The second regulatory system for Fet4 expression involves Aft1p.  Aft1p is a 
low-iron sensing transcription factor which induces the expression of a number of genes 
related to iron import and trafficking (46).  More details of this regulatory system are 
discussed later in this chapter.  An additional, poorly characterized iron regulation 
system is also responsible for controlling Fet4p expression, in that the expression of this 
protein is lower than WT levels in iron-replete conditions in ∆aft1∆aft2 cells (44). There 
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are many other iron-related proteins whose iron regulating mechanisms are not fully 
understood, so it is possible that another pathway is responsible for regulating an iron-
induced response. 
 
Intracellular Iron Trafficking 
Once iron has been transported into the cell, it will accumulate in a “labile iron 
pool” (LIP), which is hypothesized to provide iron to the mitochondria and other 
organelles (47).  The exact composition of this iron pool has not yet been determined 
(47-49). The Fe species in this pool have remained elusive in part because the ligands 
coordinating this Fe are loosely bound. The labile nature of this Fe pool implies that the 
Fe species can be easily chelated. In 2001, Petrat, et al. studied the intracellular Fe
2+
 by 
utilizing a fluorescent compound (Phen Green SK) and Fe
2+
 chelators (50). It has been 
hypothesized that cellular iron exists predominantly in the ferrous state because the 
reducing environment of the cytosol favors Fe
2+
 rather than Fe
3+
 (49). Schneider, et al. 
showed in 1988 that in aqueous environments of pH ~7.0, Fe
2+
 is soluble (up to 10
-5
 M) 
while Fe
3+
 is not (over 10
-12 
M) (24). Phen Green SK is fluorescent when it is not bound 
to divalent transition metals, and the fluorescence quenches when these metals are bound 
(50). Intact cells were incubated with Phen Green SK, and then with specific Fe
2+
 
chelators (50). The concentration of the chelatable Fe
2+
 in the cytosol was measured by 
quantifying the change in the fluorescence intensity during incubation with and without 
the Fe
2+
 chelators (50). The concentration of the chelatable cytosolic Fe
2+
 pool was 
estimated as ~5 – 7 μM (50). 
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Other studies have also utilized iron-specific fluorescent chelators to investigate 
the cellular LIP (24, 51). These studies have estimated that the concentration of cytosolic 
iron is in the range of ~10
-7
 to 10
-6 
M (24, 49).  One fundamental problem with this 
approach is that the intracellular iron must be manipulated (i.e., chelated from its 
original ligands) to be quantified. When the samples are manipulated in this manner it is 
possible that the Fe concentrations observed are higher or lower than in untreated cells. 
In order to address this issue, iron levels must be measured using noninvasive, analytical 
techniques. In this dissertation, cellular iron distributions were studied using noninvasive 
techniques including Mössbauer and EPR spectroscopies, and ICP-MS was used to 
determine iron concentrations. Taken together, these methods provide a biophysical and 
bioanalytical approach to study iron without altering the intracellular environment. 
Another important, and yet unidentified, part of iron trafficking in the cytosol 
pertains to the molecule(s) responsible for transporting iron within the cell.  It has been 
hypothesized that common cellular components such as ATP/ADP (52), inositol 
phosphates (53), and 2,5-dihydroxybenzoic acid (DHBA) (54) are responsible for this.  
However, these molecules predominantly bind Fe
3+ 
rather than Fe
2+
, which is not 
consistent with the view that most cytosolic iron is ferrous (24).  Alternatively, thiol-
containing molecules such as glutathione and cysteine may be responsible for cytosolic 
iron trafficking (55).  It is highly probable that the iron in the cytosol is reduced by 
glutathione (24). This molecule is responsible for maintaining the reducing cytosolic 
environment (-320mV) and is present at high concentrations (55).  The structures of 
these potential ligands are shown in Figure 1.1.   
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Identifying the cytosolic iron trafficking ligands is challenging because 1) 
“clean” cytosol is difficult to isolate, 2) the iron is most likely loosely bound, and 3) 
there could be more than one iron trafficking molecule.  First, cytosolic fractions are 
generally obtained by lysing cells in a harsh manner, such as glass beads or sonication.  
These processes will also damage iron-containing organelles such as mitochondria and 
vacuoles.  Therefore, the iron in the “cytosolic” fractions could also have come from 
broken organelles.  Secondly, because this pool is labile it can be assumed that many 
cellular components (i.e., polyphosphates in vacuoles and mitochondria) could readily 
bind this iron when organelles are broken.  Finally, there is the possibility that more than 
one trafficking molecule is utilized in this system.  Perhaps many compounds transfer 
iron between cellular compartments.  This uncertainty in the chelation environment of 
cytosolic iron has led to the utilization of more iron-specific sensing techniques and non-
invasive approaches to studying iron in cell biology, such as Mössbauer, EPR, and UV-
Visible spectroscopies (56). 
 
Yeast Mitochondrial Iron Trafficking 
Once iron has entered the cell it has different “fates”, including transport to the 
mitochondria and vacuoles.  The mitochondria are the major hubs of iron metabolism in 
cells because they house the components used for Fe/S cluster assembly, heme 
biosynthesis, and components designed to install such iron centers into apoproteins. 
Mitochondria are composed of an outer mitochondrial membrane (OMM) and an inner 
mitochondrial membrane (IMM) (57). The space between these two membranes is called 
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the inner-membrane space (IMS) (57). The area within the IMM is known as the 
mitochondrial matrix (57). 
In yeast, mitochondrial iron is brought in through Mrs3, Mrs4, and Rim2 proteins 
(58-63). These proteins span the IMM and are specific for iron (60, 61). Mrs3p and 
Mrs4p are homologous to mitoferrin transporters in human cells, and are responsible for 
transporting iron into the mitochondrial matrix where it can be utilized for Fe-S cluster 
and heme biosynthesis (61, 64). Fre5p, a mitochondrial ferric reductase, could be 
involved in reducing iron prior to import by Mrs3/4 because the IMS of the 
mitochondria is an oxidizing environment.  However, the precise role of Fre5p is 
unknown (65).   
The iron transport role of Mrs3/4p was identified using a triple-deletion strain 
∆mrs3∆mrs4∆yfh1 (60). The YFH1 deletion alone resulted in mitochondrial iron 
overload while the additional deletion of MRS3 and MRS4 suppressed this phenotype 
(60).  This indicates that lower levels of iron are imported into the mitochondria in the 
absence of Mrs3p and Mrs4p. Over-expression of MRS4 showed an increase in heme 
biosynthesis and in overall mitochondrial iron levels, which indicates that this protein is 
involved in mitochondrial Fe import. The deletion of MRS3 and MRS4 resulted in a 
decrease in mitochondrial iron, as well as an increased sensitivity to high medium iron 
(58). These results suggest that without Mrs3p and Mrs4p Fe can accumulate to toxic 
levels which are likely localized to the cytosol. The iron-regulon is induced when Mrs3p 
and Mrs4p are over-expressed, which indicates that the cytosol becomes iron deficient in  
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Figure 1.1. Possible ligands for cytosolic iron. A) ATP, B) Myo-Inositol 1,2,3-
triphosphate, C) 2,5-Dihydroxybenzoic acid (2,5-DHBA), and D) glutathione (GSH). 
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these conditions (58). These data support a model in which the mitochondria accumulate 
Fe from the cytosol via Mrs3p and Mrs4p. It is clear from these studies that Mrs3p and 
Mrs4p are necessary for mitochondrial iron import and cellular iron homeostasis, but 
they are not the only pathway for mitochondrial iron import.   
Rim2p was recently identified in 2011 as another mitochondrial iron import 
protein (62).  This protein has two separate functions, and was first identified as a 
pyrimidine nucleotide exchanger in the mitochondria (66).  Its role in iron metabolism 
was discovered when it was found to be up-regulated in ∆mrs3∆mrs4 cells (62).  Other 
experiments show that expression of RIM2 in ∆mrs3∆mrs4∆ccc1 cells can alleviate iron 
toxicity caused by iron overload in the cytosol (67).  Interestingly, when Rim2p is 
deleted and Mrs3/Mrs4 proteins are intact, iron is not utilized as efficiently as in wild-
type cells (62).  This suggests that there may be an additional role of Rim2p in iron 
homeostasis or utilization in the mitochondria, but this role has yet to be identified.   
 
The Labile Iron Pool in Mitochondria 
When iron is brought into the mitochondria, but before it is incorporated into iron 
centers, it may to accumulate in a mitochondrial labile iron pool (MLIP).  The first 
evidence for the existence of this pool was shown in 1980, when isolated mitochondria 
were incubated with bathophenanthroline sulfonate (BPS) and ~25% of the total iron in 
the mitochondria was available to be chelated, and was therefore hypothesized to be 
labile (68).  The MLIP was also studied in later experiments utilizing an iron-specific 
fluorescent chelator which would quench upon iron binding (69).  The concentration of 
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iron in these studies (~15μM) was found to be much lower than the values reported in 
the previous BPS experiments (>100μM).  As previously mentioned, studying LIPs 
using indirect methods such that the iron must be chelated from its original ligands is not 
an ideal approach.  In 2010, Holmes-Hampton, et al. demonstrated that isolated 
mitochondria contain a pool of non-heme, high spin (NHHS) Fe
2+
 of ~30 μM (31, 70).  
This iron can be chelated when the mitochondria are disrupted but not when the 
mitochondria are intact, indicating that this NHHS Fe
2+
 is indeed inside the mitochondria 
(70).   
 
Nanoparticle Accumulation in Mitochondria 
 Another form of iron in the mitochondria accumulates under conditions which 
model human disease states (i.e., Freidrich’s Ataxia).  In various strains of yeast (Δyfh1, 
Atm1p-deplete, Yah1p-deplete, Aft1-1
up
) iron accumulates in the mitochondria as 
superparamagentic ferric nanoparticles (71-74).  These nanoparticles apparently are not 
detected by cells because the cells demonstrate Fe-deficient phenotypes (ie, elevated 
cellular Fe import) even when nanoparticles accumulate in high (mM) concentrations 
(71-73).  The composition of nanoparticles was investigated further using TEM 
elemental analysis and EXAFS (72, 74).  Electron microscopy images of mitochondria 
showed insoluble particles accumulating, and further elemental analysis revealed that 
these particles were composed of iron, phosphorus, and oxygen (72, 74). The particles 
were also found to be devoid of carbon and nitrogen (72, 74).  Additional EXAFS 
studies revealed that these “nanoparticles” are composed of iron bound by oxygen in the  
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Figure 1.2. Potential structure of nanoparticles found in mitochondria and vacuoles 
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are possible (while maintaining overall charge neutrality). 
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first coordination sphere and phosphorus in the second, and that iron is coordinated by 4-
6 ligands (72).   
These studies led to a potential structure for these ferric phosphate nanoparticles, 
shown in Figure 1.2 (72). Interestingly, although these nanoparticles are redox active 
(reduced by dithionite) they do not seem to be sensed by the mitochondria. This was 
demonstrated when nanoparticles were shown to accumulate at high levels but did not 
necessarily affect levels of other iron-containing mitochondrial proteins (72). Similar 
ferric phosphate nanoparticles have been found in vacuoles and are discussed in Chapter 
III. 
 
Mitochondrial Iron-Sulfur Cluster Assembly and Heme Biosynthesis 
 Perhaps the most commonly known Fe-related functions of the mitochondria are 
to assemble iron-containing centers such as iron-sulfur clusters and hemes. Iron-sulfur 
cluster assembly occurs in the mitochondrial matrix (75). This process is complex and 
not fully understood.  The common iron-sulfur cluster centers found in biology are 
shown in Figure 1.3.  The formation of iron-sulfur clusters requires three primary 
components- iron, sulfur, and reducing equivalents (75).  Upon entry through Mrs3/4p 
iron is bound by Yfh1p and transported to a scaffolding complex on which clusters are 
formed (76-79).  This protein is necessary for iron-sulfur cluster assembly, and 
mutations in this protein (Frataxin) in humans can lead to the disease Friedreich’s ataxia 
(80).  Sulfur is donated to this system through Nfs1p and Isd11p (75). Nfs1p is a 
cysteine desulfurase which catalyzes the conversion of cysteine to alanine and a  
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Figure 1.3. Common Iron-Sulfur Clusters in Reduced States.  A) [Fe2S2] cluster, B) 
[Fe3S4] cluster, and C) [Fe4S4] cluster.  These clusters can also exist in oxidized states as 
[Fe2S2]
2+
, [Fe3S4]
1+
, and [Fe4S4]
2+
.  The [Fe2S2] cluster can also have two N-His ligands 
in place of two S-Cys lignads, which is known as a Rieske center (85). 
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persulfide (81-83). Isd11p is necessary for Nfs1p activity and is thought to play a role in 
stabilizing this protein (76, 84). 
Finally, reducing equivalents are provided by an electron transport chain 
composed of NAD(P)H, ferredoxin (Yah1p) (86), and ferredoxin reductase (Arh1p) (75, 
87, 88).  These proteins are necessary for iron-sulfur cluster assembly, which implies 
that a reduction step is essential for cluster formation on Isu1p (59, 86, 87); however, 
Yah1p has not been shown to interact with other proteins in this system (75). These 
components are assembled on a scaffolding protein, Isu1p (89-91).  This scaffolding 
protein is highly conserved, from bacteria to humans, and possesses three cysteine 
residues which are critical for iron-sulfur cluster assembly (75, 91).  Once iron-sulfur 
clusters are assembled they must be transferred and incorporated into apoproteins.  This 
process is facilitated in vivo by a number of proteins including Ssq1p, Jac1p, Mge1p, 
Grx5p, and Atm1p (75).  Ssq1p is a Hsp70 chaperone protein and Jac1p is a co-
chaperone which associates with Ssq1p (92).  Mge1p is a nucleotide exchange factor 
which is required to replace ADP with ATP at Ssq1p (93).  Grx5p is a monothiol 
glutaredoxin which is necessary for iron-sulfur cluster assembly and transfer from Isu1p, 
but its precise role in this pathway has not been identified (75, 94). 
 
Heme Biosynthesis in Mitochondria 
Other important roles of iron trafficking in mitochondria are heme biosynthesis 
and incorporation of such centers apoproteins. Heme synthesis begins with the 
conversion of Succinyl CoA and glycine to δ-aminolevulinic acid (ALA) in the 
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mitochondria (95).  This product is transported to the cytosol where 2 ALA molecules 
are used to form porphobilinogen (95).  Four porphobilinogen molecules are used to 
form protoporphyrin-IX in a pathway that begins in the cytosol and ends in the 
mitochondria (95).  Finally, Fe
2+
 is inserted into protoporphyrin-IX by Hem15p 
(homologous to human ferrochelatase) (96).  The product of this pathway is heme b. 
Heme a and heme c are modified from heme b.  Heme a is formed by heme a synthase 
(97), and heme c is produced from heme b and heme c lyase (98).  The structures of 
these heme groups are shown in Figure 1.4. 
 
Iron Trafficking in Yeast Vacuoles 
Due to the necessity and potential lethality of iron in the cell, iron must be stored 
in a form that cannot facilitate ROS formation but still be available as soon as the cell 
needs.  The vacuoles function as a compartment to store iron and other metals safely to 
avoid ROS damage.  Yeast vacuoles are similar to mammalian lysosomes in that these 
organelles maintain low pH environments (~4.5-5.5) (99).  The acidification of vacuoles 
is vital to maintain its roles in cellular metabolism (99).  The process of acidification 
occurs through the vaculolar H
+
-ATPases, which couple ATP hydrolysis and proton 
transport from the cytosol into the vacuoles (99).  Without these H
+
-ATPases the 
vacuoles are unable to efficiently transport metals, such as Fe
2+
, because metal import is 
coupled to H
+
 export (99-101).  Moreover, phosphate and other stored metabolites can 
be affected by higher vacuolar pHs (45, 102).    
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Figure 1.4. Heme centers found in biological systems. A) Heme a, B) Heme b, C) 
Heme c.  These centers can also have a 3+ oxidation state.   
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Vacuolar Iron Import 
Vacuoles are dynamic organelles that can undergo fusion and fission processes 
(102). Typically these transformations occur in conjunction with import/export processes 
(endo- or exocytosis) and during cellular stress and cell division when the volume of 
vacuoles is highly regulated (102). During log-phase growth, vacuoles occupy ~20-30% 
of the total cell volume, with 2-3 vacuoles per cell (102). Iron is imported from the 
cytosol into vacuoles through two known pathways. The first is via Ccc1p, a 34-kDa 
transmembrane protein which reportedly accounts for ~85% of vacuolar iron import 
(103). The Ccc1 protein is regulated by Yap5p (104). The Yap5 protein is a member of 
the YAP transcription family, and it promotes CCC1 gene transcription under medium 
iron conditions (104). Yap5p is localized to the nucleus and is constitutively bound to 
the CCC1 promoter (104). This protein also contains two cysteine residues which are 
required for promoter activity (104).  
Iron may facilitate the reduction of these cysteine residues to a disulfide and 
change the conformation of Yap5p, which results in the promotion of CCC1 gene 
transcription (104).  When CCC1 is up-regulated, more iron can be moved from the 
cytosol into a vacuolar storage form, thereby reducing the concentration of cytosolic iron 
(103).  Ccc1 protein levels are also controlled by Cth2p and Aft1p (105).   CTH2 is part 
of the iron regulon, and encodes a cytosolic protein which is responsible for 
destabilizing and degrading different mRNA transcripts responsible for reducing 
cytosolic iron levels (105).  Because CTH2 is in the iron regulon it is transcribed during 
iron deficient conditions by Aft1p (105). This process causes the vacuoles to accumulate 
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less iron and therefore increase the concentration of cytosolic iron.  The second pathway 
for iron import in vacuoles is endocytosis, which imports reportedly ~15% of vacuolar 
iron (103). 
 
Phosphate Storage in Vacuoles 
Once inside the vacuoles iron can be stored in a non-toxic form which is most 
likely ligated by polyphosphate (discussed in Chapter III).  The concentration of 
phosphorus in cells is very high (≥ 30 mM) (106).  This excessive amount of phosphorus 
exists in many forms including inorganic phosphate, pyrophosphate, orthophosphate, 
and polyphosphate (107).  Polyphosphate is the primary storage form of phosphate, and 
is localized primarily to vacuoles (107, 108).  Polyphosphate has also been found in 
nuclei and mitochondria (107).  One difference between polyphosphates in vacuoles and 
other organelles is the chain length (107).  In vacuoles, polyphosphate chain lengths are 
approximately 150 residues, while mitochondria polyphosphate chain lengths are 
substantially shorter (≤ 15 residues) (106).   
Vacuolar polyphosphate can be degraded and supplied to the cytosol under 
phosphorus-limiting conditions.  In the vacuoles polyphosphate is utilized to store metals 
and other anions (107). The vacuoles can also accumulate phosphorus-containing 
granules, which have been observed by electron microscopy (109) . These granules are 
precipitated forms of polyphosphate (109). Therefore in vacuoles two forms of 
polyphosphate can exist: a soluble form and an insoluble form.  The ratios of these two 
forms may depend on culture conditions and the physiological state of the cell. Evidence 
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is presented in Chapter III that both of these forms of polyphosphate bind iron in 
vacuoles.  Models for changes in these storage forms are proposed in Chapters III and 
IV. 
 
Export of Iron from Vacuoles 
The vacuoles also have mechanisms which can transport iron from the vacuolar 
lumen to the cytosol (110, 111).  These pathways are activated when the cytosol is 
deficient in iron (110, 111).  The proteins responsible for this iron export are 
homologous to Fre1p, Fre2p, Fet3p, Ftr1p, Smf1p, and Smf2p on the plasma membrane 
(110).  The pathways are similar because the oxidation state of iron in the extracellular 
environment and the vacuolar lumen is 3+ (12, 112).  Therefore, the iron must be 
reduced before it can be transported into the cytosol (12).  The vacuolar proteins in this 
pathway consist of a ferric reductase Fre6p (113, 114), and a high-affinity and low-
affinity transport pathway.   
Fre6p is homologous to the Fre1 protein on the plasma membrane, which reduces 
vacuolar iron to Fe
2+
 before it enters the cytosol (113, 114).  The high-affinity export 
pathway in vacuoles is composed of a multi-copper oxidase Fet5p and ferric permease 
Fth1p, which is homologous to the Fet3p/Ftr1p complex on the plasma membrane (110, 
115, 116).  These proteins must be complexed before they are trafficked to the vacuolar 
membrane, and expression of both is required for the system to operate (110).  Like 
those of Fth1/2p, Fet3p, and Ftr1p, the expression levels of vacuolar iron proteins are 
also regulated by Aft1p (117-120).   
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The low-affinity transport system is composed of Smf3p, an Nramp-family, 
divalent metal transporter (43, 111, 121).  This protein is homologous to Smf1p on the 
plasma membrane and is regulated by Rox1p (121), Aft1p, and Aft2p (43, 111).  Smf3p 
is expressed in Fe-depleted, anaerobic conditions (122). The anaerobic expression of this 
protein is probably due to the oxygen-dependent mechanism of iron export from 
vacuoles via Fet5p/Fth1p (44, 122). Fet5p activity requires oxygen, so Smf3p becomes 
the primary iron export pathway when oxygen is unavailable (43). 
Also like Fet4p, Smf3p is regulated by Aft1p and Aft2p, as well as another 
unidentified iron-regulation system (111).  The SMF3 gene contains two Aft-like 
binding sites (65, 111).  However, even when these regions are deleted Smf3 transcript 
levels are still regulated in response to iron availability (43).  Smf3 protein levels also 
change in response to iron levels in ∆aft1∆aft2 strains (43).  These data suggest that 
another iron-regulation pathway exists, but it has not been identified.  The various types 
of regulation of the vacuolar import and export proteins are essential for controlling 
cellular iron levels and for understanding iron trafficking. 
 
Iron Regulation in Saccharomyces cerevisiae Cells 
Although the vacuoles provide a safe environment for iron storage, cells have 
developed mechanisms which tightly regulate iron levels in the cytosol.  The primary 
iron regulation pathway in Saccharomyces cerevisiae is through the low-iron sensing 
transcription factor Aft1p.  Under conditions where cytosolic iron is depleted, Aft1p is 
found in the nucleus where it binds to DNA and induces the transcription of ~20 genes, 
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collectively known as the “iron regulon”.  The genes discussed in this dissertation are 
shown in Table 1.1.  
Under high-iron conditions Aft1p is localized to the cytosol. Several components 
of the Fe/S cluster biosynthetic pathway in mitochondria are important for cytosolic 
localization of Aft1p.  In cells lacking Yfh1 or Grx5, both of which are essential for 
mitochondrial Fe/S cluster assembly, Aft1p is not activated (45, 123, 124).  When cells 
lack cytosolic Fe/S cluster assembly machinery Aft1p is activated (45, 125).  This 
demonstrates the involvement of mitochondrial Fe/S cluster assembly in the iron-sensing 
mechanism of Aft1p.  But how does Aft1p sense iron? When Aft1p is inactive it forms a 
homodimer which contains a Fe2S2 cluster (126). Under high intracellular Fe conditions, 
Fe2S2 clusters could bind to Aft1p and facilitate inactivation.  
 How does Aft1p acquire the Fe2S2 cluster?  Aft1p interacts with glutaredoxin 
proteins (Grx3p and Grx4p), Fra1p, and Fra2p proteins in the cytosol (45). Grx3/4p, 
Fra1/2p, and glutathione also form a complex in the cytosol, which contains a bridging 
Fe2S2 cluster. A model of these protein interactions shows that the Fe2S2 cluster 
transfer to Aft1p is facilitated by the Grx/Fra proteins. The precise mechanism of this 
transfer has not been established (102, 127-130) . 
  
Integrated Biophysical Approach 
To better understand how iron assembly and utilization occurs we must study the 
basic mechanisms of iron trafficking to different organelles.  Saccharomyces cerevisiae 
is an excellent model system for these studies because it grows well in large suspension 
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Gene Gene Product 
Localization 
Function Regulation 
ARN1 Cell Wall Siderophore Transporter Aft1p 
ARN2 Cell Wall Siderophore Transporter Aft1p 
ARN3/SIT1 Cell Wall Siderophore Transporter Aft1p 
ARN4 Cell Wall Siderophore Transporter Aft1p 
FRE1 Plasma Membrane Ferric Reductase Aft1p 
FRE2 Plasma Membrane Ferric Reductase Aft1p 
FET3 Plasma Membrane Multicopper Oxidase Aft1p 
FET4 Plasma Membrane Divalent Metal Transporter Aft1p, Aft2p,  
Rox1p, Other 
FTR1 Plasma Membrane Ferric Permease Aft1p 
SMF1 Plasma Membrane Divalent Metal Transporter --- 
SMF2 Plasma Membrane Divalent Metal Transporter --- 
MRS3 Inner Mitochondrial 
Membrane 
Iron Transporter (Fe
2+
) Aft1p 
MRS4 Inner Mitochondrial 
Membrane 
Iron Transporter (Fe
2+
) Aft1p, Aft2p 
FRE5 Inner Mitochondrial 
Membrane 
Ferric Reductase Aft1p 
RIM2 Inner Mitochondrial 
Membrane 
Iron Transporter (Fe
2+
) --- 
CCC1 Vacuolar Membrane Iron Transporter (Fe
2+
) Yap5p 
FRE6 Vacuolar Membrane Ferric Reductase Aft1p 
FET5 Vacuolar Membrane Multicopper Oxidase Aft1p 
FTH1 Vacuolar Membrane Ferric Permease Aft1p 
SMF3 Vacuolar Membrane Divalent Metal Transporter Aft1p, Aft2p,  
Rox1p, Other 
CTH2 Cytosol mRNA Destabilization Aft1p 
 
 
 
Table 1.1. Gene products involved in iron trafficking, discussed in this dissertation.  
Gene product location, function, and gene regulation are also summarized in this table.  
This information was collected from (30, 131, 132). 
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cultures, possesses homologous proteins to human cells and effectively incorporates 
57
Fe 
into the cells. Mössbauer spectroscopy is the most powerful technique for studying iron, 
because all the 
57
Fe in a sample is detected.  Mossbauer can also distinguish spin states 
and oxidation states of iron nuclei.  Simulations of this data are performed to give 
relative percentages of each iron species.  
EPR spectroscopy was also utilized because it will detect various the 
paramagnetic species in sample.  Each EPR signal can be quantified to give an absolute 
concentration value.  This, taken with Mossbauer data, allows a more accurate 
quantification of the iron species in a sample.  Finally, ICP-MS is used to accurately 
determine the concentration of iron in a sample.  Using the concentrations found with 
ICP-MS, absolute concentrations of each iron species in a sample can be obtained.  This 
is unique for a cell biology system, because concentrations are generally reported in 
ratios (ug Fe/mg protein).   
Past studies of iron which have focused on distributions have not been able to 
distinguish oxidation states and spin states of iron.  This information is valuable for 
determining what iron is in a given part of the cell.  These techniques will be discussed 
further in Chapter II. 
The majority of this dissertation is focused on iron trafficking in yeast, and 
specifically between the vacuoles and cytosol.  Chapter III discusses the development of 
a protocol for isolating large quantities of vacuoles and analyzing the iron content by 
Mössbauer spectroscopy, EPR spectroscopy, and ICP-MS.  In Chapter IV we studied 
two strains of yeast which alter vacuolar Fe import (ΔCCC1 and CCC1-up). The Fe 
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distributions in these strains were characterized using the aforementioned techniques. 
WT cells treated with concanamycin A, a vacuolar H
+
-ATPase inhbitior, were also 
investigated. We determined that two key factors are involved in controlling Fe 
distributions in vacuoles- redox state and pH. These results led to the development of a 
model which describes the dynamics of vacuolar Fe distributions. Although the iron 
trafficking mechanisms in yeast are extremely complex, the changes in various iron 
levels are becoming clearer with the use of biophysical approaches for solving cell 
biology questions.  
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CHAPTER II 
MATERIALS AND METHODS 
Biophysical Methods Used 
 In these studies biophysical techniques were employed to approach cell biology 
questions. These techniques are typically used to study iron compounds, and are often 
applied to biological systems; however, these techniques are more commonly used for 
studying isolated proteins rather than entire cell systems. The primary technique used in 
these studies was Mössbauer spectroscopy, which is specific for 
57
Fe. Paramagnetic 
species in these samples were analyzed via EPR spectroscopy, and metal concentrations 
were determined using ICP-MS. Heme centers in whole cell samples were also analyzed 
with electron absorption spectroscopy. To investigate metal-containing LMM species an 
anaerobic in-line SEC-ICP-MS system was used. 
 
Mössbauer Spectroscopy 
 Mössbauer spectroscopy is the most powerful tool for studying iron containing 
species. With this technique it is possible to visualize ALL of the 
57
Fe in a sample, 
meaning no 
57
Fe nucleus is invisible when using Mössbauer (133). This technique is 
somewhat similar to NMR spectroscopy, and can be thought of as “nuclear gamma-ray 
resonance spectroscopy”. As with NMR, Mössbauer involves nuclear transitions. One 
difference between these techniques is that the energy required for Mössbauer (gamma 
radiation) is much greater than the energy used in NMR experiments (radio frequency). 
Mössbauer can be used with other elements, but the majority of Mössbauer experiments 
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are used to study iron. Gamma radiation is supplied to the samples with a 
57
Co source; 
however, few iron centers absorb at this energy (14.4 keV) (133). Therefore, to collect 
meaningful and interpretable data the energy seen by the sample is modulated by the 
Doppler Effect (133). The emitting source is mounted on a driver which moves the 
source towards and away from the sample at a given velocity (133). This allows the 
sample to be exposed to a range of energies, which induces transitions in different 
57
Fe 
nuclei.  The resulting data is plotted as percent effect (y-axis) vs. velocity in mm/s (x-
axis).   
 The nuclear transitions in Mössbauer occur between a ground state (for 
57
Fe, I = 
1/2) and the first excited state (I = 3/2). Based on the selection rules for Mössbauer, there 
are 6 allowed transitions (133). In some conditions some of these transitions are 
degenerate, and the degeneracy is based on the environment around the 
57
Fe nucleus 
(133). For example, a NHHS Fe
2+
 species at low temperature and low field will give rise 
to a doublet, where only two transitions are observed. A NHHS Fe
3+
 species will 
produce a paramagnetically split spectrum, where all 6 allowed transitions are observed 
(Figure 2.1).  
 Mössbauer data is analyzed using two main parameters- the isomer shift (δ) and 
quadrupole splitting (∆EQ). The isomer shift is reported with respect to a given 
reference, for 
57
Fe Mossbauer spectroscopy the δ reported with respected to an iron foil 
where it is fixed at zero. The δ is dependent on the s-electron density in the nucleus. This 
parameter provides information about the oxidation state of an iron center. The ∆EQ is  
 
 28 
 
 
 
 
 
 
 
 
 
Figure 2.1. Allowed 
57
Fe nuclear transitions in Mössbauer spectroscopy.   
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dependent on asymmetry of the electronic field around an iron nucleus. The EFG is 
affected by the chemical environment of the nucleus. Therefore, different ΔEQ values are 
observed depending on the coordination environment of a given 
57
Fe nucleus. A list of 
ΔEQ values which describe biologically relevant Fe centers is shown in Table 2.1.  
 Because Mössbauer is 
57
Fe-specific, the contributions of each Fe species in a 
sample can be directly quantified. Each Fe species is simulated using the WMoss 
program (See Co, Inc.), and the percent of the spectrum due to each of feature represents 
the absolute percent of Fe in the sample. When Mössbauer is used in combination with 
analytical techniques such as ICP-MS, we can determine the absolute concentration of 
each Fe species in the sample. This is highly advantageous for our studies because whole 
cells and organelles contain a variety of different Fe nuclei. This combination of 
techniques allows us to quantify the Fe centers in an analytical fashion, without 
disrupting the intracellular dynamics through external manipulations. 
 
EPR Spectroscopy 
EPR spectroscopy is used for studying paramagnetic species, and detects 
electronic transitions rather than nuclear transitions. This technique is advantageous for 
studying many metal species in cells and is not specific for iron. In EPR spectroscopy, 
half-integer spin systems can be detected. Common Fe-containing proteins which can be 
identified by EPR include cytochrome c oxidase, succinate dehydrogenase, and others. 
FeS clusters can be detected as long as the overall spin system is paramagnetic. A list of 
EPR-active centers found in biological systems is shown in Table 2.1. Because EPR is  
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Table 2.1. Mössbauer and EPR parameters for common biological Fe centers. The 
specified parameters were collected from (133). 
 
  
Fe Center 
Oxidation 
State 
Spin 
State 
δ (mm/sec) ΔEQ (mm/sec) g-value 
Mononuclear HS Fe
2+
 S = 2 1.0 – 1.4 2.8 – 3.7 ≥ 13 
Mononuclear HS Fe
3+
 S = 5/2 0.4 – 0.6 0.6 – 0.8 4.3 
Heme LS Fe
2+
 S = 0 0.4 – 0.6 1.0 – 1.1 N/A 
Heme HS Fe
2+
 S = 2 0.7 – 1.0 2.1 – 2.5 ≥ 13 
Heme LS Fe
3+
 S = 1/2 0.2 – 0.3 ~ 2.0 3 – 3.5 
Heme HS Fe
3+
 S = 5/2 ~ 0.4 ~ 0.8 ~ 6.0 
[Fe2S2] 1
+
 S = 1/2 
0.4 – 0.6 
0.2 – 0.4 
2.5 – 3.2 
0.4 – 1.0 
1.96 – 1.91 
[Fe2S2] 2
+
 S = 0 0.2 – 0.4 0.4 – 0.6 N/A 
[Fe3S4] 0 S = 2 
0.46 
0.49 
0.31 
1.15 
1.46 
0.56 
≥ 13 
[Fe3S4] 1
+
 S = 1/2 0.30 0.66 1.94 
[Fe4S4] 1
+
 S = 1/2 0.53 
0.80 
1.18 
1.94 
[Fe4S4] 2
+
 S = 0 0.4 – 0.5 0.8 – 1.2 N/A 
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not specific for Fe, other metals having half-integer spins can also be detected, such as 
copper and manganese. EPR is especially useful for our samples due to its low detection 
limits (μM). This technique is complementary to Mössbauer spectroscopy because low 
concentrations of NHHS Fe
3+
 can be more accurately quantified.  
The origin of an EPR signal is based on the magnetic moment and spin quantum 
number of an electron (133). The spin quantum number s has magnetic components ms = 
+ ½ and ms = - ½. When an external magnetic field is present, the electron’s magnetic 
moment will align parallel (ms = - ½) or antiparallel (ms = + ½) to the field (133). Each 
alignment has a specific energy, and the two spin states have the same energy in the 
absence of an applied magnetic field. The energy difference between the two spin states 
increases linearly with increasing magnetic field strength (133). In other words, without 
the presence of an external magnetic field no transitions will occur, and as the strength 
of the magnetic field increases so does the energy difference between the electronic spin 
states. 
One factor used to characterize paramagnetic species by EPR is the g-value. This 
is a proportionality factor which relates the intrinsic magnetic moment of an electron and 
the magnetic moment arising from the electron orbiting the nucleus (133). The g-value 
for a free electron is 2.00232. This value will change depending on the environment of 
the electron (133). Some g-values describing paramagnetic species observed in the 
biological samples are listed in Table 2.1. EPR spectra are collected by holding the 
frequency of radiation constant (i.e., 9.5 GHz for these studies) and varying the magnetic 
field (0-5000 Gauss) (133). When the energy difference between the electronic spin 
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states is equal to the radiation, absorption occurs. EPR spectra are plotted as a first 
derivative of the electron absorption (133). The point at which the signal passes through 
0 represents the point of maximum absorption (133). By investigating the different 
paramagnetic species in a sample we can establish a more complete understanding of the 
Fe-containing species in cells and organelles.  
 
Electron Absorption Spectroscopy 
Electron absorption spectroscopy is commonly used to detect hemes and iron-
sulfur clusters. Reduced heme centers feature 3 distinct Soret bands (α, , and ). The α 
bands of heme a, b, and c are observed at ~605, ~565, and ~550 nm, respectively. These 
bands are not present when cytochromes are oxidized. FeS clusters, including Fe4S4 and 
Fe2S2, also show features at ~410 and ~430 nm, respectively. These features arise from 
oxidized clusters, but the intensity of the peaks diminishes when the clusters become 
reduced.  
The extinction coefficients of heme a, b, and c are well established and can be 
used to determine the concentration of each heme component in a sample (134). This is 
advantageous for our studies because Mössbauer spectroscopy cannot distinguish 
between LS hemes and Fe4S4 clusters. Moreover, the concentrations of these hemes in 
whole cell samples are quite low (< 100 μM). Therefore, UV-Vis is a good 
complementary technique to Mössbauer and EPR spectroscopy which can provide 
additional information about absolute concentrations of Fe centers in a sample. This 
analysis also provides information about levels of mitochondria in the cells. 
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Inductively-Coupled Plasma Mass Spectrometry  
ICP-MS is an analytical technique used to determine precise concentrations of 
metals in a sample, including Fe. This technique ionizes a sample with inductively 
coupled plasma and uses a mass spectrometry to separate and quantify ions. This method 
has detection limits as low as one part per trillion (10
12
). This is advantageous for 
biological samples which have low concentrations of Fe or other metals. The detection 
of ICP-MS is based on mass, which means this technique can distinguish different 
isotopes of a given metal. This allows us to measure the concentrations of 
56
Fe and 
57
Fe.  
It is important to know the concentrations of each of these isotopes because only 
57
Fe is detected with Mössbauer. For these studies, samples must be enriched with 
57
Fe 
because it is only 2% naturally abundant. By utilizing ICP-MS, we can determine the 
percent enrichment of 
57
Fe in Mössbauer samples. Moreover, as discussed previously, 
simulations of Mössbauer spectra give relative percentages of different 
57
Fe-containing 
species in a sample. By determining the overall concentration of 
57
Fe in a sample by 
ICP-MS and correlating this with Mössbauer data, we can determine the concentrations 
of different 
57
Fe-containing species in a sample. Additionally, ICP-MS can be interfaced 
with a separations system (i.e., size exclusion chromatography) to separate metal-
containing components in a sample. The ICP-MS experiments were conducted using an 
Agilent ICP-MS (7700x).  
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Biophysical Studies  
MB, EPR, and UV-Vis spectra were collected and analyzed as described (135). 
MB spectra were collected using a MS4 WRC spectrometer (SEE Co., Edina MN). The 
instrument was calibrated using a spectrum of α-Fe foil collected at room temperature. 
Spectra were analyzed and simulations were generated using WMOSS software. EPR 
spectra were collected on an X-band EMX spectrometer (Bruker Biospin corp., Billerica, 
MA) equipped with an Oxford Instruments ER910A cryostat. Signals were integrated 
using a custom Matlab (Mathworks.com) program. Spin concentrations of the observed 
signals were calculated as described using 1.00 mM CuSO4-EDTA as a standard (136). 
 Signals were simulated using SpinCount (http://www.chem.cmu.edu/groups/ 
hendrich/facilities/index.html). UV-Vis spectra of whole cells were collected on a 
Hitachi U3310 spectrometer with a Head-on photomultiplier tube, and then simulated 
using OriginPro as described (137). Packed cell samples were diluted 3-fold with ddH2O 
and analyzed in a 10 mm path length quartz UV-vis cuvette (Precision cells). After 
collecting MB, isolated mitochondria were thawed anaerobically in a glovebox (≤ 5 ppm 
O2, MBraun, Labmaster), diluted 3-fold with SH buffer (0.6 M Sorbitol, 0.02 M HEPES, 
Fisher Scientific, pH 7.4), and transferred to a 2mm path length quartz UV-vis cuvette 
(Precision cells). The cuvette was sealed with a rubber septum and brought out of the 
glovebox. The samples were immediately analyzed by UV-vis.  
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Yeast Strains and Growth Conditions 
Cells were grown and prepared as described (138). WT (W303-1B and DY150) 
and ∆CCC1 strains were stored in YPAD medium containing 15% glycerol at -80 C. 
CCC1-up cells were stored using MM-Leu medium. Frozen cells were removed with a 
wooden stick and streaked on to YPAD plates (CCC1-up cells were maintained on MM-
Leu plates). Saccharomyces cerevisiae strains W303 (MATα, ura3-1, ade2-1, trp1-1, 
his3-11,15, leu2-3,112; ATCC) were used for the studies described in Chapter III, and 
DY150 (MATa, ura3-1, ade2-1, trp1-1, his3-11,15, leu2-3,112; ATCC) were used for 
the studies described in Chapter IV. 
∆CCC1 and CCC1-up S. cerevisiae cells were a generous gift of Dr. Jerry Kaplan 
(University of Utah). Both strains were derived from DY150 (isogenic to W303) as 
described (139). The CCC1 gene was over-expressed using a LEU2-marked multicopy 
plasmid that contained CCC1 under its native promoter (140, 141). For this reason, 
leucine was omitted from the medium used to grow CCC1-up cells (called MM-leu). 
WT and ∆CCC1 cells were grown in minimal medium supplemented with 10 μM copper 
sulfate; the resulting medium will be abbreviated MM. Fermenting MM contained 2% 
w/v glucose (Fisher Scientific), 0.5% w/v ammonium sulfate (Fisher Scientific), 1.7 g/L 
YNB without ammonium sulfate, ferric citrate, or copper sulfate (MP Biomedicals, LLC 
#4027-112), 100 mg/L L-leucine (MP Biomedicals, LLC #0219469480), 50 mg/L 
adenine hemisulfate dehydrate (MP Biomedicals, LLC #0219460790), 20 mg/L L-
histidine (MP Biomedicals, LLC #0210195480), and 20 mg/L L 
57
Ferric citrate (FC). 
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The 
57
Fe citrate (40 mM, pH ~5) solution was prepared as described (138). This stock 
was added to MM to final concentrations of 1, 10, 20, and 40 μM.  
Ccc1p overexpression in the CCC1-up strain was verified by performing Western 
blots on vacuoles isolated from WT and CCC1-up cells (see figure on p. 86). Vacuoles 
were isolated as described,(112) and 60 μg of protein was used per lane. The Ccc1p 
antibody, also provided by Dr. Jerry Kaplan, was generated as described (141).  The 
absence of the CCC1 gene in the ∆CCC1 strain was verified by PCR, using primers 5' 
TTTCGGTCTGGACCAATCGC 3' and 5' GCGACCAAATGACGAATTAG 3'. The 
PCR reaction was performed at two different annealing temperatures (54C and 58C). 
WT and ∆CCC1 strains produced PCR products of 1.5 kb and 2.5 kb, respectively (see 
figure on p. 86).  
 
Preparation of Whole Cell Samples 
Cells were grown and prepared as described (138). All strains were stored at -80 
C in YAPD medium containing 15% glycerol. Frozen cells were removed with a 
wooden stick and streaked on to YPAD plates (CCC1-up cells were maintained on 
YPAD-Leu plates). Single colonies were inoculated into 50 mL of MM cultures and 
grown for 24 hr at 30 C with shaking. These cells were used to inoculate 1 L of MM 
cultures which were grown to an OD600 = 1.0 (± 0.1) and harvested. Cells were pelleted 
(4,000×g, 10 min, Sorvall Evolution RC centrifuge, SLC-6000 rotor), washed 1× with 1 
mM EGTA, 3× with ddH2O, and then packed into MB cups or EPR tubes, or 
resuspended in ddH2O for UV-vis analysis. Samples were frozen in LN2 and stored for 
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subsequent analysis. Whole cell samples were prepared aerobically. Mitochondria and 
vacuoles were isolated anaerobically and prepared for spectroscopic analysis as 
described (135). 
 
Isolation of Vacuoles 
1L cell cultures (inoculated from 50ml cultures) were grown to an OD600 ~ 1, 
then inoculated into 25L cultures. The 25 L cultures were grown to an OD600 of 0.6-0.8 
and harvested (6 L at a time) by centrifugation at 4000xg for 5 minutes (Sorvall 
Evolution RC centrifuge, SLC-6000 rotor). The cell pellet was transferred to a 
refrigerated argon-atmosphere glovebox (MBraun Labmaster, 6 C, ~ 2 ppm O2) where 
vacuoles were isolated essentially as described (142), except that cells were treated with 
~1000 U lyticase/g of wet cell paste for 50-90 min at 30 C (Sigma-Aldrich).  
In some batches, TCEP-HCl (Tris(2-carboxyethyl)phosphine, Thermo Scientific, 
#20491; 5 mM final concentration) was used instead of dithiothreitol (DTT, 10 mM 
final). Cells were disrupted using 100 µg/ml of diethylaminoethyl dextran (DEAE-
Dextran, Sigma-Aldrich) in 15% Ficoll (Fisher Bioreagents) buffer (143).  The resulting 
cell lysate was subjected to density gradient centrifugation (Beckman Coulter Optima L-
90K ultracentrifuge, Sw-32 Ti rotor; 110,000 x g, 90 min).  The first gradient consisted 
of cell lysate in 15% Ficoll buffer overlayed with 8% Ficoll buffer and with PS buffer 
layered on top.  The material collected from the PS - 8% interface was diluted with 15% 
Ficoll buffer and overlayed with 4% Ficoll buffer and with PS buffer layered on top.  
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Purified vacuoles were collected at the PS - 4% interface. Vacuoles were washed in PS 
buffer and centrifuged at 38,000g for 20 min.   
Pelleted organelles were resuspended in PS buffer and packed into Delrin 
Mössbauer cups (12 mm OD  10 mm) and Suprasil Quartz EPR tubes (Wilmad 
Labglass; 4 mm OD; 89 mm long) were packed by centrifugation at 10,900g for 45 
min. Cups and tubes were frozen and stored in liquid N2 for subsequent analysis. 
Mössbauer and EPR spectra were obtained as described (135).  EPR signals were 
integrated using a program written in Matlab (Mathworks.com) and spin concentrations 
were calculated as described previously (136). UV-Vis spectra of vacuole suspensions in 
a 2 mm pathlength quartz cuvette were collected using a Hitachi Model U3310 
spectrophotometer with a Head-On photomultiplier tube. 
 
Western Blot Analysis and Electron Microscopy 
Protein concentrations were determined using the BCA method (144). Western 
blots used 60 g of vacuolar or cell extract protein per lane, and mitochondrial porin 
(Invitrogen), vacuolar carboxypeptidase Y (CPY) (AbCam), cytosolic 3-
phosphoglycerate kinase (PGK) (Invitrogen), and endoplasmic reticular Kar2 (Santa 
Cruz Biotechnology) proteins were detected. Goat anti-mouse HRP-conjugated 
secondary antibodies (Invitrogen) were used with Porin and PGK, while goat anti-rabbit 
HRP-conjugated secondary antibodies (Santa Cruz Biotechnology) were used with CPY 
and Kar2.  Enhanced chemiluminescent western blotting substrate (Thermo Scientific) 
was added, and images were obtained (FujiFilmLAS-4000mini) with a 10 s standard 
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exposure and the chemiluminescence setting. Images were analyzed using MultiGauge 
version 3.1. 
For electron micrographs, samples were fixed in 1% acrolein (isolated vacuoles) 
or 5% acrolein (whole cells) (Sigma-Aldrich) solutions at 4 C with shaking, then rinsed 
4 times with 1% dimethylsulfoxide (DMSO) and stored overnight at 4 C. The alkaline 
phosphatase reaction was performed as described (145, 146).  Samples were fixed 
overnight with 1% osmium tetroxide (OsO4) then dehydrated using a cold methanol 
series.  Samples were infiltrated using three 100% changes of Quetol/Araldite/DDSA 
resin and polymerized.  Ultrathin sections were cut using an Ultracut E microtome 
(Reichert-Jung), visualized using a transmission electron microscope (JEOL 1200-EX), 
and photographed using a bottom-mounted 3Kx3K, slow scan, lens-coupled CCD 
camera (SIA 15C).  
 
Packing Efficiency of Isolated Vacuoles 
 The packing efficiency of vacuoles was determined as described (147). Briefly, 
the fractional volume of interstitial buffer in packed vacuoles was calculated using the 
cell-impermeable fluorescent Compound 5 (148).  Vacuoles were isolated from cells 
grown to OD(600) ~ 0.8, transferred to an EPR tube, and pelleted by centrifugation 
(10,900g, 45 min). The volume of the pellet (Vpel) was determined from its height in 3.0 
mm ID EPR tubes. The pellet was resuspended using 200 L of buffer containing 0.1 M 
Compound 5. The vacuoles were pelleted, the supernatant fraction was collected, and its 
volume determined (Vsup1). The concentration of Compound 5 in the supernatant fraction 
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(Csup1) was determined from a standard curve generated using a fluorescence 
spectrometer (Koala 90080; ISS Inc.). Fluorescence was detected at 654 nm (fixed) with 
ten scans per sample. Pellet volumes were assumed to be due exclusively to vacuole and 
buffer volumes ( pel vac1 buf1V V V  ).  The conservation of matter requires that the molar 
amount of Compound 5 added in the buffer,  
sup1 sup1 sup1 120 bufnmol C V C V        
Solving for Vbuf1 allowed the packing efficiency of vacuoles, defined as 
1( ) / 100pel buf pelV V V  , to be determined. The same steps were repeated with buffer 
lacking the compound. In this case,  
sup1 buf1 sup2 sup2 sup2 buf2C V C V C V      
The equation was solved for Vbuf2 and packing efficiency was defined as 
2( ) / 100pel buf pelV V V  . Vpel was found to be unchanged with each centrifugation step.  
 
Metal Concentration Determination 
 Pellets of isolated vacuoles (typically with volumes ranging from 50 – 100 L) 
were resuspended in sufficient PS buffer for the suspension volume to total 225 L. 
Suspensions were separated into aliquots of 50, 75, and 100 µL using 15 mL plastic 
screw-top vials. Concentrated (70%) trace-metal grade (TMG) nitric acid (Fisher 
Chemicals) (100 µL) was added to each vial. Vials were sealed with screw-top caps 
wrapped tightly with electrical tape, and then incubated at 90 C for ~ 17 hrs. Aliquots 
were diluted to 7.9 mL using high purity trace-metal-free double-distilled-deionized 
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(DDDI) water generated using a Teflon sub-boiling still (Savillex).   Samples were 
analyzed using ICP-MS (Agilent 7700x) utilizing both H2 reaction mode (
57
Fe and 
56
Fe) 
and He collision modes (Mn, Cu, Zn, and P) to eliminate interferences. Standards were 
prepared from stock solutions (Inorganic Ventures), concentrated TMG (70%) nitric acid 
(Fisher Scientific), and DDDI water. Calibration curves with a range of 0 – 1000 ppb 
were generated for each element, as well as for the two isotopes of Fe.  
 
Redox Activity of Fe in Isolated Vacuoles 
 After collecting the 7 K low-field Mössbauer spectrum of a preparation of 
isolated vacuoles (Figure 3.3 Batch 14), the sample was brought into the glove box, 
thawed, and suspended in PS buffer containing 1% deoxycholate (final concentration). 
The suspension (200 µL) was transferred to a 2 mm pathlength quartz cuvette, which 
was sealed with a rubber septum and removed from the box. After collecting the UV-Vis 
spectrum, the sample was returned to the box, treated with dithionite (400 µM, final 
concentration) and another UV-Vis spectrum was collected after ca. 5 min incubation. 
The sample was returned to the box, transferred to a Mössbauer cup, and frozen in liquid 
N2.  
 
Preparation of Fe Complexes 
 Sodium phosphate (Dihydrate, Sigma-Aldrich) (50 mM final) and aqueous 
57
Fe
3+
 
(5 mM, final) were mixed in an acetate/acetic acid buffer (100 mM, pH ~ 5 final) in an 
effort to generate Fe
3+
 phosphate. The same approach was used to prepare Fe
3+
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polyphosphate, except that sodium polyphosphate (Thermo-Fisher) was used. The 
aqueous 
57
Fe
3+
 stock solution was prepared by dissolving 
57
Fe metal (Isoflex USA) in 
concentrated TMG HNO3 (Fisher Scientific) and concentrated TMG HCl (Thermo-
Fisher Scientific) in a 1:1 ratio and then diluted with DDDI H2O to a final 
57
Fe 
concentration of 80 mM and a final acid content of ~0.5%.  To ensure complete 
oxidation, samples were treated using an excess of H2O2 (Thermo-Fisher Scientific).   
 
Concanamycin-A and Glucose Treatment 
 Cells were treated with glucose and ConA as described (149). WT cells were 
grown in minimal medium (MM) containing 40 μM FC and harvested during late 
exponential phase (OD600 = 1.0 ± 0.1). The wet pellet was washed once with MM, then 
resuspended and incubated in MM lacking glucose for 10 min at 30 C. Glucose (50 mM 
final) and ConA (2 μM final) were then added and the cells were incubated at 30C for 
0, 15, and 60 min. After the given incubation time the cells were packed into MB cups 
by centrifugation at 4,000xg for 10 minutes then frozen with LN2. Control experiments 
were performed without ConA.     
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CHAPTER III 
MÖSSBAUER AND EPR STUDIES OF IRON IN VACUOLES ISOLATED FROM 
SACCHAROMYCES CEREVISIAE
1
 
 My role in these studies was to grow large cultures of S. cerevisiae, to develop 
the protocol to isolate large quantities of vacuoles, and to harvest the vacuoles from 
these cells. I was also responsible for collecting and interpreting Mössbauer, EPR, and 
UV-Visible spectroscopy data. I made the Fe monophosphate and Fe polyphosphate 
complexes and biophysically characterized these compounds using Mössbauer 
spectroscopy. Dr. Gregory P. Holmes-Hampton was responsible for maintaining the 
Mössbauer instruments, for preparing the whole cell samples, and for interpreting these 
results. Mr. Sean P. McCormick, another graduate student, was responsible for 
maintaining the ICP-MS, and for collecting the ICP-MS data. Dr. Mrinmoy Chakrabarti 
provided guidance regarding the biophysical interpretation of the Mössbauer and EPR 
data, and was responsible for maintaining the high-field Mössbauer instrument and 
collecting and interpreting these data. All of the authors contributed to discussions 
regarding the interpretation of these data.   
 Vacuoles were isolated from fermenting yeast cells grown on minimal medium 
supplemented with 40 µM 
57
Fe.  Absolute concentrations of Fe, Cu, Zn, Mn, Ca, and P 
in isolated vacuoles were determined by ICP-MS. Mössbauer spectra of isolated 
                                                 
1
 Reprinted with permission from Allison L. Cockrell, Gregory P. Holmes-Hampton, Sean P. 
McCormick, Mrinmoy Chakrabarti, and Paul A. Lindahl (2011) Mössbauer and EPR Study of  
Iron in Vacuoles Isolated from Saccharomyces cerevisiae, Biochemistry 50 (47), 10275-10283. 
Copyright 2011 American Chemical Society. 
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vacuoles were dominated by two spectral features; a mononuclear magnetically isolated 
high-spin (HS) Fe
3+
 species primarily coordinated by hard/ionic (mostly or exclusively 
oxygen) ligands, and superparamagnetic Fe
3+
 oxyhydroxo nanoparticles. EPR spectra of 
isolated vacuoles exhibited a gave ~ 4.3 signal typical of HS Fe
3+
 with E/D ~ 1/3.  
Chemical reduction of the HS Fe
3+
 species was possible, affording a Mössbauer 
quadrupole doublet with parameters consistent with N/O ligation. Vacuolar spectral 
features were present in whole fermenting yeast cells; however, quantitative 
comparisons indicated that Fe leaches out of vacuoles during isolation.  The in vivo 
vacuolar Fe concentration is estimated to be ~1.2 mM while the Fe concentration of 
isolated vacuoles was ~220 µM. Mössbauer analysis of Fe
3+
 polyphosphate exhibited 
properties similar to those of vacuolar Fe. At the vacuolar pH of 5, Fe
3+
 polyphosphate 
was magnetically isolated, while at pH 7, it formed nanoparticles. This pH-dependent 
conversion was reversible. Fe
3+
 polyphosphate could also be reduced to the Fe
2+
 state, 
affording similar Mössbauer parameters to that of reduced vacuolar Fe. These results are 
insufficient to identify the exact coordination environment of the Fe
3+
 species in 
vacuoles, but they suggest a complex closely related to Fe
3+
 polyphosphate.  A model for 
Fe trafficking into/out of yeast vacuoles is proposed.   
 
Introduction 
 Yeast vacuoles are major hubs for iron trafficking, and have many Fe-related 
functions (102, 142, 150). One function is to sequester and detoxify Fe, so as to restrict 
the formation of reactive oxygen species that would otherwise be toxic to the cell (150, 
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151). Vacuoles also function as reservoirs of Fe, allowing cells to survive in Fe-deficient 
environments (131, 150) and transition from fermenting to respiring metabolism (152). 
They also buffer cytosolic Fe against fluctuations, so as to maintain cellular Fe 
homeostasis (131).  
Raguzzi et al. (152) and Singh et al. (142) have proposed that vacuoles contain 
ferric ions coordinated by hydroxide, phosphate, and/or polyphosphate ions. They 
suggested the Fe
3+
 oxidation state because the vacuolar lumen is more acidic than the 
cytosol, which raises the effective electrochemical potential of the glutathione 
disulfide/glutathione couple. This couple dominates the redox status of the vacuole and 
cytosol; a higher effective potential translates into diminished reducing power. 
Phosphate and polyphosphate have been suggested as ligands because of the high 
concentration of these species in vacuolar lumen (142, 153) and the ability of these 
anions to bind Fe
3+
 ions tightly (154, 155).     
Fe is imported into vacuoles through two major pathways, including endocytosis 
and through Ccc1p, a transporter on the vacuolar membrane (156, 157). The exact 
species imported is unknown, but the Fe
2+
 state is generally assumed (131, 150, 158). 
CCC1 gene expression is responsive to cytosolic Fe concentrations and the CCC1 
mRNA is destabilized under Fe-deficient growth conditions (129). Vacuoles isolated 
from cells that could not engage in endocytosis were phenotypically normal and 
contained proportionately more Fe/mg protein than found in ∆CCC1 vacuoles (150). 
These results suggest that the Ccc1p pathway is responsible for a larger portion of the Fe 
imported into the vacuole, relative to the endocytosis pathway (140).  
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The vacuole membrane contains two Fe export systems, Fth1p/Fet5p (159) and 
Smf3p (122). Fet5p and Fth1p are homologs of the plasma membrane multicopper 
oxidase Fet3p and permease Ftr1p (142). These two plasma-membrane proteins form a 
complex that transports Fe
3+
 from the environment into the cytosol, reducing it to the 
Fe
2+
 state in the process. Fet5p and Fth1p are presumed to function similarly. Fre1p 
catalyzes the reduction of Fe
3+
 to Fe
2+
 by NADPH prior to delivering this ion to the 
Ftr1p/Fet3p complex (19, 20). Fre6p catalyzes the analogous reduction during the export 
of vacuolar Fe (142, 160). The vacuolar membrane protein Smf3p exports Fe (and other 
divalent metal ions) from the vacuolar lumen to the cytosol under low-Fe growth 
conditions (122, 161, 162).  
In summary, the import of Fe
2+
 from the cytosol to the vacuole appears to be 
associated with its oxidation to Fe
3+
, and the export of Fe
3+
 from the vacuole to the 
cytosol is associated with the reduction of Fe
3+
 back to Fe
2+
. This scenario is reasonable 
and well-grounded from a biochemical/genetics perspective, but it has not been 
examined using biophysical methods. In the study described here, we isolated vacuoles 
from fermenting WT S. cerevisiae cells and characterized their Fe content using 
Mössbauer, EPR and UV-vis spectroscopies, as well as ICP-MS. We demonstrate that 
the Fe in this organelle consists predominately of mononuclear nonheme high-spin Fe
3+
 
ions, mostly likely as a single complex. A second species consisting of Fe
3+
 oxyhydroxo 
nanoparticles, is also present. The two species probably interconvert in a pH-dependent 
fashion. 
 
 47 
 
Results 
Bioanalytical Characterization of Isolated Vacuoles  
We isolated vacuoles from 23 independent batches of WT yeast cells, each 
grown under fermenting conditions using minimal medium supplemented with 40 µM 
57
Fe (or 
56
Fe) citrate. Each batch could not be analyzed by every method available due to 
insufficient material; Table 3.1 lists which batches were analyzed by which methods. 
Purity and membrane integrity were evaluated by electron microscopy (Figure 3.1, top 
panel) and Western Blot analysis (Figure 3.1, bottom panel). Electron micrographs 
revealed a dominance of intact vacuolar membranes in the samples. Relative to the cell-
extract lane, isolated vacuoles contained 3-fold more CPY, a vacuolar marker protein, 5-
fold less KAR2, an ER protein, 16-fold less of mitochondrial Porin, and 4-fold less of 
the cytosolic protein PGK. Overall, this analysis suggests that our isolated vacuoles were 
largely intact and purified, with minor contamination of ER, mitochondrial, and 
cytosolic proteins.  We determined the packing efficiency of isolated vacuoles using a 
fluorescent compound that does not penetrate cellular plasma membranes (148). Neither 
does this compound appear to penetrate vacuolar membranes, in that samples exposed to 
it and then washed repeatedly did not exhibit substantial fluorescence beyond that of 
unexposed samples. The percentage of the volume of packed vacuoles due to the 
vacuoles themselves, taken as the average of the 6 values was 76%  5%. The remainder 
was assumed to be due to interstitial buffer.   
The concentrations of Fe, Cu, Zn, Mn, Ca and P in 18 batches of isolated 
vacuoles (taking packing efficiency into account) were determined (Table 3.1); averages  
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  SD in M were: Fe, 220  100; Cu (low) 30  30; Cu(high) 540  280; Zn, 160  120; 
Mn, 1.7  0.6; Ca, 190  110; and P, 14,000  8,700. Batch-to-batch variability was 
significant, with relative errors of ca.  60% or higher. This suggests that there are 
unknown and uncontrolled variables in our growth and/or isolation procedures. Cu 
concentrations were especially scattered, but they bifurcated rather cleanly into low and 
high groups. The low Cu concentrations are perhaps more reliable, in that they are more 
consistent with the concentration of Cu in whole cells (see below). Mn concentrations 
were the least scattered. Phosphorus levels, which almost certainly reflect phosphate and 
polyphosphate ions, were orders-of-magnitude higher than metal numbers. The 
[Fe]ave/[Protein]ave ratio of 1.9 g Fe/mg protein was 10 fold higher than in previous 
reports (142, 150), suggesting that our vacuoles contained more Fe (or less protein, or 
some combination of the two) than those studied previously. For the 16 batches isolated 
from cells grown on media enriched in 
57
Fe, the average level of enrichment was 74  
13%. The Fe concentration in a batch of whole WT cells grown on the same media was 
380 M, similar to the value of 440 M previously reported (147).       
 
Spectroscopic Characterization of Isolated Vacuoles 
 Figure 3.2 shows the variable field, variable temperature Mössbauer spectra of 
isolated vacuoles from Batch 15.  The 4.3 K, 0.05 T spectrum (Figure 3.2A) is 
dominated by a paramagnetic species with absorption between -10 to + 10 mm/s. This   
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Figure 3.1. TEM images and Western blots of isolated vacuoles. Top panel; images 
of Batch 6 vacuoles obtained at 10,000 magnification. Bottom panel; isolated vacuoles 
from Batch 2 (lane 1) were compared with cell extract (lane 2).  
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Table 3.1. Elemental and protein concentrations of isolated vacuoles. Tabulated 
values were obtained by multiplying measured concentrations of isolated vacuole 
solutions by the fold dilution used to resuspend packed pellets (typically ×120), and 
dividing by the packing efficiency ( 0.76). Element concentrations are given in M, 
protein concentrations in mg/mL. Abbreviations, (un), unenriched; (low) and (high), 
batch with low and high concentrations of Cu; (-), not included in average. 
 
 
 
 
Batch [
56
Fe]; [
57
Fe];   
% enrichment 
[Fe]tot [Cu] [Zn] [Mn] [Ca] [P]  Protein  
 
1 018; 053; 75 071 007
(low)
 023 0.9 103 07,200 1.2  
3 009; 026; 74 035 007
(low)
 023 0.8 093 10,100 7.1 
7 061; 200; 77 261 018
(low)
 273 2.3 158 12,200 5.3 
8 054; 156; 74 210 352
(high)
 018 1.8 102 08,600 2.9 
10 038; 040; 51 078 008
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Figure 3.2. Mössbauer spectra of isolated vacuoles. (Batch 15) A, 4.2 K, 0.05 T; B, 7 
K, 0.05T; C, 12 K, 0.05T; D, 100 K, 0.05 T; E, 4.2 K, 6 T. Applied fields in A and E 
were perpendicular to the gamma radiation, while those in B – D were parallel to the 
radiation.  The solid red lines are simulations assuming S = 5/2, D = 0.5 cm
-1
 and E/D = 
0.33, Ao/γN•βN = -230 KG,  = 0.54 mm/sec, EQ = 0.39 mm/sec, and η = 2.  
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spectral feature is typical of a mononuclear high spin Fe
3+
 species and was analyzed with 
a S= 5/2 spin Hamiltonian 
2 2 2( 35 / 4) ( )z x y n n QD S E S S S g B S A I g B I                
where D and E are the axial and rhombic zero-field-splitting parameters, A is the 
57
Fe 
magnetic hyperfine tensor, and Q describes the nuclear quadrupole interactions.  
This feature represented 75% of the overall spectral intensity in this batch. 
Residual intensity was unresolved and centered near 0 mm/s. At 7 K and 0.05 T (Figure 
3.2B) the middle doublet (ms = ± 3/2) of the S = 5/2 spin multiplet has an appreciable 
population, shown by the strong absorption features in the +4 and -4 mm/sec region. 
This indicates that D is small. Mössbauer and EPR fitting trials suggest that D = 0.5 cm
-1
 
and E/D = 0.33 (rhombic symmetry).  The fitted isomer shift and quadruple splitting 
values suggest a hexacoordinated HS Fe
3+
 species with oxygen/nitrogen donor atoms 
 (133). The isotropic Ao/γN•βN = -230 KG obtained from simulations are also typical of a 
HS Fe 
3+
 species (133).   
The spectra of all batches examined by Mössbauer also included a second 
component in varying relative proportions. The batch just described (Batch 15) exhibited 
the lowest proportion of this component, while Batch 23 exhibited the highest proportion 
(Figure 3.4). The spectra of three other batches, with intermediate levels of the second 
component, are shown in Figure 3.3. In batches showing greater resolution of this 
second feature, a quadrupole doublet was evident. These parameters were similar to 
those of Fe
3+
 (phosphorus) oxyhydroxo nanoparticles observed in various genetic strains 
of yeast (71, 135, 147, 163).  The spectral features due to the nanoparticles could be 
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removed, affording difference spectra (Figure 3.4, C and F) that could be simulated 
using the same H.S. Fe
3+
 parameters as used above. A somewhat different spectral shape 
was reported previously (71, 135, 147, 163) but in those spectra the field was applied 
parallel to the gamma radiation, affording different selection rules. The magnetic 
features due to these nanoparticles in Figure 3.4 were broad because the hyperfine 
coupling tensor A values were widely distributed as is typical of aggregated 
superparamagnetic materials.   
 X-band EPR spectra of isolated vacuoles supported this analysis, as all 10 
batches examined displayed a dominant feature at gave ~ 4.3 (Figure 3.5A). Such features 
are typical of HS Fe
3+
 species with rhombic symmetry (E/D ~ 1/3). However, the 
quantified intensity of the signal varied considerably, with spin concentrations ranging 
from 110 to 175 M in samples of packed isolated vacuoles from 4 separate batches 
(Batches 14, 16, 17 and 23). When normalized to the [Fe], and to the fraction of Fe 
Figure 3.4 associated with the six-line pattern in the Mössbauer spectra (measured to be 
56% and 85% in Batches 23 and 14, respectively; and assumed to be midway between 
these percentages in Batches 17 and 16), the ratio of [spin]/[HS Fe
3+
] was 0.9, 0.7, 0.8 
and 0.6, respectively.
1
 No Cu
2+
-based EPR signals were observed, even in the 4 batches 
examined that had high Cu concentrations (Batches 8, 20, 21 and 22).  Cu ions in this 
organelle may be in the cuprous state, which is counterintuitive given the oxidizing 
environment of the vacuolar lumen. They may also be in the cupric state and EPR-silent 
for other reasons, e.g., involving spin-coupling. 
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Figure 3.3. Additional 6 K, 0.05T Mössbauer spectra of isolated vacuoles.  A, Batch 
7; B, Batch 14; C, Batch 11.  Applied fields were parallel to the gamma radiation.     
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Figure 3.4. Mössbauer spectra of isolated vacuoles and mitochondria isolated from 
a genetic strain (Aft1-1
up
) known to contain Fe
3+
 (phosphate) nanoparticles. 
Vacuoles were from Batch 23, and nanoparticle spectra were shown in (147). A, 
vacuoles at 7 K and 0.05 T; B, mitochondria at 4.3 K and 0.05 T; C, same as A after 
spectrum B was subtracted at the 40% level. The solid red line is a simulation assuming 
the parameters specified in Figure 3.2; D, vacuoles at 4.2 K and 6 T; E, mitochondria at 
4.2 K and 6 T. F, same as D after spectrum E was subtracted at the 40% level. The solid 
line is a simulation assuming the same parameters as in C except that the applied field 
was 6T. In D and E, applied fields were perpendicular to the gamma radiation. In A and 
B, applied fields were parallel to the radiation. 
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Figure 3.5. EPR of isolated vacuoles and whole cells.  A, Batch 23; temperature, 4 K; 
microwave frequency, 9.46 GHz; microwave power 0.08 mW; B, Temperature, 10 K; 
microwave frequency, 9.46 GHz; microwave power 0.2 mW. The whole-cell spectrum 
includes low-intensity features at g = 6.4 and 5.4, and signals in the g = 2 region which 
are absent or of diminished intensity in the spectrum of isolated vacuoles. These features 
originate from mitochondria (135, 164). The whole-cell spectrum includes low-intensity 
features at g = 6.4 and 5.4 (135, 164). The low-field features probably arise from 
cytochrome c oxidase while the high-field features arise from other respiration-related 
proteins.  
50004000300020001000
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 When suspended in buffer, solutions of isolated vacuoles were milky white, and 
have electronic absorption spectra dominated by the effects of light scattering (Figure 
3.6, top panel). We considered that the low-intensity feature at ~ 410 nm was due to the  
HS Fe
3+
 species evidenced by Mössbauer and EPR spectra, as it reminded us of the 
broad low-intensity transition at 470 nm from diferric transferrin (165). However, 
subsequent treatment with dithionite had no effect on this feature (Figure 3.6, top panel). 
The effectiveness of dithionite in reducing the HS Fe
3+
 species was evidenced by the 
quadrupole doublet generated in the Mössbauer spectrum of the treated sample (Figure 
3.6, bottom panel). We conclude that the dominant HS Fe
3+
 species in as-isolated 
vacuoles is redox-active, and can be reduced to the Fe
2+
 state. However, neither redox 
state is associated with the observable electronic absorption feature. The Mössbauer 
parameters associated with the Fe
2+
 doublet suggest that this species is primarily 
coordinated by oxygen and/or nitrogen donor ligands. Whether the exchange of one 
oxygen- or nitrogen- dominating ligand set for another accompanied reduction remains 
undetermined. 
 
Related Fe
3+
 Compounds  
We attempted to reproduce the mononuclear HS Fe
3+
 species in vacuoles by 
adding phosphate and polyphosphate ions to hex(aqua/hydroxo) Fe
3+
 ions in pH 5 buffer. 
This pH was used to mimic the vacuolar lumen, which has pH between 4.8 and 5.4 
(166). Presuming that the intended complexes formed, the 6 K and 0.05 T Mössbauer  
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Figure 3.6. Electronic absorption spectra of isolated vacuoles, before and after 
treatment with a reductant (upper panel), and Mössbauer spectrum of the same 
after treatment with a reductant (lower panel). Vacuoles were isolated from Batch 
15. The corresponding Mössbauer spectrum prior to adding the reductant is shown in 
Figure 3.3, spectrum B. The 6 K, 0.05 T Mössbauer spectrum of Fe
3+
 polyphosphate (pH 
7) after treatment with dithionite is also shown in the lower panel. The red lines are 
simulations assuming (vacuoles)  = 1.41 mm/s and ∆EQ = 3.15 mm/s and (
57
Fe
3+
 
polyphosphate)  = 1.39 mm/s and ∆EQ = 2.88 mm/s.  
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spectrum of Fe
3+
 phosphate (Figure 3.7A) and Fe
3+
 hex(aqua/hydroxo) species (data not 
shown) exhibited features typical of Fe
3+
 oxyhydroxo nanoparticles. In contrast, the 
spectrum of Fe
3+
 polyphosphate (Figure 3.7B) exhibited features associated with 
mononuclear HS Fe
3+
 ions with similar parameters to those used to fit the equivalent 
spectrum in Figure 3.2B. After data collection, the Fe
3+
 polyphosphate sample was 
thawed, adjusted to pH = 7, and refrozen. The resulting Mössbauer spectrum (Figure 
3.7C) indicated the presence of both nanoparticles and HS Fe
3+
 ions. This suggests that 
mononuclear HS Fe
3+
 polyphosphate can convert to Fe
3+
 nanoparticles simply by raising 
the pH. The nanoparticle-forming reaction was reversible, in that thawing the pH-7-
adjusted sample, lowering its pH to 4, and refreezing it resulted in a Mössbauer spectrum 
again indicating the mononuclear HS Fe
3+
 state. In contrast, the Fe
3+
 (phosphate) 
nanoparticles at pH 5 could not be converted into the mononuclear HS Fe
3+
 state by 
lowering the pH to 3, 2 and finally 1. Similar to the Fe species in vacuoles, the Fe
3+
 
polyphosphate sample could be reduced by dithionite, resulting in a quadrupole doublet 
(Figure 3.5, bottom panel) with parameters very similar to that observed when the HS 
Fe
3+
 complex in vacuoles was reduced. 
 
Whole Cells 
 We calculated the concentration of Fe (and other metal ions) within fermenting 
yeast cells grown in the same medium used to grow the cells from which vacuoles were 
isolated. Measured values using packed cells were normalized using the previously 
determined packing efficiency (167). Low-temperature Mössbauer spectra of whole cells  
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Figure 3.7. 6 K and 0.05 T Mössbauer spectra of 
57
Fe
3+
 phosphate and 
57
Fe
3+
 
polyphosphate at different pH values. A, 
57
Fe
3+
 phosphate at pH 5; B, 
57
Fe
3+
 
polyphosphate at pH 5; C, 
57
Fe
3+
 polyphosphate at pH 7. Applied fields were parallel to 
the gamma radiation.  Samples were prepared in 0.1 M acetate/acetic acid buffer (pH 5) 
and excess H2O2 was added to each sample obtain an oxidizing environment. The solid 
line in A is a simulation assuming  = 0.53 mm/s and ∆EQ = 0.63 mm/s.  The solid line 
in B is a simulation assuming S = 5/2, D = 0.5 cm
-1
, E/D = 0.33, Ao/γN •βN = -238 KG,  
= 0.54 mm/s, ∆EQ = 0.39 mm/s, and η = 3.  
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(Figure 3.8) were dominated by the same pattern that was observed in spectra of isolated 
vacuoles; i.e. typical of a mononuclear HS Fe
3+
 species. EPR spectra of same whole cells 
from which the vacuoles of Figure 3.5A were isolated were dominated by a gave = 4.3 
signal (Figure 3.5B), essentially indistinguishable from that of isolated vacuoles. 
 
Discussion and Conclusions 
Two Types of Fe in Vacuoles  
 Our results indicate that vacuoles isolated from Fe-sufficient fermenting yeast 
cells contain two major types of Fe species. One is a mononuclear, magnetically isolated 
(i.e. soluble) high-spin Fe
3+
 complex; the other is magnetically interacting (i.e. insoluble) 
Fe
3+
 oxyhydroxo nanoparticles. The nanoparticles contained in Yah1p-depleted, Atm1p-
depeleted, Yfh1p-depleted and Aft1-1
up
 mitochondria have similar Mössbauer 
properties, and in the three cases investigated, phosphorus, presumed to be in the form of 
phosphate, was found to be associated with this material (71, 135, 147, 163). 
The composition and structure(s) of the Fe
3+
 nanoparticles in vacuoles is 
unknown, including whether phosphate or a phosphate-related species is associated. We 
suspect that these nanoparticles are related to ferrihydrite, a metastable iron oxyhydroxo 
generated by titrating Fe
3+
(NO3)3 with hydroxide ions to pH ~ 7.5 (168). Ferrihydrite 
contains both octahedrally and tetrahedrally coordinated Fe
3+
 ions (169). When present, 
phosphate ions and other oxyanions coprecipitate with Fe
3+
 (170-172). This alters the 
structure, crystallinity and superparamagnetic properties of the resulting nanoparticles 
(173-175).  
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Figure 3.8. Mössbauer spectra of WT whole cells. A, 4.2 K and 0.05 T; B, 4.2 K and 6 
T; Applied fields were perpendicular to the gamma radiation.  The solid red lines are 
simulations assuming the parameters specified in Figure 3.2. 
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We propose that the two major forms of Fe in vacuoles interconvert by reactions 
promoted by a simple change in pH. As illustrated in the model of Figure 3.9, low pH 
(protonation) favors the mononuclear species while high pH (deprotonation) favors 
nanoparticles. Deprotonation of a ligand (e.g. water, phosphate, or polyphosphate group) 
on one isolated HS Fe
3+
 molecular species, and dissociation of a ligand on a neighboring 
species (to create an open coordinate site) might be sufficient to promote an association 
between the two, ultimately generating nanoparticles. At the normal pH of vacuoles (pH 
~ 5) we would expect that the majority of the Fe would be present as the mononuclear 
HS Fe
3+
 species, as is observed in whole cells and in most batches of isolated vacuoles. 
Nanoparticles probably form when the pH of the vacuole lumen is somewhat higher than 
5.  Perhaps the pH of the vacuoles increases slightly during isolation, or the ratio of  
phosphate:polyphosphate in the vacuoles is altered.  Studies are currently underway to 
test these hypotheses. 
Our results are insufficient to unambiguously identify the coordination 
environment of the HS Fe
3+
 species, but they are consistent with an Fe
3+
 polyphosphate 
complex and inconsistent with an Fe
3+
 phosphate complex or with hex(aqua/hydroxo) 
Fe
3+
. Of these three possibilities, only the Fe
3+
 polyphosphate complex was present as a 
HS mononuclear species at the pH of the vacuolar lumen (pH ~ 5); the Fe
3+
 phosphate 
and hex(aqua/hydroxo) complexes were present as nanoparticles. Fe
3+
 phosphate 
remained as nanoparticles at pH’s as low as 1 (the behavior of the hex(aqua/hydroxo) 
complex was not evaluated at lower pHs). Our results indicate that the HS Fe
3+
 complex  
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Figure 3.9. Model showing the dynamics of Fe import and export in yeast vacuoles. 
An unknown ferrous species enters the vacuole via Ccc1p. Associated with this import is 
the exchange of ligands and oxidation to HS Fe
3+
. Polyphosphate is suggested as a 
possible coordinated ligand, but further studies are required to establish this. Upon 
export, the HS Fe
3+
 species is reduced to Fe
2+
 and ligands are again exchanged. At pH > 
ca. 5, some or all of the species precipitates in the form or Fe
3+
 (phosphate-based) 
oxyhydroxo nanoparticles perhaps associated with polyphosphate. 
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in vacuoles is closely related to an Fe
3+
 polyphosphate complex, consistent with earlier 
and quite perceptive proposals by Lesuisse, Crichton, and Kosman that vacuolar Fe is 
bound by polyphosphate (142, 152).  However, further studies are required to 
unambiguously identify the HS Fe
3+
 complex in vacuoles.  
 
Vacuolar Metal Concentrations  
 We report here the first absolute (M) concentrations of the metal content of 
vacuoles; previously only ratios of metal concentrations divided by protein 
concentrations (or dry weight) had been reported. Such ratios cannot be used in mass-
balance equations and are difficult to interpret because differences might arise from 
changes in either protein concentration or metal concentration (or some combination of 
the two). For example, in the current study, metal-to-protein ratios were found to be ~10-
fold higher than previously reported (142, 150). Whether this is due to higher Fe 
concentrations or lower protein concentrations (or both) in our vacuoles cannot be 
determined.  
We suspect that we achieved higher concentrations of Fe in isolated vacuoles 
than have been obtained previously, due to our use of TCEP rather than DTT to prepare 
the cell wall for digestion by lyticase.  Raguzzi, et al. (152) reported that adding a 
chelator and reductant mobilizes vacuolar Fe stores, and DTT is a membrane-permeable 
reducing agent. TCEP is a membrane-impermeable reducing agent. EGTA was also 
excluded from our isolation buffers to avoid loss of vacuolar Fe, whereas EGTA is 
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commonly added to buffer solutions to remove loosely-bound Fe from membranes.  
  
Loss of Fe from Vacuoles During Isolation  
 Vacuoles isolated from cells grown under fermenting conditions and in the 
presence of 40 M Fe contained an average of ~ 220 M Fe, with 56% - 85% present as 
a HS Fe
3+
 species. Whole cells grown under the same conditions contained 380 M Fe 
with ~ 75% of the Mössbauer spectral intensity due to what appears to be the same HS 
Fe
3+
 species. Assuming that it is the same species and that it is located exclusively in 
vacuoles (which occupy ~ 25% of cell volume) suggests that the concentration of this 
species in vacuoles in whole cells is ca. 1.2 mM. This is ca. 5-times higher than found in 
our isolated vacuole preps, implying that the majority of Fe in the vacuole is lost during 
isolation. Other groups have suggested that Fe leaches from vacuoles during isolation 
(150). Given their function in the cell (dynamic storage and release of Fe as needed), it is 
not surprising that Fe can be easily mobilized from this organelle. 
The export of Fe has been associated with its reduction (142). Our results show 
that there is no build up of HS Fe
2+
 in the vacuole even though the Fe
3+
 contained in the 
organelle is redox active (reducible by dithionite). We have not observed by Mössbauer 
spectroscopy any Fe
2+
 in isolated vacuoles, suggesting that reduction of Fe
3+
 to Fe
2+
 is 
slower than export from the vacuoles. Essentially, the Fe
3+
 species is trapped in 
vacuoles, escaping immediately once it is reduced. 
In the future, we hope to identify the mononuclear HS Fe
3+
 species present in 
vacuoles.  We also hope to use our biophysical methods, in conjunction with genetic and 
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biochemical investigations, to explore the mechanisms of vacuolar Fe import and export 
and the regulation of these processes. Since vacuoles are a major hub of iron trafficking, 
understanding how they store and release iron is a prerequisite to better understanding 
cellular Fe metabolism. 
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CHAPTER IV 
INSIGHTS INTO VACUOLAR IRON TRAFFICKING USING MÖSSBAUER 
SPECTROSCOPY AND ΔCCC1 AND CCC1-UP SACCHAROMYCES CEREVISIAE 
My contribution to this project was to grow ΔCCC1, WT, and CCC1-up whole 
cells under various conditions, to prepare these cells for Mössbauer, EPR, UV-Visible, 
and ICP-MS analyses, and to interpret these data. Another graduate student, Mike 
Moore, harvested mitochondria from the ΔCCC1 strain and collected the Mössbauer 
data. I fit and interpreted this Mössbauer data, and prepared the ΔCCC1 mitochondria 
for ICP-MS and UV-Vis analyses. Sean McCormick, another graduate student, was 
responsible for maintaining the ICP-MS instrument and for collecting the ICP-MS data. 
Dr. Mrinmoy Chakrabarti, a post-doctoral fellow in the Lindahl group, was responsible 
for maintaining the Mössbauer and EPR instruments, and for assisting in the 
interpretation of the Mössbauer and EPR results. All of these authors contributed in 
group discussions regarding these results. 
Saccharomyces cerevisiae strains lacking or over-expressing CCC1 were 
characterized using Mössbauer and EPR spectroscopies, and using ICP-MS. Ccc1p is the 
only known vacuolar Fe import protein. ∆CCC1 cells contained ~ 20% less Fe than 
equivalently grown WT cells and the Fe was distributed differently, with more non-heme 
high spin (NHHS) Fe
2+
 and less vacuolar high-spin (HS) Fe
3+
 and less Fe
3+
 
oxyhydroxide nanoparticles (NP). The concentrations of vacuolar Fe
3+
 and NHHS Fe
2+
 
increased with increasing medium [Fe]. Mitochondria isolated from ∆CCC1 cells 
contained more NHHS Fe
2+
 than WT mitochondria, but this did not account for most of 
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the NHHS Fe
2+
 observed in whole-cell spectra. The concentration of Fe in CCC1-up 
cells was much higher than in WT cells, with most extra Fe present as NHHS Fe
2+
 and 
NP. The majority of Fe in isolated vacuoles was Fe
3+
 nanoparticles, with little NHHS 
Fe
3+
 and no NHHS Fe
2+
. As the concentration of medium [Fe] was increased from 1 to 
40 μM, the NHHS Fe2+ accumulated before the vacuolar NHHS Fe3+ and NP. 
Supplementing the medium with additional adenine caused a decline of NHHS Fe
2+
. 
Inhibition of the V
+
-ATPase with concanamycin A (ConA) promoted Fe accumulation 
as NP in WT cells, consistent with an increased vacuolar pH.  
 
Introduction 
Iron is a critical component of biological systems where it is found in various 
forms, including hemes and other mononuclear centers, iron-sulfur clusters (ISCs) and 
diiron centers (7, 12).  Mitochondria are perhaps the major site of Fe metabolism, as 
both ISCs and heme biosynthesis occurring in this organelle and Fe-rich respiratory 
complexes housed within this structure (75). In yeast, vacuoles are another major site of 
Fe metabolism, but their role is less understood. Vacuoles are acidic organelles that 
sequester Fe and other cellular metabolites. Fe is imported into vacuoles under Fe-
replete growth conditions and exported under Fe-deficient conditions (122, 140, 142, 
159). Most of this Fe enters the vacuole through Ccc1p, a protein that localizes on the 
vacuolar membrane (140). Some Fe enters this organelle through endocytosis (140, 176).   
Ccc1p is tightly regulated through a number of mechanisms (Scheme 4.1), one of 
which involves the Yap5p protein (141). This Fe-sensing transcription factor is 
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constitutively bound to the CCC1 promoter which induces transcription of the CCC1 
gene under high-Fe conditions (141). This promotes the import of Fe into the vacuole 
under Fe-replete conditions. Ccc1p expression is also regulated by Cth2p (105). CTH2 is 
a member of the Fe regulon, a collection of > 20 genes involved in Fe metabolism (177). 
Under low-Fe conditions Cth2p binds and destabilizes CCC1 mRNA, causing its 
degradation which prevents Cccp1 biosynthesis and Cccp1-dependent Fe import into 
vacuoles (105). Cth2p expression is controlled by Aft1p, an Fe-sensitive transcription 
factor (105). Under high-Fe conditions Aft1p localizes to the cytosol where it is inactive. 
Under low-Fe conditions, Aft1p localizes to the nucleus where it promotes the 
expression of the Fe regulon, including Cth2p (131). These mechanisms collectively 
regulate Ccc1p-dependent entry of Fe into the vacuole. 
Under Fe-sufficient growth conditions (> 10 µM Fe in minimal medium), ~ 75% 
of Fe in WT cells is located in vacuoles (112). The majority is stored as one or more 
mononuclear, high-spin (HS) Fe
3+
 complexes, most likely coordinated by 
polyphosphate-related ligands (112). Depending on growth or isolation conditions, 
vacuoles can also contain aggregates of Fe
3+
 oxyhydroxide (phosphate or polyphosphate-
related) nanoparticles (NP) (112, 178). Vacuoles export Fe to the cytosol in times of Fe 
deprivation. The proteins involved in this process are homologous to Fe import proteins 
on the plasma membrane. Just prior to export, vacuolar nonheme high-spin (NHHS) Fe
3+
 
is reduced by Fre6p, a ferric reductase (142).  
The reduced Fe
2+
 can be exported from the vacuole by the Fet5p/Fth1p complex 
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Scheme 4.1. Regulation of Ccc1p. Ccc1p is regulated via two primary pathways: 
Yap5p and Aft1p. Yap5p is constitutively bound to the CCC1 promoter. In high 
cytosolic Fe conditions Yap5p up-regulates CCC1 transcription which leads to high 
Ccc1p levels. In low cytosolic Fe conditions Aft1p is active. Aft1p negatively regulates 
Ccc1p expression through Cth2p. Cth2p causes the destabilization and degradation of 
CCC1 mRNA, which results in low levels of Ccc1p expression. This information was 
collected from (103) and (104). 
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and by Smf3p, both of which are vacuolar membrane-bound proteins (122, 159). Fet5p, 
a multicopper oxidase, and Fth1p, a ferric permease, comprise the high-affinity export 
system (159). The low-affinity system is composed of Smf3p, a divalent metal transport 
protein which is not specific for Fe (122). High-affinity Fe transporters allow cells to 
grow on media containing low concentrations of Fe (< ~ 1 μM) (139, 179, 180). Fre6p, 
Fet5p, and Fth1p are regulated by Aft1p (131, 132) whereas Smf3p is regulated by 
Aft2p, a homolog to Aft1p (122, 161). When intracellular Fe levels decrease, these 
vacuolar Fe export proteins are up-regulated by Aft1p and Aft2p (130, 131, 159). This 
causes Fe to efflux from the vacuoles and move into the cytosol, probably in the Fe
2+
 
redox state.  
Vacuoles isolated from cells in which CCC1 is deleted (ΔCCC1) only contain 
~20% of the Fe concentration typical of WT vacuoles (140). The residual Fe level in 
ΔCCC1 vacuoles is due to Fe uptake via END4-associated endocytosis (103). The 
vacuolar Fe concentration in END4 vacuoles (containing functional CCC1) is ~ 60% of 
WT levels (103). Thus, Ccc1p appears to import 60% - 80% of vacuolar Fe (103).  
∆CCC1 cells have difficulty growing in medium containing > 3 mM Fe (140).  
Kaplan has proposed that the cytosolic Fe concentration is high in these cells because Fe 
import from the cytosol into vacuoles is largely blocked (103, 181). Accordingly, the 
high concentrations of cytosolic Fe would promote ROS formation, leading to cell death 
when the concentration of this species becomes sufficiently high (140). Conversely, 
when Ccc1p is constitutively over-expressed, vacuolar and cellular Fe levels are 3 – 4 
times higher than in WT cells (140, 142). Kaplan has hypothesized that in this strain, 
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excessive cytosolic Fe is transported to vacuoles, leaving the cytosol Fe-deficient (103). 
This induces the Fe regulon which up-regulates Fe-import proteins on the plasma 
membrane which increases cellular Fe import. This import process would continue until 
the sensed Fe species in the cytosol exceeds some threshold concentration.  
Kaplan has hypothesized further that a common Fe pool is shared between the 
mitochondria and vacuoles (181). Deleting the genes which encode the mitochondrial Fe 
import proteins, MRS3 and MRS4, impedes mitochondrial Fe import and promotes 
vacuolar Fe import (58, 181). When CCC1 is deleted, the total cellular Fe concentration 
declines (181). The decline in total cellular Fe implies that Fe import levels are also 
decreased (182). A decline in Fe import is often associated with inactivation of Aft1p 
(132). Aft1p is inactivated when cytosolic Fe levels are high (183). Therefore, the 
decline in total cellular Fe indicates that cytosolic Fe levels are elevated in ∆CCC1 cells 
compared with WT cells (181). These data suggest that the concentration of a common 
cytosolic Fe pool is dictated by competing fluxes of Fe into vacuoles and mitochondria 
along with Aft1-based regulation of cellular Fe import proteins.   
In this study, Mössbauer (MB), EPR, and UV-Vis spectroscopies, as well as ICP-
MS, were used to study the Fe content of CCC1-up and ∆CCC1 cells grown under 
various conditions. Our results support and extend Kaplan’s hypotheses. They suggest 
that the shared pool of cytosolic Fe is a mononuclear nonheme high-spin Fe
2+
 complex 
coordinated predominately by O and N donor ligands. We present circumstantial 
evidence that this species accumulates in cytosol of ∆CCC1 cells grown in medium 
supplemented with high concentrations of Fe, and is sensed by the machinery used to 
 74 
 
regulate Fe import into the cell. It has been proposed that intracellular Fe is sensed via 
Fe-S clusters (184). If this is the case, this implies that the accumulated form of Fe 
which we observe can be utilized for Fe-S cluster biogenesis. We further suggest that 
CCC1-up cells contain a similar species that is not sensed, either because it’s a different 
complex or because it is sequestered in a noncytosolic compartment such as the 
vacuoles. The forms of Fe present in vacuoles appear to be controlled by the redox status 
and pH of these organelles.  
We used Mössbauer (MB), EPR and UV-visible spectroscopy to characterize the 
Fe content of two genetic strains of S. cerevisiae, namely CCC1 and Cccp1-up. CCC1 
cells lack the Cccp1 transporter on the vacuolar membrane, whereas Cccp1-up cells 
contain an abundance of this vacuolar Fe importer, relative to in WT cells. As 
hypothesized by Kaplan, CCC1 cells should contain unusually high concentrations of 
cytosolic Fe, since such Fe should be largely unable to move into vacuoles (140). Thus, 
we expected to observe a diminished percentage of the HS Fe
3+
 sextet in the MB 
spectrum of these cells. We also anticipated an increase in a new spectral feature due to 
cytosolic Fe. In previous studies, assigning MB features of whole yeast spectra to 
cytosolic Fe has been hampered by the low concentration of such Fe in WT cells. 
Likewise, Ccc1-up cells should contain more vacuolar HS Fe
3+
 and less cytosolic Fe. 
Our initial objective was to evaluate these expectations and if so to spectroscopically 
characterize cytosolic Fe in a yeast cell.  
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Results 
DY150 WT Cells  
We have described the Fe composition of W303-1B WT cells previously(138) 
but we briefly summarize it here to provide a baseline against which the other strains 
investigated in this study (derived from the same WT strain) can be compared. Notable 
differences between the current strain (DY150) and the previous strain (W303-1B, a 
generous gift from Roland Lill, Philipps Universität, Marburg Germany) were observed.  
The Fe concentrations of both WT strains, when grown on MM supplemented 
with 40 μM FC, were similar (Table 4.1, and Table 1 from (138)); however, the 
distribution and speciation of Fe were not. The low-temperature (6 ± 1 K), low-field 
(0.05 T) MB spectrum of DY150 cells shown in Figure 4.1A was dominated by a sextet 
due to one or more mononuclear nonheme high-spin (NHHS) Fe
3+
 species located in the 
vacuoles (112). This feature was simulated by the orange line above the spectrum. The 
cellular concentration of Fe associated with these species (~270 μM) was lower than that 
in W303-1B cells (~380 μM) (112). Other components of the DY150 spectrum were 
more intense, including a broad quadrupole doublet arising from superparamagnetic Fe
3+
 
oxyhydroxide nanoparticles (NP), and a doublet arising from one or more NHHS Fe
2+
 
species. The NP doublet (with parameters δ = 0.53 mm/s and ∆EQ = 0.45 mm/s, 
simulated by the green line) was 4.5× more intense than the corresponding doublet in the 
W303-1B spectrum. The NHHS Fe
2+
 doublet (with parameters δ = 1.3 mm/s and ∆EQ = 
3.0 mm/s, simulated by the blue line) was 1.4× more intense. The intensity of the so-
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Table 4.1. Summary of Fe percentages and concentrations determined by biophysical methods. Mössbauer percentages 
and corresponding concentrations are ± 3%. Concentrations of Fe
2+
 hemes (UV-vis) are the sum of individual heme 
components (hemes a, b, and c), which were simulated as described (137). The g = 4.3 EPR signals were quantified from 
individual samples (Table 4.2), using the equation described (136). Sample concentrations were corrected for packing 
efficiencies which are 73% for whole cells, 75% for isolated vacuoles, and 78% for isolated mitochondria (185-187). ND = not 
determined 
 
 
 
Sample 
Total [Fe] 
(ICP-MS) 
NHHS Fe
2+
 
(MB) 
HS Fe
2+
  
Hemes (MB) 
CD 
(MB) 
Nanoparticles 
(MB) 
NHHS Fe
3+
 
(MB) 
Fe
2+
 Hemes 
(UV-vis) 
g = 4.3 
(EPR) 
WT1 
170 ± 45  
(6) 
25% 
(43 μM) 
5% 
(9 μM) 
60% 
(103 μM) 
< 5% 
(< 9 μM) 
0% 
 
44 ± 1 0 
WT40 
490 ± 140  
(8) 
13% 
(64 μM) 
3% 
(15 μM) 
8% 
(39 μM) 
18% 
(88 μM) 
55% 
(269 μM) 
55 ± 3 152 
D1 
148 ± 64  
(8) 
15% 
(22 μM) 
10% 
(15 μM) 
57% 
(85 μM) 
< 5% 
(< 7 μM) 
0% 
 
46 ± 2  < 1 
D10 
209 ± 8  
(2) 
26% 
(54 μM) 
7% 
(15 μM) 
39% 
(82 μM) 
5% 
(11 μM) 
23% 
(48 μM) 
ND ND 
D20 
285 ± 5  
(2) 
35% 
(100 μM) 
5% 
(14 μM) 
27% 
(77 μM) 
8% 
(23 μM) 
28% 
(80 μM) 
ND ND 
D40 
360 ± 100  
(7) 
30% 
(107 μM) 
5% 
(18 μM) 
19% 
(69 μM) 
17% 
(61 μM) 
30% 
(108 μM) 
43 ± 4 73 
UP1 
250 ± 60  
(3) 
51% 
(130 μM) 
3% 
(10 μM) 
10% 
(30 μM) 
19% 
(50 μM) 
18% 
(50 μM) 
32 ± 3 30 
UP10 
565 ± 10  
(2) 
53% 
(300 μM) 
2% 
(11 μM) 
5% 
(28 μM) 
25% 
(141 μM) 
18% 
(102 μM) 
ND ND 
UP20 
979 ± 24  
(2) 
39% 
(382 μM) 
≤ 1% 
(≤ 10 μM) 
3% 
(29 μM) 
39% 
(382 μM) 
17% 
(167 μM) 
ND ND 
UP40 
1839 ± 750  
(5) 
38% 
(700 μM) 
≤ 1% 
(≤ 18 μM) 
2% 
(37 μM) 
24% 
(441 μM) 
17% 
(313 μM) 
31 ± 6 372 
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Table 4.1 Continued. 
 
 
 
Sample 
Total [Fe] 
(ICP-MS) 
NHHS Fe
2+
 
(MB) 
HS Fe
2+
  
Hemes (MB) 
CD 
(MB) 
Nanoparticles 
(MB) 
NHHS Fe
3+
 
(MB) 
Fe
2+
 Hemes 
(UV-vis) 
g = 4.3 
(EPR) 
D40, Mitochondria 
854 ± 102 
(2) 
37% 
(316 μM) 
5% 
(43 μM) 
32% 
(273 μM) 
23% 
(197 μM) 
0% 364 ± 9 ND 
UP1+A 
385 ± 68  
(3) 
70%  
(270 μM) 
2% 
(8 μM) 
7% 
(27 μM) 
11% 
(42 μM) 
10% 
(39 μM) 
29 ± 3 39 
UP40+A 
1040 ± 108  
(4) 
18% 
(187 μM) 
2% 
(21 μM) 
4% 
(42 μM) 
29% 
(301 μM) 
45% 
(468 μM) 
40 ± 4 415 
WT40 – glucose  
+ ConA, 0m 
1014 
(1) 
38% 
(385 μM)  
2% 
(20  μM) 
4% 
(40  μM) 
17% 
(172  μM) 
20% 
(203  μM) 
ND ND 
WT40 - ConA, 15m 
990  
(1) 
60% 
(594 μM) 
2% 
(20 μM) 
4% 
(40 μM) 
7% 
(70 μM) 
23% 
(230 μM) 
ND ND 
WT40 + ConA, 15m 
1060  
(1) 
39% 
(414 μM) 
3% 
(32 μM) 
4% 
(43 μM) 
19% 
(202 μM) 
20% 
(213 μM) 
ND ND 
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Figure 4.1. Mössbauer spectra of DY150 WT whole cells. WT cells grown with 40μM 
FC (A) and 1μM FC (B). The orange simulation shows NHHS Fe3+ with the parameters 
D = 0.5, E/D = 0.33, A = -228, and η = -3.0. The blue simulation shows NHHS Fe2+ 
with the parameters δ = 1.35 and ∆EQ = 3.05. The green simulation shows ferric 
phosphate nanoparticles with parameters δ = 0.53 and ∆EQ = 0.50. The purple 
simulation shows the Central Doublet, which is composed of Fe4S4 clusters and LS 
Hemes, with the parameters δ = 0.45 and ∆EQ = 1.14. The red simulations contain all of 
these features, and the respective percentages are outlined in Table 4.1. 
 
  
-1.0
-0.5
0.0
a
b
s
o
rp
ti
o
n
 [
%
]
-10 -5 0 5 10
velocity [mm/s]
-0.2
-0.1
0.0
0.1
a
b
s
o
rp
ti
o
n
 [
%
]
A
B
 79 
 
called “central doublet” (CD), which originates from S = 0 [Fe4S4]
2+
 clusters and LS 
Fe
2+
 heme centers (the two types of centers cannot be distinguished by MB), was similar 
to that obtained previously.
25
 The purple line above the spectrum, which simulates the 
CD, was generated using the parameters δ = 0.45 mm/s and ∆EQ = 1.14 mm/s at 8% 
intensity). The simplest interpretation of these differences is that ca. 100 µM of the 
vacuolar NHHS Fe
3+
 species in W303-1B cells were replaced by ca. 60 µM of 
nanoparticles and ca. 40 µM of NHHS Fe
2+
 in DY150 cells. We will argue below that 
this arises because vacuoles in DY150 cells are slightly less acidic (higher pH) than 
those in W303-1B cells.  
The EPR spectrum of DY150 cells grown on MM40 (to be called WT40 cells) 
was dominated by a g = 4.3 signal (Figure 4.2E) which arose from a mononuclear, 
NHHS Fe
3+
 S = 5/2 center with rhombic symmetry (E/D ~ 1/3).
16
 The spin concentration 
associated with this signal was ~ 130 μM (Table 4.1). This concentration was divided by 
the cellular Fe concentration (~350 μM in this sample) and the fraction of the NHHS 
Fe
3+
 sextet in the MB spectrum (0.55) to yield a [spin]/[HS Fe
3+
] ratio of 0.8. Given the 
large uncertainties associated with these determinations, we regard this ratio as 
acceptably close to 1. The g = 2 region was dominated by a Mn
2+
-based hyperfine split 
signal (see below), but it also included low intensity (2 - 5 μM) free-radical (g = 2.00) 
and gave = 1.94 signals.  
DY150 cells grown on MM containing 1 M 57FC (called WT1 cells) contained 
less Fe than WT40 cells (Table 4.1). The low-temperature low-field MB spectrum of  
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Figure 4.2. EPR of WT, ∆CCC1, and CCC1-up whole cells. A, WT1 cells; B, D1 
cells; C, UP1 cells; D, UP1+A cells; E, WT40 cells; F, D40 cells; G, UP40 cells; H, 
UP40+A cells. Spectra were collected at temperature 4K, microwave frequency 9.63 
GHz, and microwave power 0.2 mW. 
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WT1 cells (Figure 4.1B) was dominated by the CD. A NHHS Fe
2+
 doublet and HS Fe
2+
 
hemes were also strong. Minor amounts of nanoparticles and HS Fe
2+
 hemes were also 
evident. WT1 cells did not exhibit a g = 4.3 EPR signal (Figure 4.2A), suggesting the 
absence of NHHS Fe
3+
 associated with vacuoles. The corresponding MB spectrum 
(Figure 4.1B) was noisy and there was no evidence for a NHHS Fe
3+
 sextet. These 
results confirm that WT1 cells do not accumulate significant Fe in the vacuoles under 
Fe-deficient growth conditions (138).  
UV-vis spectroscopy was used to determine the concentrations of hemes a, b, 
and c in WT1 and WT40 cells (Figure 4.3, A and B; Table 4.1). The concentrations of 
the heme features did not change significantly as the medium FC concentration was 
increased. The total Fe content of yeast cells was decomposed into vacuolar Fe and 
mitochondrial Fe (112, 187). This suggests that the majority of heme centers in a yeast 
cell are probably mitochondrial. Similarly, the CD and HS Fe
2+
 heme concentrations 
determined by MB and ICP-MS also did not show significant changes in these features, 
which are also probably associated with the mitochondria. Viewed collectively, these 
results strongly suggest that the concentration of mitochondria in WT1 and WT40 cells 
was similar. The differences in intracellular Fe concentrations (170 vs. 490 μM) were 
largely due to differences in the Fe levels in the vacuoles (empty in WT1 cells; ca. 300 
M Fe in WT40 cells).   
 
 
 
 82 
 
 
Figure 4.3. Electronic absorption spectroscopy of WT, ΔCCC1, and CCC1-up whole 
cells. A, WT1; B, WT40; C, D1; D, D40; E, UP1; F, UP40; G, UP1+A; H, UP40+A. 
Cells were grown to OD600 = 1.0, washed 1x with EDTA and 2x with ddH2O, then 
diluted 1:3 with ddH2O.  
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∆CCC1 Cells  
The absence of CCC1 in this strain was verified by PCR (Figure 4.4, B). ∆CCC1 
cells grown on MM that were supplemented with 1, 10, 20 and 40 M Fe will be 
referred to as 1, 10, 20 and 40 cells, respectively. The Fe concentrations in these  
cells were ~20% less than in the corresponding WT cells (Table 4.1). The low-
temperature low-field MB spectrum of 1 cells (Figure 4.5A) was dominated by the CD. 
Although the spectrum was noisy, doublets due to NHHS Fe
2+
 and HS Fe
2+
 Hemes could 
be discerned; the red line is a composite simulation, using percentages given in Table 
4.1. EPR of Δ1 cells exhibited a very low intensity g = 4.3 signal, consistent with the 
MB spectrum devoid of a sextet. UV-vis spectra of 1 cells (Figure 4.4C) showed that 
the concentrations of reduced hemes in 1 cells were similar to those in WT1 cells. 
These results indicate that the absence of CCC1 under low-Fe conditions has no 
significant effect on cellular Fe content, relative to WT cells grown under similar 
conditions. This makes sense because vacuoles do not store Fe under low-Fe conditions 
and so the absence of the vacuolar Fe import will not be evident under these conditions.  
The MB spectrum of 10, 20, and 40 cells (Figure 4.5, B, C and D) exhibited less CD 
on a percentage basis than did the 1 spectrum (Figure 4.5A), but the absolute 
concentration of CD-associated Fe in CCC1 cells grown in media containing increasing 
concentrations of Fe was similar to that of 1 cells (Table 4.1). The concentrations of 
HS Fe
2+
 hemes also remained relatively constant as the FC concentration increased. The 
concentrations of reduced hemes in 1 and 40 cells, as monitored by UV-vis (Figure  
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 Figure 4.4. Verification of CCC1-up and ΔCCC1 strains. A, Western Blot of vacuoles 
isolated from UP40 and WT40 fermenting cells (40μg of protein per lane). B, PCR of 
WT40 and D40 fermenting cells grown with 40 μM Fe in the medium. The bands at 
1.5kb correspond to the PCR product of WT DNA (CCC1) and the bands at 2.5kb 
correspond to the PCR product of ∆CCC1 DNA.  The PCR reaction was conducted at 
54C and 58C, and even-numbered lanes were loaded with twice as much DNA 
compared with odd-numbered lanes. (These different conditions were run because we 
were unsure of the annealing temp of the primers and wanted to ensure there was a 
sufficient concentration of DNA to show a PCR product.) 
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Figure 4.5. 5 K, 0.05 T Mössbauer spectra of ∆CCC1 cells and isolated 
mitochondria. A, D1; B, D10; C, D20; D, D40; E, Mitochondria isolated from D40 
cells. The red lines are simulations of the entire spectrum using the percentages of each 
feature given in Table 4.1. The blue line is a simulation of the NHHS Fe
2+
 feature with 
parameters specified in Figure 1. 
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4.3C) were similar to each other and to the analogous concentrations in WT1 cells 
(Figure 4.3A) – 40 – 50 M for each condition. Collectively, these data indicate that the 
concentration of Fe-containing centers in the mitochondria of CCC1 cells was similar 
to that in WT cells and was largely unaffected by changes in the medium Fe 
concentration.  
The major changes occurring in the MB spectra of ∆CCC1 cells prepared in MM 
with increasing Fe concentration were increases in the sextet that reflects vacuolar 
NHHS Fe
3+
 and a NHHS Fe
2+
 doublet (Figure 4.5, B – D, and Table 4.1). The 
concentration of the vacuolar Fe increased from 0  110 μM; the latter value was less 
than half of the concentration observed with WT cells at the same (40 uM) Fe 
concentration in the medium. ∆40 cells exhibited a g = 4.3 EPR signal (Figure 4.2F) that 
was also about half as intense as the signal exhibited by equivalent WT cells. These 
results show that vacuolar NHHS Fe
3+
 in ∆40 declined to about 40% of WT levels. This 
indicates that ca. 60% of the Fe that is imported into vacuoles enters via Ccc1p; the 
remaining vacuolar Fe (which we observed here) enters via other pathways (e.g. END4). 
This result agrees with the previous estimate of Kaplan, et. al. (103). Regardless of 
import pathway, the resulting vacuolar Fe exhibits the same spectroscopic signature 
suggesting the same structure (i.e. a mononuclear NHHS Fe
3+
 complex).  
The most interesting spectral feature was the NHHS Fe
2+
 doublet. The 
concentration of this feature increased from 20  110 μM as the Fe concentration in 
CCC1 growth medium increased. This represents about twice the concentration 
observed in corresponding WT cells (compare the blue doublet line shown in Figure 
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4.5D to that in 1A). This species accumulates in the range of concentrations normally 
associated with the import of vacuolar Fe. This behavior is remarkably analogous to that 
hypothesized by Kaplan regarding the cytosolic Fe species. For this reason we propose 
that the NHHS Fe
2+
 complex giving rise to the doublet in MB spectra of CCC1 cells is 
the cytosolic Fe complex that normally (in WT cells) enters into the vacuole via the 
Ccc1p-dependent import pathway. Since the Fe concentration in ∆CCC1 cells is ~ 20% 
less than in equivalent WT cells, we further propose that this cytosolic Fe complex is 
sensed by the system that regulates Fe import into the cell. Accordingly, the higher 
concentration of this species would down-regulate Fe import, as observed. Finally, we 
found that 40 cells suffered ~ 4 times more oxidative damage than comparable WT 
cells (Figure 4.6). We propose that the cytosolic NHHS Fe
2+
 complex promotes Fenton 
chemistry which is responsible for the increased extent of oxidative damage. Further 
studies are of course required to test these proposals.   
 
ΔCCC1 Mitochondria  
The Fe concentration in mitochondria isolated from 40 cells (~860 μM) was slightly 
higher than the W303-1B mitochondria (~710 μM) (137, 138, 187). However, the same 
primary features were observed in MB spectra of ΔCCC1 mitochondria, including the 
CD, a NHHS Fe
2+
 doublet, a NP doublet, and a doublet due to HS Fe
2+
 hemes (Figure 
4.5E). The percentage intensities were similar to those of WT mitochondria except that 
the NHHS Fe
2+
 doublet was more intense (37%, 316 μM). The increased concentration  
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Figure 4.6. Oxyblot of WT40, D40, UP40, and UP2x40 cells. Lane 1: MW Standard, 
Lane 2: UP2x40, Lane 3: UP40, Lane 4: WT40, Lane 5: D40. This experiment was 
performed twice.  
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of NHHS Fe
2+
 in CCC1 mitochondria might have arisen from a higher level of 
mitochondrial Fe import due to the higher concentration of cytosolic Fe. This increased  
import could be due to a faster import rate, or to elevated levels of mitochondrial Fe 
import proteins in these conditions. 
 
CCC1-up Cells 
In this strain, CCC1 was overexpressed using a LEU2-marked multicopy plasmid 
that contained CCC1 under its native promoter; thus, CCC1-up cells were grown on MM 
lacking leucine. Western blot analysis of vacuoles isolated from CCC1-up cells grown 
on this medium and with 40 μM FC (abbreviated UP40 cells) indicated that these 
vacuoles contained approximately twice the normal concentration of Ccc1p compared to 
WT40 vacuoles (Figure 4.4).  
The concentration of Fe in CCC1-up cells grown with 1 μM FC in the medium 
(“UP1 cells”) was substantially higher than in WT1 cells (Table 4.1). The low-
temperature low-field MB spectrum of UP1 cells was dominated by a NHHS Fe
2+
 
doublet (Figure 4.7A). This feature was 2 – 4 times more intense than the corresponding 
feature in spectra of WT1 or 1 cells, corresponding to absolute concentrations of 130 
M in UP1 vs. 43 M in WT1 and 22 M in 1. A sextet and doublet due to NHHS Fe3+ 
and NP species, respectively, were also more intense relative to in WT1 (4.1B) and 1 
(Figure 4.1A) spectra. Consistent with this, the intensity of the g = 4.3 EPR signal 
exhibited by UP1 cells was also higher (compare Figure 4.2, C vs. A or B; also see Table 
4.1). The dominance of the NHHS Fe
2+
 doublet in the MB spectrum of UP1 cells  
 90 
 
 
Figure 4.7. Mössbauer spectra of CCC1-up cells grown at various FC 
concentrations. A, UP1; B, UP10; C, UP20; D, UP40; E, UP1+A; F, UP40+A. The red 
lines are simulations of the entire spectrum using the percentages of each feature given 
in Table 4.1, and the green line is a simulation of the NP feature using the parameters 
specified in Figure 4.1.   
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diminished our ability to quantify the intensity of the CD. However, after removing the 
contributions of the three major components (the NHHS Fe
2+
 doublet, the NHHS Fe
3+
 
sextet, and the NP doublet) little intensity remained that could fit to the CD. Consistent 
with this, the UV-vis spectrum of UP1 cells indicated a lower concentration of Fe
2+
 
hemes in UP1 cells, relative to in WT1 or 1 cells. 
Collectively, these results indicate that the concentration of mitochondria was 
lower in UP1 cells than in WT1 or 1 cells, while the concentration of vacuolar HS Fe3+ 
species was higher. The concentration of NHHS Fe
2+
 species was much higher in UP1 
cells than in WT1 or 1 cells, but the location(s) of these species is uncertain. 
The concentration of Fe in UP10 cells was about twice that in UP1 cells. The 
low-temperature low-field MB spectrum of these cells (Figure 4.7B) was similar to that 
of UP1 cells, with the NHHS Fe
2+
 doublet again dominating. The NHHS Fe
3+
 sextet was 
evident, as was a shoulder on the low-energy doublet line, due to a NP doublet. The 
intensity of the CD was again low, corresponding an Fe concentration of ~ 30 μM. This 
was similar to the concentration associated with the CD in UP1, UP20, and UP40 cells.  
The Fe concentration in UP20 cells was nearly twice that in UP10 cells, and the 
corresponding MB spectrum (Figure 4.7C) was correspondingly more intense. The 
NHHS Fe
2+
 doublet remained intense, but not as high (percentage-wise) as in spectra of 
UP1 or UP10 cells. The absolute concentration of this species was slightly higher but 
other features changed to a far greater extent. The major spectral change was an increase 
in the intensity of the NP doublet. The concentration of Fe associated with NPs more 
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than doubled in UP20 cells, relative to in UP10 cells. The concentration of the NHHS 
Fe
3+
 species also increased (Table 4.1).    
The Fe concentration of UP40 cells was nearly twice that in UP20 cells (Table 
4.1). Such a proportional increase in the cellular Fe concentration of UP cells with 
increasing Fe concentration in the medium (intracellular Fe concentrations doubling 
from 10 M  20 M Fe in the medium, and doubling again from 20 M  40 M) is 
unusual. It indicates that the import of Fe into these cells is effectively unregulated. This 
could arise if the regulatory system was defective in CCC1-up cells or that the 
concentration of the sensed Fe species used in regulating Fe import was consistently 
below the threshold concentration in CCC1-up cells. We will argue below for the latter 
explanation. 
The low-temperature low-field MB spectrum of U40 cells was again dominated 
by the NHHS Fe2+ doublet (Figure 4.7D).  In fact, the NHHS Fe
2+
 concentration in 
UP40 cells was the highest observed in this study. Curiously, Oxyblot analysis revealed 
that these cells exhibited less ROS damage than in ΔCCC1 cells (Figure 4.6). This raised 
the possibility that the majority of this NHHS Fe
2+
 might be sequestered in a manner that 
somehow avoids ROS formation. 
A strong NP doublet was also present, similar to the spectrum of UP20 cells 
(Figure 4.7C). The major difference between the UP40 and UP20 spectra was a more 
intense NHHS Fe3+ sextet. Consistent with this, EPR of UP40 cells showed an intense g 
= 4.3 signal representing ~415 μM HS Fe3+ ([spin]/[HS Fe3+] ~0.93; Figure 4.2G and 
Table 4.2).  
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Little intensity remained after the three dominant features were subtracted from 
this spectrum. The remaining intensity (~ 5%) fit to the CD and HS Fe
2+
 hemes (Table 
4.1). UV-vis analysis revealed that the levels of Fe
2+
 hemes were similar in UP1 and 
UP40 cells (Figure 4.3, E and F, respectively, and Table 4.1). These data indicate that 
mitochondrial Fe levels are lower in UP cells, regardless of the elevated intracellular Fe 
concentrations. We conclude that when CCC1 is overexpressed, less than the normal 
amount of Fe is trafficked into mitochondria. This indicates that there is some level of 
competition for cytosolic Fe between the mitochondria and the vacuoles. When vacuolar 
Fe import is elevated, the mitochondrial Fe levels decline. 
The MB spectrum of UP40 cells also exhibited a broad, magnetic feature that 
accounted for ~15% of the spectral intensity (~275 μM). At high temperatures (100K) 
this feature was absent and the signals in the central region of the MB spectrum 
increased, (data not shown). This feature overlayed with the NP feature which was 
present at low and high temperatures, resulting in a ~1.8x increase in this signal (45%). 
Variable temperature EPR of UP40 cells showed the appearance of a broad signal in the 
g = 2 region which displayed anti-Curie Law behavior; it was 5-times more intense at 
78K (Figure 4.8, black line) that it was at 10 K (red line). In these spectra, the g = 4.3 
signal intensity, which follows the Curie Law, served as a control. A similar though 
slightly broader signal has been observed in other samples which displayed a broad 
magnetic feature by MB (Park, et al., submitted). Broad g = 2 signals displaying anti-
Curie Law behavior have been observed in samples which contained high concentrations 
of NP (74, 178). 
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Figure 4.8. Variable temperature EPR spectra of UP40 cells. The red spectrum was 
collected at 10K; the blue line was collected at 22K; the black line was collected at 79K. 
Spectra were collected at microwave frequency 9.63 GHz, and microwave power 0.2 
mW. Spectra were normalized and plotted using SpinCount.  
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Adenine Deficiency of CCC1-up Cells 
As UP cells (UP1  UP40) reached an OD600 ~1.0, a pink color was observed, 
which indicated an adenine deficiency (188). The pink color is caused by the 
accumulation of an oxidized red adenine precursor (AIR) in yeast vacuoles. Standard 
MM, containing 50 mg L
-1
 of adenine is sufficient to suppress this phenotype in WT 
cells.  
Reducing this concentration 8-fold results in an adenine deficiency in WT cells 
(Park, et al., submitted). The Fe in adenine deficient WT cells is dominated by NHHS 
Fe
2+
 (J. Park, et al., submitted). We concluded that the vacuoles in adenine deficient 
cells are more reducing than in WT cells, causing vacuolar NHHS Fe
3+
 ions to be 
reduced to the Fe
2+
 state.  The pink color and high concentration of NHHS Fe
3+
 in UP40 
cells indicates that these cells are adenine deficient despite having been grown in 
medium containing the normal concentrations of adenine that is sufficient to prevent 
adenine deficiency in WT cells. This made us concerned that some (or all) of the 
phenotype that we would otherwise associate directly with the overexpression of Ccc1p 
might instead be associated with the adenine deficiency.  
To deconvolute these effects, we attempted to relieve the adenine deficiency in 
CCC1-up cells by growing them on MM medium containing twice the normal adenine 
concentration (100 mg/L). The resulting UP1+A cells did not turn pink. The 
concentration of Fe in UP1+A cells was slightly higher than in UP1 cells, but the MB 
spectra (Figure 4.7, E and A) were similar –dominated by a NHHS Fe2+ doublet. EPR 
and UV-vis spectra were also similar (Figures 4.2D and 4.3G). These results indicate 
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that under low-Fe growth conditions, the observed buildup of NHHS Fe
2+
 species is not 
due to an adenine deficiency in CCC1-up cells.  
The situation was somewhat different with UP40+A cells. They also did not 
develop a pink color, indicating the absence of an adenine deficiency. However, 
UP40+A cells contained about half as much total Fe as found in UP40 cells (Table 4.1), 
and the Fe was distributed differently. Relative to UP40 cells, the proportion of Fe due to 
NHHS Fe
2+
 species in UP40+A cells was lower while the proportions due to NHHS Fe
3+
 
and NP were higher. This afforded a MB spectrum (Figure 4.7F) that was reminiscent of 
the WT40 spectrum (Figure 4.1A). The concentrations of Fe species associated with 
mitochondria, including the CD (Figure 4.7F) and heme centers (Figure 4.4H) were not 
noticeably affected by relieving the adenine deficiency.   
Like UP40 cells, UP40+A cells also exhibited a broad g = 2 feature by EPR 
which displayed anti-Curie law behavior. Despite having a lower cellular Fe 
concentration, UP40+A cells exhibited a g = 4.3 EPR signal (Figure 4.3H) with greater 
intensity than that exhibited by UP40 cells.  This confirms the shift from mononuclear 
NHHS Fe
2+
 to Fe
3+
 as UP40 cells were relieved of their adenine deficiency. This means 
that ~75% of the NHHS Fe
2+
 observed in UP40 cells was due to the adenine deficiency 
(not due to the overexpression of Ccc1p). Interestingly, the loss of this NHHS Fe2+ 
resulted in a decline in the concentration of cellular Fe. If that NHHS Fe2+ were the 
sensed form of Fe in the cytosol, we would expect that its decline would be associated 
with an increase in cellular Fe. Since the opposite happened, we propose that some 
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(perhaps most) of the NHHS Fe
2+
 species present in CCC1-up cells are NOT being 
sensed by the system that regulates the import of Fe into the cell.  
 
Effect of Concanamycin A (ConA) 
Previous studies have shown a connection between the Fe content and pH of 
vacuoles (149, 189, 190), so we wondered whether some of the observed changes in the 
Fe distribution of the cell upon deleting or overexpression Ccc1p might be related to 
changes in vacuolar pH. ConA increases the pH of the vacuoles by inhibiting the 
vacuolar H
+
-ATPase following glucose-deprivation (149, 191).  Depriving WT40 cells 
of glucose and then adding glucose back 10 min later, as prescribed by the protocol, 
resulted in a decline in the vacuolar NHHS Fe
3+
 sextet and an increase in the NHHS 
Fe2+ doublet (Figure 4.9A). All of the samples treated in this way contained ~2-fold 
higher Fe compared with WT40 whole cells, suggesting that the glucose 
deprivation/loading protocol was responsible for the elevated Fe levels. We don’t 
understand this effect on the molecular level, but it served as our control nonetheless 
(moreover, it highlights the redox sensitivity of vacuolar Fe to perturbations in cellular 
metabolism). 
The MB spectrum of the ConA treated sample (Figure 4.9C) exhibited more of 
the NP doublet and less of the NHHS Fe
2+
 than the sample treated with glucose alone 
(Figure 4.9B). This shift is highlighted by the difference spectrum shown in Figure 4.9D.  
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Figure 4.9. Mössbauer spectra of cells that were resuspended in MM containing 
40μM FC and deprived of glucose for 10 minutes. A, ConA and glucose were added 
to the cell suspension which was immediately packed into a MB cup and frozen; B, same 
as A, but without ConA and frozen after 15 min of incubation; C, same as A but frozen 
after 15 min incubation; D, difference spectrum of B and C. The red lines are 
simulations of the entire spectrum, and the percentages of each feature are shown in 
Table 4.1. 
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We conclude that rendering the vacuoles less acidic causes some intracellular NHHS 
Fe
2+
 to convert into NP. This process involved oxidation and probably ligand exchange. 
This suggests that at least some of the NHHS Fe2+ species in CCC1-up cells are either 
located in vacuoles (or are closely associated with vacuolar NHHS Fe
3+
).    
Parenthetically, a broad magnetically-interacting form of Fe was evident in the 
low-temperature MB (~15%, 160 μM) of ConA-treated cells (Figure 4.9C; notice the 
discrepancy between the simulation and the data in the central region of the spectrum). 
At high temperatures (100 K) this material collapsed into an unresolved doublet with 
parameters typical of nanoparticles appeared (data not shown). An Fe species which 
behaved in a similar manner was also observed in AD CCC1-up cells (280 μM), which 
also contained high levels (> 1 mM) of intracellular Fe. A similar feature has also been 
observed in WT samples which grew for 5 days on MM supplemented with high levels 
of Fe (Park, et al. 2013, submitted). 
 
Manganese Homeostasis  
Although not the focus of this paper, some effects involving Mn seem relevant to 
our understanding of the effects of CC1 and CCC1-up on Fe metabolism. The g = 2 
regions of the WT1 and WT40 EPR spectra (Figure 4.3, A and D) were dominated by a 
Mn
2+
-based hyperfine split signal, quantifying to a spin concentration of ~35 μM in both 
spectra. This concentration was normalized to the cellular Mn concentration (~35 ± 5 
μM), yielding a [spin]/[Mn] ratio of ~ 0.9 (Table 4.2). This confirms a previous report 
that the vast majority of the Mn in yeast cells is EPR active (138), and demonstrates that  
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Strain 
[Fe] ICP-MS; 
[NHHS Fe
3+
]  
(μM) 
[Fe
3+
] 
(EPR) 
[spin]/[Fe
3+
] 
[Mn]  
ICP-MS 
(μM) 
[Mn
2+
] 
(EPR) 
[spin]/[Mn
2+
] 
WT1 163 (0) 0 - 32 29 0.91 
WT40 349 (170) 152 0.79 37 36 0.97 
D1 123 (0) < 1 - 16 < 10 - 
D40 263 (84) 73 0.87 17 < 10 - 
UP1 395 (35) 30 0.86 64 61 0.95 
UP40 2428 (413) 372 0.90 71 67 0.94 
UP1+A 395 (40) 39 0.98 83 76 0.91 
Up40+A 976 (439) 415 0.95 85 75 0.88 
 
 
Table 4.2. Fe
3+
 and Mn
2+
 concentrations and spin quantitations of cells studied in 
these experiments. These signals were quantified as described in Table 4.1. 
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the cellular Mn concentration is not significantly affected by the concentration of Fe in 
the growth medium.  
The spin concentration of the Mn
2+
 based signal exhibited by CCC1 cells were 
lower (< 10 μM), reflecting a lower Mn concentration in these cells (~16 μM, Table 4.2). 
Besides transporting Fe into vacuoles, Ccc1p also transports Mn
2+
 (103, 157). Therefore, 
when Ccc1p is absent, cytosolic Mn
2+
 may be unable to enter into vacuoles and the 
buildup of cytosolic Mn
2+
 which may inhibit further Mn import into the cell.  
The concentration of Mn in CCC1-up cells (including UP1, UP40, UP1+A, and 
UP40+A) was ca. 76 M, which is double the concentration of Mn in WT cells and 
about 5 times the concentration in CCC1 cells. These results are consistent with reports 
that cellular Mn is elevated when Ccc1p is overexpressed (103). The intensity of the 
Mn
2+
 signal in the EPR spectrum of UP1 cells was also greater than in WT1 or D1 cells, 
affording a [spin]/[Mn] ratio of ~ 0.9. Again, this indicates that the vast majority of the 
Mn in UP1 cells is EPR-active Mn
2+
 species. The Mn
2+
 signal intensities exhibited by 
UP1, UP40 and UP40+A cells were similar (Tables 4.1 and 4.3). This indicates that the 
Mn
2+
 levels were not affected by adenine supplementation or the Fe concentration in the 
medium.  
 
Discussion and Conclusions 
Synopsis 
Ccc1p is a vacuolar Fe importer in yeast. CCC1 and Cccp1 overexpression 
(UP) strains were evaluated by Mossbauer, EPR, UV-vis and ICP-MS. The objective of 
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the study was to detect the cytosolic Fe that is imported by Ccc1p into vacuoles, and the 
vacuolar Fe that resulted from this importation. Cells were grown on minimal medium 
containing 1  40 µM Fe. CCC1 cells contained ~20% less Fe than WT cells. The 
absence of CCC1 under low-Fe conditions did not affect cellular Fe content, relative to 
WT cells, probably because vacuoles do not store Fe under low-Fe conditions.  
Most of the Fe in 1 cells (grown with 1 µM Fe) was mitochondrial but some 
nonheme high-spin (NHHS) Fe
2+
 was evident. The concentration of Fe centers in 
CCC1 mitochondria was independent of the Fe concentration in the medium (1  40 
µM), and was similar to that in WT cells. Most of the changes in the Fe content of 
CCC1 cells occurred when the concentration of Fe in the growth medium was in the 
range in which vacuoles load Fe in WT cells (i.e. 10  40 µM). In this range, the 
concentration of vacuolar Fe
3+
 in CCC1 cells increased as the medium Fe concentration 
increased, but only to 60% of the level observed in WT cells; this represents the 
percentage of Fe imported into WT vacuoles via Ccc1p. Regardless of import pathway, 
the resulting vacuolar Fe exhibits the same spectroscopic signature suggesting the same 
or related structure; i.e. a mononuclear NHHS Fe
3+
 complex.  
The concentration of NHHS Fe
2+
 also increased in CCC1 cells as the Fe 
concentration in the growth medium increased within the vacuolar Fe-loading range. The 
concentration of NHHS Fe
2+
 in CCC1 cells grown with 40 µM Fe was about twice that 
observed in corresponding WT cells. The combined concentration of NHHS Fe
2+
 and 
Fe
3+
 in 40 cells was about the same as the NHHS Fe3+ level in WT40 vacuoles. The 
NHHS Fe
2+
 species in CCC1 cells is proposed to be the cytosolic Fe complex that in 
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WT cells enters the vacuoles via Ccc1p. The same Fe
2+
 species is proposed to be sensed 
by the system that regulates Fe import into cells (Aft1p). Aft1p is active when cytosolic 
Fe levels are low, but is inactive when cytosolic Fe is high. As the medium Fe 
concentration is raised from 1  40 μM, less Fe is imported in CCC1 cells than in WT 
cells. These results suggest that the accumulated NHHS Fe
2+
 species in ∆CCC1 cells is 
sensed (either directly or indirectly) by Aft1p. When Aft1p senses high-Fe levels, Fe 
import decreases. Moreover, 40 cells suffered ~ 4 times more oxidative damage than 
comparable WT cells, suggesting that the cytosolic NHHS Fe
2+
 complex may promote 
Fenton chemistry.  
The same NHHS Fe
2+
 species is probably imported into mitochondria. 
Mitochondria isolated from 40 cells contained slightly more Fe than WT40 
mitochondria, with higher levels of NHHS Fe
2+
 which might have arisen from a higher 
level of mitochondrial Fe import, due in turn to the higher concentration of cytosolic Fe. 
The concentration of Fe in UP1 cells was substantially higher than in WT1 or 1 cells. 
Most of the Fe was present as NHHS Fe
2+
; NHHS Fe
3+
 and NP species were also 
abundant. The concentration of mitochondrial Fe in Cccp1-up cells was low relative to 
in WT or CCC1 cells, perhaps because these organelles cannot import sufficient 
cytosolic Fe (due to a deficiency in this species).  
As the concentration of Fe in the medium increased 4 fold (10  20  40 µM), 
the Fe concentration in the cell increased proportionately, suggesting that the import of 
Fe into CCC1-up cells is effectively unregulated, perhaps because the concentration of 
the sensed Fe used in regulating Fe import was consistently below a threshold 
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concentration. UP40 cells contained the highest NHHS Fe
2+
 concentration measured but 
exhibited less ROS damage than ΔCCC1 cells. Some of the NHHS Fe2+ in these cells 
might be sequestered in a manner that avoids ROS formation. The concentration of Fe 
due to NP’s (and NHHS Fe3+) increased in the range of medium Fe concentrations 
associated with vacuolar Fe loading in WT cells.  
A new type of NP was observed in UP40 cells. Ccc1-up cells were adenine 
deficient when grown on normal MM, but this deficiency could be removed by growing 
them on MM that contained twice the normal adenine concentration. Vacuoles are 
reducing under adenine deficient conditions, such that some NHHS Fe
3+
 is converted to 
NHHS Fe
2+
. Adenine sufficient Cccp1-up cells contained about half as much NHHS 
Fe
2+
 as adenine deficient UP cells, suggesting that about half of the Fe buildup in UP40 
cells (and half of the NHHS Fe
2+
 observed) was associated with an adenine deficiency 
rather than Ccc1p overexpression.  
UP40 cells shifted from mononuclear NHHS Fe
2+
 to Fe
3+
 when the adenine 
deficiency was relieved. The decline in cellular Fe concentration along with the loss of 
NHHS Fe
2+
 (as adenine deficiency was relieved) suggested that the NHHS Fe
2+
 was not 
the sensed form of Fe in the cytosol. Instead, these results suggest that the NHHS 
Fe
2+
 accumulation is related to adenine deficiency. Adenine deficiency leads to the 
accumulation of a glutathione conjugate in in the vacuoles, which causes the vacuoles to 
be more reducing (192). This could promote the accumulation of NHHS Fe
2+
. Increasing 
the pH of vacuoles in WT40 cells caused NP levels to increase and NHHS Fe
2+
 levels to 
decrease. At least some of the NHHS Fe
2+
 species in CCC1-up cells are located in 
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vacuoles or are closely associated with vacuolar NHHS Fe
3+
.  Virtually all of the Mn in 
the cell was EPR-active Mn
2+
. CCC1 cells contained about half the Mn concentration 
of WT cells, and WT cells contained about half the Mn concentration of UP cells. This 
can be explained, since CCC1 also imports Mn from the cytosol to the vacuole. Deletion 
of CCC1 might increase the cytosolic Mn concentration which would inhibit Mn import 
into the cell. Ccc1p overexpression would cause greater Mn import into the vacuole, 
creating a deficiency of Mn in the cytosol which would upregulate Mn import into the 
cell.   
 
Vacuoles and Mitochondria Share a Common Fe Pool  
The Fe content of yeast cells can roughly be divided into two groups; vacuolar 
and mitochondrial. In WT40 cells, about 75% of cellular Fe is located in vacuoles while 
approximately 20% is located in mitochondria. Other forms of Fe (in other locations) are 
undoubtedly present, but they cannot be observed by MB spectroscopy because the 
collective concentration of such species is less than ca. 10% of spectral intensity.  
Although we and others have hypothesized the presence of cytosolic Fe, direct 
evidence for this form of Fe (e.g. by MB spectroscopy) is lacking. Kaplan has reported 
extensively on this issue, and have provided strong (albeit circumstantial) evidence that a 
single form of cytosolic Fe is imported into both mitochondria and vacuoles, and that the 
two organelles essentially compete for this form of Fe. Thus, deletion of the 
mitochondrial Fe importers MRS3/4 is thought to lead to an increase of cytosolic and 
vacuolar Fe. Similarly, deletion of the vacuolar Fe importer Ccc1p is thought to increase 
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the level of cytosolic and mitochondrial Fe. Correspondingly, overexpression of Ccc1p 
would be expected to cause a decrease of cytosolic Fe (and a decrease in mitochondrial 
Fe). These hypotheses motivated the current study, as they provide a strategy to detect 
(and ultimately identify) cytosolic Fe.   
 
WT Fe Distributions are Different in W303-1B and DY150 Cells  
We compared the DY150 and W303-1B cells to establish the WT background for 
these studies. DY150 cells showed higher ratios of NP to NHHS Fe
3+
 than W303-1B 
cells. Both NP and NHHS Fe
3+
 have been observed in vacuoles, and we have proposed 
that a higher vacuolar pH could cause a shift from NHHS Fe
3+
 to NP (112). These data 
showed that WT strains which were derived from the same background (W303) and are 
isogenic can have slightly different intracellular Fe distributions. NP accumulation has 
been observed in cells which have Fe overload phenotypes (i.e., Aft1-1
up
), and in 
isolated vacuoles (74, 112, 178). In DY150 cells the overall Fe concentration was similar 
to W303-1B cells, which shows that the NP accumulation was not due to increased Fe 
uptake. Therefore, the differences in WT DY150 and W303-1B cells could be due to a 
slightly less acidic vacuolar environment in DY150 cells. 
 
ΔCCC1 Cells are Fe-Replete 
The regulation of Fe import into yeast has been well studied, and both high- and 
low-affinity transporters on the plasma membrane have been identified (19, 33-35, 44, 
159). Also, the major Fe-sensitive transcription factor involved (Aft1p) and the 
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mechanism by which it activated the Fe regulon genes has been well documented (35, 
123, 126, 182, 183). Aft1 toggles between the cytosol and the nucleus in an Fe-
dependent fashion (126, 183).  
What remains unknown is the particular form and location of the Fe species that 
serves as a sensor in this regulation. In principle, the homeostatic regulatory process 
would sense the concentration of this species and compare it to some threshold 
concentration. When the sensor concentration exceeds the threshold concentration, the 
rate of Fe import would decrease; when it was less than the threshold, the Fe import rate 
would increase. In the simplest situation, the sensor would be located in the cytosol (but 
other scenarios are possible).   
In the most basic scenario, the same cytosolic Fe species that is imported into 
vacuoles and mitochondria would also be sensed by the regulatory system. In this case, a 
buildup of cytosolic Fe would be expected to lower the cellular Fe concentration, while a 
deficiency in cytosolic Fe would be expected to raise the cellular Fe concentration. This 
is essentially the behavior that we observed. The ΔCCC1 strain exhibited somewhat 
lower Fe concentrations than WT cells, consistent with a buildup of the sensed molecule.  
  
NHHS Fe
2+ in ΔCCC1 Cells is the Cytosolic LIP  
Our studies of ΔCCC1 fully supports the Kaplan hypothesis in that we indeed 
observed a decline in vacuolar NHHS Fe
3+
 and the formation of a new form of Fe - 
NHHS Fe
2+
- which we propose is the long-sought-after cytosolic Fe. Although further 
studies will be required to isolate and characterize this(these) species, the current study  
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Figure 4.10. Model for Fe Trafficking in WT, ΔCCC1, and CCC1-up cells. These 
models are based on the effects that we have observed in these studies, and that have 
been previously proposed in the Kaplan hypothesis.   
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allowed quantification of this species under various circumstances. The NHHS Fe
2+ 
nature of this species fits well with our expectations that it is involved in cellular Fe 
trafficking into vacuoles and mitochondria. High spin complexes are generally correlated 
with weak/labile coordinating ligands. Fe involved in trafficking would be expected to 
have weak and labile ligands, as the ligand environment of the trafficking Fe would 
likely change as the Fe reaches its final destination in the cell. Tightly bound ligands, 
which might give rise to low-spin configurations, might not dissociate as needed. These 
same types of NHHS Fe
2+
 complexes would also be expected to participate in Fenton 
chemistry and be associated with an increase in ROS damage. In agreement with this 
expectation, CCC1 cells exhibited substantially higher ROS damage than equivalently 
grown WT cells. A model of Fe trafficking in ΔCCC1 cells is proposed in Figure 4.10. 
 
CCC1-up Cells Accumulate an Un-sensed form of NHHS Fe
2+
  
The Cccp1-up strain accumulated Fe, consistent with a deficiency in the sensed 
Fe. One apparent inconsistency with this model and our results is that the CCC1-up 
strain contained a high concentration of NHHS Fe
2+
. By MB spectroscopy, the 
parameters of the doublet associated with this species were indistinguishable from those 
associated with the NHHS Fe
2+
 species in ΔCCC1 cells. Thus, one might regard the two 
species as the same, e.g. both cytosolic, sensing, and used for import into vacuoles and 
mitochondria.  
However, we argue that these represent different species, with only the NHHS 
Fe
2+
 species in ΔCCC1 cells being sensed in the cytosol and used for import into 
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vacuoles and mitochondria. The NHHS Fe
2+
 species in CCC1up cells, we argue, is not 
sensed or used for import into these organelles. Either it is sequestered in the vacuoles, 
or it is cytosolic but is bound in a way that cannot be sensed. Sensing ultimately would 
involve binding recognition and thus the structure of the NHHS Fe
2+
 complex would be 
critical.  
What is our evidence for this? First, Fe accumulates in CCC1-up cells, which 
indicates that these cells “feel” Fe deficient. This means that the concentration of the 
sensed form of Fe is much greater than the threshold concentration. The concentration of 
Fe in this strain was nearly directly proportional to the concentration of Fe in the 
medium (see Table 4.1), which indicates that Fe import is not regulated in CCC1-up 
cells under these conditions. This lack of regulation could result if the concentration of 
the sensed Fe were substantially lower than threshold throughout this medium 
concentration range.  
The second line of evidence is that as the NHHS Fe
2+
 concentration of Ccc1-up 
cells declined (e.g., UP40 to UP1), the total cellular iron concentration also declined. If 
the NHHS Fe
2+
 was the sensed species in Cccp1-up cells, then lowering its concentration 
should cause the Fe concentration in the cell to increase – opposite of what was 
observed. A model of Fe trafficking in CCC1-up cells is proposed in Figure 4.10. 
  
Reducing Conditions and Increased Vacuolar pH Promote NHHS Fe
2+
 Accumulation  
Most of the effects that we observe are due to changes in vacuolar Fe. We can 
rationalize these changes by assuming a thermodynamic box in which the Fe contents of  
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Scheme 4.2. Thermodynamic Box Model of Vacuolar Fe Distributions. The ratios of 
these species change based on the redox environment and pH conditions of the vacuoles. 
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the vacuole is controlled by redox status and pH (Scheme 4.2). This model proposes that 
the vacuolar Fe can exist in four different states. In oxidized conditions the vacuolar Fe 
will exist in the 3+ oxidation state. The vacuolar pH then determines if the Fe
3+
 is 
present as NHHS Fe
3+
 (e.g., W303-1B WT) or as NP (e.g., DY150 WT). In reduced 
conditions the vacuolar Fe is in the ferrous (2+) form. The ligands which chelate this Fe 
could be protonated (LH) or deprotonated (L
-
) based on the pH.  
According to this model, low pH conditions would favor NHHS Fe
2+
:LH and 
NHHS Fe
3+
 will be dominant, while NHHS Fe
2+
:L
-
 and NP are favored at higher pH. 
Cells treated with ConA (a specific V
+
-ATPase inhibitor) have higher vacuolar pH’s 
than untreated cells (101, 193, 194). Here, we observed accumulation of NHHS Fe
2+
 and  
NP in ConA-treated cells (Figure 4.9). Similar Fe distributions were also 
observed in UP40 cells. Based on our model, we hypothesize that the vacuolar pH is 
higher and more reducing in UP40 cells than in WT cells. The vacuolar pH could 
increase as a result of excess H
+
 export during Ccc1p-mediated Fe
2+
 import (195).  
The addition of excess adenine to UP40 cells showed lower NHHS Fe
2+
 and 
more NP. According to the thermodynamic model, NP formation is favored in oxidizing 
and high pH conditions. This would suggest that adenine deficiency leads to a more 
reducing vacuolar environment, as predicted in Park, et al. (submitted). The pH in these 
cells would be higher due to Ccc1p overexpression and elevated Fe
2+
 import.  
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CHAPTER V 
CONCLUSIONS 
The overall goal of these studies was to determine the form of Fe in vacuoles and 
how these organelles are involved in cellular Fe homeostasis. The initial studies were 
focused on isolating large quantities of purified intact vacuoles which could be studied 
with biophysical and bioanalytical techniques. In previous work with whole cells, Dr. 
Greg Holmes-Hampton showed that the dominant Fe species was NHHS Fe
3+
 (~75%). 
When mitochondria were isolated, this feature was not present. Therefore, the goal of 
this project was to determine if isolated vacuoles contained the major NHHS Fe
3+
 
species observed in whole cells but not in isolated mitochondria.  
Chapter III discusses the process of isolating sufficient quantities of vacuoles for 
biophysical analysis, and the form of stored Fe in isolated vacuoles grown with 40 μM 
FC in the medium. The isolated vacuoles did not contain as much Fe as we expected 
based on whole cell calculations (~300 μM vs. ~1 mM). The vacuoles are extremely 
delicate organelles, and any disruption during the isolation procedure could induce Fe 
loss. EM showed that vacuoles were intact, which implies that Fe could be lost through 
protein-mediated export. 
Biophysical analyses of isolated vacuoles showed that Fe exists primarily in two 
forms: NHHS Fe
3+
 and NP. The ratios of these two forms varied between ~20 different 
WT preps, with 60-85% NHHS Fe
3+
 and 15-40% NP. Model compounds of Fe
3+
 
polyphosphate, Fe
3+
 monophosphate, and Fe
3+
 hexaaqua were made in order to 
determine if these are possible ligands involved in Fe storage. At pH 5.0 (the average 
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vacuolar pH), Fe
3+
 polyphosphate showed a sextet with the same Mössbauer parameters 
as vacuolar NHHS Fe
3+
. Fe
3+
 monophosphate gave a quadrupole doublet with similar 
parameters to NP. When the pH was raised to 7.0, Fe
3+
 polyphosphate was redistributed 
to give NHHS Fe
3+
 and NP. From these studies, we concluded that vacuolar Fe is stored 
as NHHS Fe
3+
 with a polyphosphate-like ligand in low pH conditions. An increase in the 
vacuolar pH induces a shift from NHHS Fe
3+
 to NP.  
We also investigated strains where the vacuolar Fe import protein, Ccc1p, was 
deleted or was overexpressed (Chapter IV). These strains were made in DY150 cells, 
which have a W303 background. The DY150 strain contained more NP than W303-1B 
cells, which could result from a slightly higher vacuolar pH in DY150 cells.  
Kaplan, et al., proposed that there is a common pool of cytosolic Fe that is shared 
between the mitochondria and the vacuoles (Li, 2004). In conditions where Ccc1p is 
absent (ΔCCC1) this cytosolic Fe pool accumulates and vacuolar Fe declines. We 
observed that ΔCCC1 cells contained more NHHS Fe2+ and less vacuolar NHHS 
Fe
3+
 than WT cells. 
MB of mitochondria isolated from ΔCCC1 cells showed overall higher Fe 
concentrations and ~2x higher levels of NHHS Fe
2+
 compared with WT, which 
suggested that accumulation of cytosolic Fe promotes mitochondrial Fe accumulation. 
This was consistent with the Kaplan hypothesis that the mitochondria and vacuoles share 
a common Fe pool. We proposed that the NHHS Fe
2+
 which accumulates in ΔCCC1 
cells is cytosolic.  
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The Ccc1p-overexpression strain was also investigated in Chapter IV. CCC1-up 
cells showed increased levels of NHHS Fe
3+
 and NP compared with WT cells. Both 
NHHS Fe
3+
 and NP were previously observed in isolated vacuoles, which indicated that 
the vacuolar Fe was elevated with Ccc1p overexpression. Vacuoles isolated from CCC1-
up cells primarily contained NP (> 80%), which indicated that the vacuolar pH was 
lower in CCC1-up cells than in WT cells. We proposed that the vacuolar pH increases in 
this strain due to excess Fe import and H
+
 export.  
The CCC1-up cells also showed a surprisingly high concentration of NHHS Fe
2+
. 
ΔCCC1 cells also showed an accumulation of NHHS Fe2+, but the overall Fe 
concentration was lower than WT, which indicated that this Fe was sensed by the cell. 
CCC1-up cells accumulated ~3x more total Fe and ~10x more NHHS Fe
2+
 than WT, 
which suggested that the Fe import was not shut down in this case. We proposed that the 
NHHS Fe
2+
 that accumulated in CCC1-up cells was sequestered such that it was not 
sensed by Aft1p. 
CCC1-up cells also demonstrated an adenine deficient (AD) phenotype, which 
leads to the accumulation of a red pigment in the vacuoles. Previous studies on AD WT 
cells have been conducted by Mr. Jinkyu Park, a graduate student in the Lindahl lab. In 
low-adenine grown WT cells an accumulation of NHHS Fe
2+
 was also observed. In 
CCC1-up cells, when the medium adenine concentration was raised 2-fold (UP2x40) the 
CCC1-up cells contained less NHHS Fe
2+
 than normal-adenine CCC1-up cells. This 
showed that the accumulation of NHHS Fe
2+
 was most likely related to adenine 
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deficiency, which could promote a more reducing vacuolar environment. The 
mechanism for this process was summarized in the model proposed in Chapter IV. 
We also hypothesized that the accumulation of NP in CCC1-up cells could be 
related to elevated vacuolar pH. To investigate this, WT cells were treated with ConA to 
inhibit the V
+
-ATPase. WT cells treated in this manner showed a Fe distribution very 
similar to CCC1-up cells. This indicated that maintaining a low vacuolar pH influences 
NHHS Fe
3+
 levels, and that disrupting this system results in the formation of NHHS Fe
2+
 
and NP. These experiments led us to develop a predictive mathematical model, which 
summarizes the effects of vacuolar pH and redox status on intracellular Fe distributions. 
Overall, these studies demonstrated that the vacuoles play an important role in cellular 
Fe homeostasis. The pH and redox environments of these cellular compartments must be 
maintained in order to properly utilize, traffic, and store intracellular Fe.  
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CHAPTER VI 
FUTURE WORK 
Vacuoles are central in maintaining intracellular Fe homeostasis, and the studies 
presented here have demonstrated that changes in the vacuolar environment leads to a 
disruption of intracellular Fe distributions. In Chapter IV, cells were treated with 
concanamycin A to inhibit the V
+
-ATPase and to study changes in intracellular Fe 
distributions. It would be interesting to investigate how Fe distributions change in 
mutants which are deficient in vacuolar acidification (i.e., vma mutants). The Vma 
proteins are essential for proper V
+
-ATPase assembly and function, and have shown 
alterations in Fe homeostasis (149, 189, 190). These cells sense Fe deficiency and 
activate Aft1p, which elevates cellular Fe import. It would be interesting to determine if 
these cells show similar Fe distributions to other strains which have been investigated- 
particularly CCC1-up. We expect the vma and CCC1-up cells to be similar based on the 
ConA studies presented in Chapter IV of this dissertation. These studies could reveal 
information about how intracellular Fe distributions change when the vacuolar pH is 
disrupted, and may provide further support for the model proposed in Chapter IV. 
The form(s) of Fe which is(are) transported via Ccc1p into the vacuoles 
has(have) not been identified, but some groups suggest that molecules like glutathione or 
2,5-DHBA could be responsible for intracellular Fe trafficking (24). It would be 
interesting to incubate isolated vacuoles with these different Fe-bound molecules to 
determine if Fe could accumulate in isolated vacuoles. Because ICP-MS is able to detect 
different isotopes, this could be done using 
56
Fe and 
57
Fe, which are readily available in 
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the Lindahl laboratory. These studies could provide some information about the 
specificity of Ccc1p and potentially give information about the components of the 
cytosolic LIP. These studies could also be performed with isolated mitochondria, to 
determine if the same species taken up by vacuoles could be brought in to the 
mitochondria. If one (or more) of these species are transported into the mitochondria and 
the vacuoles, this would provide further evidence that the vacuoles and the mitochondria 
share a common pool of Fe in the cytosol.  
The composition of the cytosolic LIP must be determined in order to fully 
understand intracellular Fe trafficking. Currently, LC-ICP-MS studies are being 
conducted with the WT and ∆CCC1 strains. At this time, the lack of reproducibility of 
the Fe traces in these experiments has revealed the complications involved in isolating 
labile Fe trafficking complexes. In the studies presented in this dissertation, we have 
suggested that redox and pH effects can alter the distribution of intracellular Fe 
complexes which may or may not be involved in trafficking. LC-ICP-MS separations 
experiments could be used to determine if the concentrations of Fe species in whole cells 
change with various redox or pH conditions.  
Additional experiments could also be used to determine the composition of the 
cytosolic LIP. For example, a protocol to isolate cytosol (mostly free of vacuolar 
components) could be developed. Current protocols in which “cytosol” is isolated 
involve harsh lysis procedures with glass beads or sonication. These techniques result in 
soluble lysate fractions, but are most likely contaminated with vacuolar and/or 
mitochondrial material which could be released during lysis. We have shown in Chapter 
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III that the vacuoles are very delicate organelles that must be isolated with a gentle lysis 
procedure. Therefore, to obtain a more purified cytosolic fraction a gentler lysis method 
could be employed. For example, mammalian cells are typically lysed using N2 
cavitation. This technique is used for isolating mammalian lysosomes, which are 
structurally and functionally similar to the yeast vacuoles (102). Isolating these delicate 
organelles in this manner demonstrates a possible way to isolate cytosol from yeast cells. 
The yeast cells could be treated to form spheroplasts, resuspended in a minimal amount 
of buffer, and lysed with N2 cavitation. The resulting lysate fraction would most likely 
contain intact organelles, which could be separated from the cytosolic fraction by 
differential centrifugation.  
Iron metabolism is related to many cellular processes, and there are various 
studies which have provided genetic, molecular, biochemical, and biophysical 
information about intracellular Fe trafficking. The studies presented here have provided 
insight into vacuolar Fe dynamics and metabolism which had not been previously 
observed. There are many questions that remain, but the information gained from these 
studies has provided a more complete picture of vacuolar Fe distributions and 
trafficking.  
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APPENDIX A  
IRON TRAFFICKING IN MAMMALIAN SYSTEMS 
 The studies presented in Appendices A, B, and C were performed as a group 
effort with Dr. Lora Lindahl, Dr. Mrinmoy Chakrabarti, Dr. Gregory Holmes-Hampton, 
Mr. Sean McCormick, and Mr. Jinkyu Park. The goal of these projects was to analyze 
the Fe distributions in mouse brains using biophysical and bioanalytical techniques. My 
role in these projects was to care for the animals, perform organ dissections, prepare 
samples for the appropriate studies, and participate in discussions to analyze and 
understand these systems.  
 
Iron Uptake in Mammalian Systems 
The second portion of this dissertation focuses on the importance of iron in 
mammalian systems, specifically in the brain.  Iron delivery in mammalian systems (ie, 
mice, humans) is more complex than in S. cerevisiae, although there are some 
similarities between the systems.  In mammals iron is absorbed from the diet by 
enterocytes in the duodenum as either heme or nonheme iron.  Heme iron (ie, from 
meats) is transported by heme carrier protein 1 (HCP1).  Nonheme iron (ie, from 
vegetables) absorption is facilitated by a reductase (DCytb1) and divalent metal transport 
protein (DMT1).  DMT1 is a member of the Nramp-family of metal transporters, which 
also includes Smf proteins in yeast, and will transport divalent metals including Fe
2+
, 
Cu
2+
, Mn
2+
, Zn
2+
, Co
2+
, Cd
2+
, and Pb
2+
 (1).  While this protein is not specific for iron, it 
is highly expressed under low-iron conditions.  Because extracellular iron exists as Fe
3+
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it must be reduced before it is transported by DMT1.  The DCytb1 protein is co-
expressed with DMT1 in enterocytes, and appears to be an ascorbate-dependent 
reductase (1). 
After absorption iron is transported across enterocytes and into the blood.  The 
export of iron from enterocytes and into the circulation is facilitated by ferroportin 
(FPN) and hephaestin. FPN is the only identified exporter protein in cells, and transports 
ferrous iron into the blood stream.  This protein is regulated by Hepcidin, which is a 
peptide hormone secreted by the liver.  Under high iron-conditions hepcidin binds to 
FPN, resulting in the internalization and consequent degradation of FPN in the 
lysosome.  Also, Fe
2+
 must be bound to FPN before it is internalized (1).  The regulation 
of hepcidin is controlled in part by CCAAT/Enhancer-binding protein α (C/EBPα).  This 
protein is indicated as an iron-mediated transcriptional regulator of hepcidin mRNA.  
Under high-iron conditions C/EBPα is up-regulated, and mice devoid of C/EBPα have 
low levels of hepcidin.  The exact mechanism by which C/EBPα may sense iron and 
regulate hepcidin mRNA is unclear.  Other regulatory factors are possibly involved in 
hepcidin expression levels as well, (ie, hepatocyte nuclear factor 4 and signal transducer 
and activator of transcription- STAT- proteins) but defined mechanisms remain to be 
identified. 
In order for iron to be trafficked throughout the blood it must be oxidized to Fe
3+
.  
Therefore, FPN is associated with ferroxidase proteins like ceruloplasmin (Cp) and 
hephaestin (Heph).  Cp and Heph share 50% sequence similarity and contain types I-III 
Cu binding sites.  Iron accumulates in the cell upon disruption of these proteins, 
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indicating they are necessary for efficient cellular iron export (1).  The expression of Cp 
or Heph is dependent on the cell type; for example, Heph is expressed in intestinal cells 
while Cp is found in liver, heart, and brain (astrocytes).  The purpose of Heph and Cp is 
to catalyze the oxidation of Fe
2+
 to Fe
3+
, which allows transferrin (Tf) to bind iron and 
deliver it to different tissues. 
Tf is circulated throughout the body and is responsible for binding and 
transferring iron to non-intestinal cells.  This protein is recognized by Transferrin protein 
receptors (TfR) located on cell surfaces and iron is imported via receptor-mediated 
endocytosis.  Upon acidification in the endosome iron is released from Tf, reduced by a 
vesicular reductase (Steap3), and subsequently transported into the cytosol by the ferrous 
transporter DMT1.  The Tf-TfR complex is then recycled to the plasma membrane 
where Tf is released into the circulation.  Tf is produced by hepatocytes and secreted by 
the liver to the plasma.  There are two homologous amino acid domains in Tf which bind 
one Fe
3+
 atom each.  When Tf is endocytosed, the release of bound iron is facilitated by 
a decrease in pH, which induces a conformational change in the iron-binding domains 
and allows iron release from Tf.  There are two different receptors- TfR1 and TfR2- 
which bind Tf[Fe
3+
]2.  TfR1 is found in many cell types and is relatively abundant in 
organs; whereas TfR2 is primarily localized to hepatocytes, and enterocytes in the 
duodenum.  The TfRs exist as homodimers, each binding one Tf[Fe
3+
]2.  Therefore, 4 
iron atoms are imported by each TfR dimer.  These two receptors seem to serve different 
purposes based on their regulation.  Expression of TfR1 is regulated by IRP1, IRP2, 
which are discussed in more detail later in this chapter.  IRP1 and IRP2 regulate protein 
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expression at a translational level in response to iron concentrations in the cytosol.  TfR1 
is also regulated at a transcriptional level by hypoxia-responsive element (HRE), where 
TfR1 expression is up-regulated under hypoxic conditions.(1)  Finally, TfR1 is regulated 
by hereditary hemachromatosis protein, HFE.  This protein is expressed in intestinal 
cells and is hypothesized to act as a competitive inhibitor of Tf on TfR1.  On the other 
hand, TfR2 has a lower affinity for Tf[Fe
3+
]2 than TfR1, is not regulated by IRP1, IRP2, 
or HFE, and its expression does not appear to change with iron levels.  Deletion of this 
protein results in phenotypes associated with hereditary hemachromatosis (HH). The 
deletion of this protein in mice having type 3 HH results in a severe disruption in iron 
metabolism.  This indicates that TfR2 plays an important role in iron metabolism, but the 
mechanism of regulation and iron sensing is unclear.(1) 
 
Iron Storage in Mammalian Systems 
Once iron has entered the cell it can be trafficked to different organelles or to 
ferritin.  Ferritin exists in the blood plasma and within cells in the nucleus, cytosol, and 
mitochondria.  This multimeric protein is responsible for storing up to 4,500 iron atoms.  
It replaces the role of vacuoles in yeast cells by sequestering and storing iron safely.  
This protein is composed of 24 subunits of heavy (H) and light (L) chains, which 
assemble to form a hollow shell in which iron is stored.  The H subunit acts as a 
ferroxidase, which oxidizes iron for storage as a precipitated ferric-oxide form while the 
L subunits stabilize the protein shell structure and facilitate iron uptake into the protein.  
The ratios of H to L chains are tissue, cell, and organelle dependent.  For example, 
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mitochondrial ferritin is H-rich while serum ferritin is rich in L-chains.  Iron is 
transported from the cytosol to ferritin via poly(rC) binding proteins (PCBP1 and 
PCBP2).  These proteins were found to be involved in iron transport to ferritin, although 
it is unclear whether or not PCBP1 and PCBP2 are responsible for iron transport to other 
iron centers as well (REF).   
Under conditions where cytosolic iron levels are decreased due to the addition of 
a chelator, bacterial infection, or amino acid starvation ferritin is degraded through a 
lysosomal autophagy mechanism in order to recycle iron from ferritin to the cytosol.  
Under low-iron growth conditions Ferritin is monoubiquitinated and degraded via a 
proteosome-mediated pathway.  Further studies are needed to understand this 
mechanism and to distinguish the different triggers for lysosome- and proteosome-
mediated degradation pathways.   
Ferritin is regulated via IRP1 and IRP2, although the deletion of IRP2 has a 
greater effect on Ferritin levels than IRP1 indicating IRP2 is the more prominent 
regulator for Ferritin expression.  Due to the ability of ferritin to sequester iron and 
thereby prevent ROS formation, Ferritin can also be thought of as an antioxidant protein.  
The ferritin gene contains an antioxidant-responsive element (ARE), which responds to 
oxidative stress signals and up-regulates transcription of ferritin.   
 
Mammalian Mitochondrial Iron Trafficking 
As stated earlier, mitochondria are the major hubs of iron metabolism and iron 
plays a crucial role in metabolic pathways.  Iron metabolism in mammalian cells is 
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extremely similar to iron metabolism in yeast.  For example, iron enters the 
mitochondria through mitoferrin proteins 1 and 2 (Mfrn1p and Mfrn2p), which are 
homologous to Mrs3p and Mrs4p in yeast.  The oxidation state and ligand environment 
of transported iron is unclear, but it has been hypothesized that the molecule is an iron-
glutathione complex, or an organic ligand or peptide which can bind iron.  The 
concentrations of iron, citrate, and GSH are higher in the mitochondrial matrix than in 
the cytosol, but again this has not been shown conclusively.  The main difference in iron 
homeostasis in mammalian and yeast mitochondria is that mammalian mitochondria also 
contain ferritin, which is rich in H chains, as mentioned previously.    
De novo Fe-S cluster biosynthesis is also an extremely important function of the 
mitochondria, and is conducted in a similar pathway as in yeast.  The primary proteins 
involved include Frataxin (Yfh1p in yeast), IscU (Isu1 in yeast), and Ferredoxin (Yah1 
in yeast).  Frataxin acts as an iron trafficking protein which binds Fe
2+
 and may assemble 
[2Fe-2S] clusters on IscU.  Nfs1 serves as a cysteine desulfurase which donates sulfur to 
IscU.  Heme biosynthesis in human cells is also reliant on Frataxin, just as heme 
synthesis in yeast depends on Yfh1p.  The protoporphyrin-IX ring is assembled as in 
yeast (see earlier section) and frataxin is hypothesized to deliver Fe
2+
 to ferrochelatase 
which inserts Fe
2+
 into protoporphyrin-IX.  In this dissertation Appendix X discusses the 
process of isolating mitochondria from mouse brains and investigating the distribution of 
iron by Mössbauer, EPR, and UV-vis spectroscopy.  This research shows that the iron 
distributions in mitochondria are conserved across organisms.  Moreover, the 
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mitochondria in these organelles show a NHHS Fe
2+
 species which could represent the 
MLIP.   
 
Iron Trafficking to the Brain 
While iron trafficking to cells is the same for most tissues, the transport of iron 
into some tissues is more complex.  Iron is necessary for brain function, such as 
respiration, production of neurotransmitters, and myelinogenesis.(1)  Just as in other 
systems, iron overload can have detrimental effects.  In the brain these effects can be 
extremely detrimental, often resulting in neurodegenerative diseases including 
Alzheimer’s disease and Parkinson’s disease.  Iron entry in the brain is tightly controlled 
because of the potentially fatal effects.  The first level of iron control in the brain is a 
physical barrier known as the blood-brain barrier (BBB).  In the systemic circulation 
iron is transported through the blood by Tf, but because the central nervous system 
(CNS) is physically separated from the systemic circulation, iron must be transported 
into the cerebrospinal fluid (CSF) from the blood before it can be transported into brain 
cells.   
The BBB consists of endothelial cells of capillaries and epithelial cells from the 
choroid plexus.  The choroid plexus is composed of tight-junction epithelial cells which 
surrounds each of the four ventricles of the brain. This structure is responsible for 
producing CSF and acts as a kind of filtration system which is responsible for 
maintaining the extracellular environment in the brain. The barrier between the choroid 
plexus and CSF is known as the blood-CSF barrier, which iron and other nutrients must 
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cross to be accessible to brain cells.  CSF plays a major role in delivering and 
maintaining brain iron levels as brain Tf is found in this fluid (2).  The proteins 
responsible for transporting iron to and from the CSF are the same as (or very similar to) 
those expressed in cells exposed to serum Tf, including DMT1, FPN, Cp, Heph, TfR1, 
and Dcytb (2).   
 
Iron Regulation by IRP1 and IRP2 
Iron must be tightly regulated in mammalian cells in order to maintain the 
delicate balance between necessity and toxicity.  There are many stages at which iron is 
regulated.  For example, iron uptake and release into the circulation is regulated by 
hepcidin and hypoxia inducible factor 2α (HIF2α) (2).  Hepcidin is a hormone secreted 
by the liver in response to inflammation or iron overload (2).  HIF2α is a transcription 
factor which responds to hypoxia by regulating the transcription of DMT1 and Dcytb (3, 
4). 
Iron is also regulated within cells by two iron regulatory proteins: IRP1 and 
IRP2.  These proteins bind to mRNA to regulate protein expression under iron deficient 
conditions.  When iron is abundant IRP1 acquires a 4Fe-4S cluster and acts as a 
cytosolic aconitase protein.  In these conditions the IRP2 protein is degraded by the 
proteasome.  The degradation of IRP2 is induced by FBXL5, which has an iron-sensing 
mechanism.  FBXL5 contains an iron-binding hemerythrin domain which regulates the 
protein stability.  If iron is bound, FBXL5 will become more stable and bind to IRP2, but 
when iron is not bound FBXL5 is degraded and ultimately results in the expression of 
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IRPP2.  It must be noted that FBXL5 favors Fe
2+
 rather than Fe
3+
, which indicates that 
cytosolic iron is most likely ferrous.   
In these studies iron distributions in mice brains were investigated using 
biophysical approaches (Mössbauer, EPR, UV-Vis) and bioanalytical techniques (LC-
ICP-MS).  One problem in studying brain iron is that most of the samples are prepared 
and analyzed in an aerobic environment, which allows any labile or reduced iron to be 
oxidized. Moreover, many imaging techniques (ie, Perl staining) visualize iron 
aggregates and cannot detect iron at low levels.  In the following studies the isolation 
conditions were tightly controlled by using an anaerobic environment for organ 
dissections and sample preparation. By applying the biophysical and bioanalytical 
techniques described in Appendices B and C it was possible to detect low levels of iron 
which have not previously been visualized. Therefore, by taking advantage of these 
biophysical methods in conjunction with molecular biology and genetic approaches 
reported previously it is possible to observe changes in iron-containing components in 
the brain. 
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APPENDIX B  
CHANGING IRON CONTENT OF THE MOUSE BRAIN DURING 
DEVELOPMENT
2
 
Abstract 
Iron is crucial to many processes in the brain yet the percentages of the major 
iron-containing species contained therein, and how these percentages change during 
development, have not been reliably determined. To do this, C57BL/6 mice were 
enriched in 
57
Fe and their brains were examined by Mössbauer, EPR, and electronic 
absorption spectroscopy; Fe concentrations were evaluated using ICP-MS. Excluding the 
contribution of residual blood hemoglobin, the three major categories of brain Fe 
included ferritin (an iron storage protein), mitochondrial iron (consisting primarily of 
Fe/S clusters and hemes), and mononuclear nonheme high-spin (NHHS) Fe
II
 and 
Fe
III
 species. Brains from prenatal and one-week old mice were dominated by ferritin 
and were deficient in mitochondrial Fe. During the next few weeks of life, the brain 
grew and experienced a burst of mitochondriogenesis. Overall brain Fe concentration 
and the concentration of ferritin declined during this burst phase, suggesting that the rate 
of Fe incorporation was insufficient to accommodate these changes. The slow rate of Fe 
import and export to/from the brain, relative to other organs, was verified by an isotopic 
labeling study. Iron levels and ferritin stores replenished in young adult mice. NHHS 
                                                 
2
 Holmes-Hampton, GP; Chakrabarti, M; Cockrell, AL; McCormick, SP; Abbott, LC; Lindahl, LS; 
Lindahl, PA. (2012) Changing Iron Content of the Mouse Brain During Development. Metallomics 4, 761-
770. http://pubs.rsc.org/en/Content/ArticleLanding/2012/MT/c2mt20086d#!divAbstract. Reproduced by 
permission of The Royal Society of Chemistry. 
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Fe
II
 species were observed in substantial levels in brains of several ages. A stable free-
radical species that increased with age was observed by EPR spectroscopy. Brains from 
mice raised on an Fe-deficient diet showed depleted ferritin iron but normal 
mitochondrial iron levels. 
 
Introduction 
Iron plays a major role in generating the chemical energy required for 
neurological activity, in that Fe/S clusters and heme groups are abundant in 
mitochondrial respiratory complexes (5). This transition metal is found at the active sites 
of numerous metalloenzymes in the brain (6) and is required for myelin biosynthesis 
(7). Over a billion people worldwide suffer from anemia (8), and Fe deficiency affects 
neonatal brain development and cell-mediated immunity (9). An overabundance of Fe is 
also problematic, as certain forms of iron, particularly NHHS Fe
II
 complexes, promote 
Fenton chemistry that generates reactive oxygen species (ROS). The brain may be 
particularly sensitive to ROS damage because of its high rate of O2 consumption 
(10) and limited ability of neuronal cells to be repaired or replaced (11). Moreover, Fe 
accumulates with age and neurodegeneration (12).  
Iron traveling into the brain passes through the blood-brain barrier (BBB) 
(13). Fe
III
-bound transferrin in the blood binds to receptors on the luminal side of the 
endothelial cells associated with this barrier (14). Once inside neurons and other cells of 
the brain, a portion of the Fe is trafficked to mitochondria, where hemes and iron-sulfur 
clusters are assembled. Another portion is stored as ferritin, a spherically shaped protein 
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complex with a hollow core into which large amounts of Fe can be deposited in the form 
of magnetically-interacting Fe
III
 oxyhydroxide material (15). Ferritin helps regulate 
cytosolic Fe concentrations and sequester Fe that might otherwise generate ROS. Similar 
forms of Fe are found in hemosiderin (16), a degradation product of ferritin, 
neuromelanin (17), and perhaps mitochondrial ferritin (18).  
X-ray fluorescence (19), high-field magnetic resonance imaging (20) and high-
resolution histological staining (21) have revealed an inhomogeneous spatial distribution 
of Fe in the brain. The globus pallidus, putamen, substantia nigra pars reticulata, red 
nucleus, cerebral dentate nucleus, the nucleus accumbens and portions of the 
hippocampus contain high concentrations of Fe; white matter and the cerebrospinal fluid 
contain lesser amounts. The distribution of brain Fe follows the distribution of ferritin 
whereas the distribution of transferrin is more homogeneous (22), reflecting the 
dominance of ferritin Fe in the brain. 
These imaging methods provide excellent spatial resolution of brain Fe but their 
ability to resolve different types of Fe-containing species is limited. Mössbauer 
spectroscopy can distinguish different types of Fe (23), but it has barely been applied to 
the brain, perhaps due to the insensitivity of the technique, the low concentration of Fe in 
the brain, and the ability of Mössbauer to detect only 
57
Fe (2% natural abundance). 
We have used Mössbauer spectroscopy, in conjunction with EPR and UV-vis 
spectroscopies, and ICP-MS, to assess the Fe content of yeast mitochondria, vacuoles 
and whole cells (24-26). Our objective in those studies was to evaluate the types and 
relative amounts of Fe present in these organelles and cells. In yeast, the two dominant 
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Fe “traffic hubs” include vacuoles, which store Fe, and mitochondria, which use it to 
obtain cellular energy. 
Here we apply the same methods to study the iron content of intact 
57
Fe-enriched 
mouse brains. Previous Mössbauer studies of the brain have focused on particular Fe-
rich subcomponents of unenriched human brains. These studies found that virtually all 
Fe in these regions consists of magnetically interacting, superparamagnetic ferric 
species, including ferritin and neuromelanin (12, 15-18) curiously, mitochondrial 
Fe, e.g. Fe/S clusters and heme groups were not observed. This is difficult to rationalize, 
given the enormous role of mitochondria in brain function, and the substantial proportion 
of yeast Fe due to this organelle. We show here that, besides ferritin-like species, the 
brains of mice contain substantial amounts of Fe/S clusters, much of it arising from 
mitochondria. Also detected were nonheme high-spin (NHHS) Fe
II
 and Fe
III
 species. A 
portion of these mononuclear species may constitute the labile iron pool (LIP) and which 
may participate in ROS-generating reactions. 
 
Experimental Procedures  
 
Animal Care and Dissections 
C57BL/6 mice were raised and manipulated in accordance with the TAMU 
Animal Care and Use committee (AUP 2010-226). Mice were housed in disposable 
plastic cages (Innovive Innocage Static Short) with all-plastic water bottles and plastic 
feeders with zinc electroplated reinforcements. Mice were fed Fe-deficient chow (Harlan 
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Laboratories, Inc. Teklad ID TD.80396.PWD) supplemented as follows. For 
experiments involving 
56
Fe or
57Fe, the chow was supplemented with 50 μg/g of either 
natural abundance Fe citrate or 
57
Fe citrate (IsoFlex USA) prepared as described 
(26). For each kg of chow, 22 mL of a 40 mM stock solution of Fe citrate (adjusted to 
pH 7) was added. The chow was further moistened with ca. 45 mL of double-distilled 
water containing 0.6 ng Fe/g water. The chow was compressed into pellets, heated at 100 
°C for 20 min, and then stored at −20 °C in zip-locked plastic bags. Samples of the 7 
batches of this chow examined contained an average of 33 ± 2 μg Fe/g chow as 
determined by ICP-MS. 
Fe-deficient pups were born to a mother that was fed the Fe-sufficient diet 
until 3 days prior to birth when her diet was switched to Fe-deficient (1.2 μg Fe/g 
chow). Fe-deficient animals received water that was house-distilled, deionized using ion-
exchange columns (Thermo Scientific 09-034-3), and distilled again using a sub-boiling 
still (Savillex DST-1000). The resulting sub-boiling distilled water contained 0.02 ng 
Fe/g water. 
Each cage contained ca. 200 g of synthetic bedding (Ketchum Omega Dry) with 
1.5 μg 56Fe/g. Nestlets (Ancare) that were included in the cages of pregnant females 
weighed 10 g and contained 20 μg 56Fe/g. Nitrile gloves were worn when mice, chow, 
water, bedding, etc. were handled. So-called “56Fe-enriched” mice were treated 
equivalently but were raised on chow supplemented with natural-abundance Fe citrate. 
Mice were euthanized by an IP injection of a solution that provided 3 mg 
ketamine and 0.5 mg xylazine per 20 g body wt. Immediately after breathing ceased and 
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the heart stopped beating, animals were imported into a refrigerated (5–10 °C) argon-
atmosphere glove box (MBraun Labmaster) containing between 2–20 ppm O2, where all 
dissections and tissue manipulations were performed. The “hands” of a pair of standard 
butyl rubber gloves on the box were cut off and replaced with tight-fitting surgical 
gloves using custom-designed plastic cuffs. The open end of each surgical glove was 
stretched over one end of a cuff and secured with two O-rings that fit into grooves on the 
cuff. The other end of the cuff was attached similarly to a butyl rubber glove, the other 
end of which was secured on the box glove port in standard fashion. 
Unless noted otherwise, animals were perfused with Ringer's buffer (155 mM 
NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 2 mM NaH2PO4, 10 mM HEPES, 10 mM 
glucose, and 10 U heparin/mL). A 27 gauge 1/2” long stainless-steel needle was 
inserted into the left ventricle of the heart, and buffer was pumped at ca. 0.7 mL min
−1
. 
After ensuring proper placement of the needle, the caudal vena cava was severed, and 
pumping continued for an additional 1–2 min until blanching of the liver appeared 
complete. For some dissections, blood diluted with Ringer's buffer was collected. 
Immediately after perfusion, brains and other organs were isolated by dissection 
using stainless steel and/or titanium instruments. The Fe concentration of a 50 mL 
solution of Ringer's buffer into which the stainless steel instruments were immersed for 
30 min increased by 190 nM. This is far longer than animals contacted the instruments. 
Thus, an insignificant amount of Fe was leached from these instruments during 
dissections and none of the Fe-associated features observed in the spectra originated 
from them. 
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Densities 
Masses of dissected brains were determined using an analytical balance (Toledo 
Mettler Model AB104) in the glove box. Volumes were measured using a 10 mL 
graduated cylinder into which a Delrin screen, supported by a thin plastic line, was 
submersed in buffer. Brains were submersed into the cylinder and the displaced volumes 
were measured. Densities were determined for 6 samples; an average value of 1.17 g 
mL
−1
 was obtained, similar to the reported value of 1.06 g mL
−1 
(27). The latter value 
was used for all calculations. 
 
Mössbauer Spectroscopy 
Whole brains were anaerobically loaded into Delrin Mössbauer cups and frozen 
as described (28). Low-field spectra were collected using a model MS4 WRC 
spectrometer (SEE Co., Edina MN). High-field (6 T) and low-field spectra were 
collected at 4.3 K using a model L:He-6T spectrometer. Spectra were analyzed using 
WMOSS software. Parameters are reported relative to α-Fe foil at room temperature. 
 
EPR and UV-visible Spectroscopy 
Following Mössbauer analysis, brains were transferred to disposable plastic 15 
mL tubes containing an equal volume of Ringer’s buffer. Samples were homogenized for 
1 min using a plastic rotary knife inserted into a tissue grinder (Omni TH). For EPR 
measurements, homogenates were packed (4000 × g, 10 min) and frozen in custom 
quartz tubes as described.
24
 Spectra were collected on an X-band spectrometer (EMX, 
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Bruker Biospin Corp., Billerica MA) with an Oxford Instruments ER910 cryostat. 
Signals were quantified using a 1.00 mM CuEDTA standard and Spincount 
(http://www.chem.cmu.edu/groups/hendrich) software. For UV-Vis measurements, 
samples were transferred to a 2 mm pathlength custom-designed quartz cuvette (NSG 
Precision Cells), sealed anaerobically with a septum. RT UV-vis spectra were collected 
on a Hitachi 4400U spectrophotometer with a head-on photomultiplier tube. Spectra 
were analyzed as described for specific heme a, heme b, and heme c content as described 
(24). 
The contributions of blood from the UV-vis spectra of brain homogenates were 
removed, based on the percentage contribution of deoxyhemoglobin present in 
corresponding Mössbauer spectra of the same brain sample. This percentage was 
multiplied by the concentration of Fe in the sample, affording the concentration of 
hemoglobin (typically 20 μM). The UV-vis spectrum of 100-fold diluted blood was 
determined (data not shown), as was the Fe concentration of undiluted blood (7.6 mM 
Fe). The spectral absorbance was scaled based on the ratios of Fe concentrations in 
blood vs. in the brain samples, and the scaled spectra were subtracted from the raw UV-
vis spectra of the corresponding brain homogenate. 
 
ICP-MS 
Homogenized brain samples were transferred to plastic tubes containing 350 μL 
of concentrated trace-metal-grade nitric acid (Fisher). After overnight digestion at 90 °C, 
 165 
 
samples were diluted with 6.5 mL of H2O and analyzed by ICP-MS (Agilent model 
7700x). The H2O used was sub-boiling distilled as described above. 
 
Results 
57
Fe-Enrichment. 
The concentration of Fe in the mouse brain was so low (Table B1) that 
57
Fe 
enrichment was required for Mössbauer studies. To evaluate enrichment rates, mice born 
to an 
56
Fe-enriched mother were fed 
57
Fe-supplemented chow immediately after 
weaning. Their brains enriched slowly such that only partial 
57
Fe-enrichment was 
achieved after 58 wks on the 
57
Fe-supplemented diet (Figure B1). Other organs, 
including liver, spleen, heart, and kidney enriched faster and to a greater extent than the 
brain, with the duodenum enriching fastest (data not shown). The slow incorporation 
of 
57
Fe into the brain was probably due to the blood-brain barrier (13). Cu, Mn, Zn, Mo 
and P concentrations in these organs were also determined (data not shown).  
The rate of Fe enrichment was biphasic, with the transition from fast to slow 
phase occurring 4–6 wks postnatal. During the fast-enrichment period, the total 
nanomoles of 
56
Fe in the brain declined rapidly while that of 
57
Fe increased gradually 
(Figure B1). The overall concentration of Fe in the brain declined during the fast-
enrichment phase, followed by a gradual recovery in the slow-enrichment phase. Brain 
mass increased rapidly during the fast-enrichment phase and slowed thereafter. The 
concentration of 
57
Fe in the brain increased with each generation raised under 
57
Fe-
enrichment conditions, maximizing at 80% after about 3 generations. Thus, Mössbauer 
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spectra were typically collected from animals raised under 
57
Fe-enrichment conditions 
for ≥ 2 generations. 
 
Brains from three-week-old mice 
The low-temperature, low-field Mössbauer spectrum of a 3-wk-old brain 
exhibited 4 discernible features. A sextet typical of ferritin-bound Fe
III
 ions dominated 
(Figure B2, A); the blue line is a simulation with δ = 0.5 mm s−1, ΔEQ = −0.3 mm 
s
−1
 and Γ = 0.6 mm s−1, and Heff = 480 kG. At 70 K, this feature collapsed into a doublet 
(δ = 0.5 mm s−1 and ΔEQ = 0.7 mm s
−1
) (Figure B2, B), similar to the behavior of 
authentic ferritin (16). The baseline of the 70 K spectrum did not reveal underlying 
features. When a 6 T field was applied at 4.3 K, the resulting pattern (Figure C2, C) 
associated with this feature was again indistinguishable from that of ferritin. We 
conclude that this feature arises from ferritin, but other magnetically interacting Fe
III
 ions 
such as Fe-bound haemosiderin (16), neuromelanin (17)or mitochondrial ferritin 
(18) could have contributed. 
Another major feature in the spectrum was a quadrupole doublet with δ = 0.45 
mm s
−1
 and ΔEQ = 1.15 mm s
−1
; these values are typical of S = 0 [Fe4S4]
2+
 clusters and 
low-spin Fe
II
 heme centers. At 6 T, the splitting pattern observed for this so-
called Central Doublet (CD) was simulated (Figure B2, C, purple line) confirming the 
expected diamagnetism. A doublet with identical parameters in spectra of isolated 
mitochondria from yeast (24) arises primarily from respiratory complexes, and so we 
assign the majority of the CD intensity in brain to mitochondrial respiratory complexes. 
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Animal ID F053PNP 
F016
P 
F019P F019P F020P (Fe def) 
F050P 
F019P 
M013 
M014 
M001 
Age (wks) -1 1 2 3 3 4 24 60 
Comments Not Perfused    Iron Deficient    
Number and Sex 
6 
(sex not  
determined) 
7F 
2M 
1F 
2M 
0F 
3M 
1F 
8M 
1F 
3M 
0F 
2M 
0F 
1M 
Average (SD) brain mass (mg) 
52 
 6 
200 
 30 
350 
 4 
310 
 40 
350 
 10 
390 
 30 
377 
 2 
456 
Num. used for element, protein analysis 6 4 2 3 3 2 2 1 
[Protein] (mg/mL) 21 30 29 40 32 40 28 33 
[Cu] (M) 33 15 10 7 28 16 26 42 
[Mn] (M) 21 3 6 6 26 11 5 6 
[Zn] (M) 123 210 179 205 167 197 172 206 
[Fe] (M) 270 121 195 199 149 182 212 322 
% 
57
Fe 60 72 66 73 57 85 83 58 
Hemoglobin Doublet subtracted (%) 37 3 5 10 11 14 11 18 
Effective [Fe] in brain (M) 170 117 185 179 132 157 188 264 
Ferritin-like Fe (% of effective Fe) 67 54 51 57 19 42 57 56 
Central Doublet (% of effective Fe) 19 27 37 31 57 42 30 33 
Ferritin-like/CD ratio 3.5 2.0 1.4 1.8 0.33 1.0 1.9 1.7 
HS Fe
II
 hemes (% of effective Fe) ~ 0 13 8 6 13 9 7 9 
HS Fe
II
 nonheme (% of effective Fe) 10 6 ~ 4 6 10 8 6 ~ 2 
 
Table B1. Summary of Results. The concentration of heme b in the prenatal brain (*) was not quantified.  Values obtained by 
EPR, UV-vis, ICP-MS and protein analyses have an estimated relative uncertainty of  20%. Values derived from Mössbauer 
analyses have an absolute uncertainty of  4%.  
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[Fe
II
 heme a] (M) ~ 0 ~ 0 4 15  15 18 18 18 
[Fe
II
 heme b] (M) * ~ 0 6 15 12 18 18 18 
[Fe
II
 heme c] (M) ~ 0 ~ 4 12 23 25 32 32 35 
gave = 4.3 (M); HS Fe
III
 nonheme  0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
g = 1.90 (M); Rieske [Fe2S2]
1+
 0 0.9 1.2 1.5 1.5 2.7 2.4 1.7 
g = 1.94 (M); SDH [Fe2S2]
1+
 0 1 1.2 1.5 1.5 2.4 2.1 1.5 
g = 2.00 (M); organic radical 0.1 0.1 0.1 0.3 0.3 0.2 0.3 0.7 
 
Table B1 Continued. 
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Figure B1. Enrichment of 
57
Fe into 
56
Fe-enriched mice raised on 
57
Fe-enriched 
chow for different durations after weaning. Upper plots refer to the % 
57
Fe scale, 
including solid triangles (duodenum), solid circles (average of liver, kidney, heart and 
spleen) and solid squares (brain). Solid diamonds in the middle group of plots refer to 
total [Fe] in the brain whereas open triangles refer to brain mass. In the lower group, 
open circles and squared refer to nmoles of 
56
Fe and 
57
Fe in the brain, respectively.  
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The 70 K, low-field spectrum also exhibited a quadrupole doublet with δ 1.4 
mm s
−1, ΔEQ 3.3 mm s
−1
 arising from one or more NHHS Fe
II
 species. This is 
simulated by the green line in Figure B2, B. These parameters are typical of such 
complexes with 5–6 O/N donor ligands. Most evident in the 70 K spectrum was the 
doublet from HS Fe
II
 heme centers (Figure B2, B, yellow line), with δ = 0.96 mm s−1 and 
ΔEQ = 2.3 mm s
−1
. 
UV-vis spectra of corresponding brain homogenate (Figure B3, D) revealed the 
Soret, α and β bands indicating reduced hemes. These features were similar to those of 
yeast mitochondria (24); their concentrations were quantified and are listed in Table B1. 
Low-temperature EPR spectra of packed 4-wk mouse brain homogenates (Figure 
B4) were virtually identical to those of a 3-wk old animal but were slightly more intense. 
The spectra exhibited overlapping signals in the g = 2 region. Resonances at g = 1.93 
and 1.86 probably arose from the S = ½ [Fe2S2]
1+
 cluster of succinate dehydrogenase and 
the reduced Rieske S = ½ [Fe2S2]
1+
 cluster associated with cytochrome bc1, respectively 
(24). Also evident was an isotropic signal at g = 2.00, probably from an organic radical. 
The weak signal at g = 4.3 undoubtedly arose from mononuclear HS Fe
III
 species with 
rhombic symmetry. The origin of the derivative-like feature atg = 2.16 is uncertain. Spin 
quantifications are listed in Table B1.  
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Figure B2. Mössbauer spectra of brains isolated at different ages. Spectra were 
collected at 6 K and with a 0.05 T field applied parallel to the radiation unless otherwise 
noted. A, 3 wk brain; B, same as A but at 70 K; C, same as A but at 4.3 K and 6 T field 
applied perpendicular to the radiation; D, 3wk Fe-deficient brain; E, −1wk brain; F, 4 wk 
brain; G, 58 wk brain. Red lines are composite simulations for E – G. Simulations 
assumed parameters mentioned in the text and percentages in Table B1. The vertical 
dashed line shows the position of the high-energy line of the central doublet. The arrow 
in E shows the position of the NHHS Fe
II
 feature. Hint values associated with the ferritin 
sextet ranged from 480 – 506 kG, perhaps reflecting subtle differences in the ferritin 
core structure. 
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Brains from iron-deficient mice 
A pregnant 
57
Fe-enriched mouse was switched to Fe-deficient chow 3 days prior 
to giving birth, and her offspring were euthanized 3 wks later at which time they 
displayed alopecia (image not shown), an indicator of Fe-deficiency (29). Also, the 
average Fe concentration in their livers (260 μM) was nearly 6-fold lower than in Fe-
replete livers. Beard et al. found a 4-fold decline of liver Fe in mice fed an Fe-deficient 
diet for 8 wks (30). The average Fe concentration in their brains (Table 1) was also less 
than in Fe-sufficient brains, but the fold change was less dramatic. Mössbauer spectra 
(Figure B2, D) exhibited less of the ferritin sextet relative to Fe-sufficient brains, while, 
unexpectedly, the CD (purple line) was more intense. Also surprisingly was that 
the absolute concentration of the CD Fe in these brains was slightly higher than that in 
comparable Fe-sufficient brains (75 μM vs. 55 μM). A minor NHHS FeII feature was 
evident (Figure B2, D, green line). EPR and UV-vis spectra of Fe-deficient brains 
exhibited the same suite of signals and comparable intensities as were observed in 
spectra from brains of Fe-sufficient mice. 
 
Brains from prenatal mice 
Prenatal mice could not be perfused, such that the quadrupole doublet due to 
hemoglobin in the corresponding Mössbauer spectra was more intense than in the 3-wk 
brain spectra. The exact position of the heme doublet (δ = 0.96 mm s−1, ΔEQ = 2.35 mm 
s
−1
) was also shifted slightly relative to that in other spectra, due to the presence 
of fetal hemoglobin in prenatal brains (31).  
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Figure B3. UV-vis spectra of brains isolated at different ages. a, -1 wk; b, 1 wk; c, 2 
wks; d, 3 wks; e, 3 wks, Fe-deficient; f, 4 wks; g, 24 wks; and h, 60 wks. Intensities at 
wavelengths longer than 500 nm were multiplied by 5. Spectra shown are prior to 
subtracting the contributions due to hemoglobin.  
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Figure B4. EPR spectrum of 3 wk brains. Highlighted signals are indicated by arrows. 
Conditions: temperature, 4 K; microwave frequency, 9.43 GHz; microwave power, 0.2 
mW; modulation amplitude, 10 G; sweep time, 335 sec; time constant, 164 msec. The 
average of 10 scans is shown. The inset shows the relative intensity of highlighted 
features as a function of age. Plots are offset by arbitrary amounts.  
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The average Fe concentration in the prenatal brains (Table B1) included a 
significant contribution from blood ( 100 μM). Since the concentration of Fe in 
undiluted blood was 7.8 mM (data not shown), we calculate that 1.3% of the dissected 
prenatal brain volume was occupied by blood. This underestimates the value in living 
animals, as some blood exited the tissue during dissection. Apart from the blood 
contribution, the Mössbauer spectrum of prenatal brains was dominated by the ferritin 
sextet, with only a minor percentage due to the CD (Figure B2, E, Table B1). A NHHS 
Fe
II
 doublet was evident (arrow), with intensity comparable to that of the 3 wk brain 
spectrum. The UV-vis spectrum of prenatal brain homogenate (Figure B3, A) was 
dominated by features due to fetal hemoglobin; other heme-based species 
(e.g. mitochondrial cytochromes) could not be discerned. Intensities of EPR signals from 
the prenatal brain homogenate were diminished relative to those in other spectra (Figure 
S4A). These results indicate that prenatal brains were deficient in mitochondria, with 
most Fe present as ferritin or ferritin-like species. 
 
Brains from mice of various ages 
Mössbauer spectra of brains from mice of different ages (Figure B2, E–G) 
showed an age-dependent increase in the percentages of the CD and a 
relative decrease in the ferritin-like sextet. This is indicated most reliably by the 
ferritin:CD intensity ratios (Table B1) which was highest for prenatal brains and lowest 
at 4 wks. Mössbauer spectra of the 24 and 58 wk brains exhibited age-dependent 
increases in the percentage of the ferritin-like sextet and decreases in the CD. UV-vis 
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spectra also showed an age-dependent increase in cytochromes at early ages (Figure B3). 
EPR spectra exhibited increasing intensities of the signals in the g = 2 region (data not 
shown), including features that likely originate from mitochondria. The radical signal 
at g = 2.00 also increased with age, while the g = 4.3 signal intensity was age-invariant. 
 
Discussion 
During the 150 year history of studying Fe in the brain, the vast majority of 
imaging studies have involved staining the brain with Fe chelators, e.g. using Perls' stain 
(32). This gives useful, albeit qualitative, estimates of the distribution of Fe. Quantitative 
estimates of brain Fe concentrations have been obtained by analytical methods (e.g. AA 
and ICP). Since the mid 1980's, the distribution of brain Fe has been monitored using 
NMR spectroscopy (33). With this technique, Fe is detected indirectly, in that ferritin 
and other magnetic forms of Fe shorten T2 relaxation times (34). Magnetic susceptibility 
contrast measurements have also been used as a reporter of brain Fe in MRI studies (35). 
These are very powerful techniques, but they also have limitations. They can only detect 
magnetic forms of Fe, such that diamagnetic Fe forms are not detected. Non-iron 
paramagnetic metal ions will also affect NMR-based measurements, which complicate 
analyses (36).  
X-ray absorption spectroscopy does not suffer from these problems, and has also 
been used to evaluate the spatial distribution of brain Fe (36, 37). This method measures 
Fe directly, regardless of magnetic properties, and has some ability to distinguish 
oxidation states. XAS methods have shown that the brain contains both Fe
II
 and 
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Fe
III
 ions, with the Fe
III
 state dominating (37). Wang et al. (38) and Pushie et al. 
(19) used synchrotron X-ray fluorescence spectroscopy to map the distribution of Fe and 
other metals in the mouse brain. However, the type of Fe centers, including oxidation 
states and coordination environments, could not be determined. 
Mössbauer spectroscopy can play a complementary role to these other 
spectroscopic method, as it has unique strengths and weaknesses. The low-sensitivity of 
standard Mössbauer spectroscopy precludes its use in spatially resolving brain Fe, and 
the requirement for 
57
Fe-enrichment limits the technique (for practical reasons) to the 
study of rodent brains. Although it might be possible to study micro-dissected regions of 
a mouse or rat brain, this would take many animals and thus we have focused in this 
initial study on whole intact mouse brains. Thus, our results reflect the average of all of 
the
57
Fe nuclei distributed inside the brain, without any spatial resolution. Mössbauer 
spectroscopy also has distinct and powerful advantages, relative to these other 
spectroscopic methods, in its ability to resolve different types of Fe centers in the brain 
and to determine precisely the percentage of each type of Fe present. No other method 
can compete with Mössbauer spectroscopy in this regard. 
 
Comparison to Previous Mössbauer Studies 
The only type of Fe observed in previous Mössbauer studies of the brain was a 
sextet due to ferritin or ferritin-like Fe (15, 39, 40). The Mössbauer spectra presented 
here are significantly different in that other types of Fe were observed. Why none of the 
previously published spectra of brain displayed the CD, a heme quadrupole doublet, or 
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NHHS Fe
II
 species is puzzling but perhaps rationalizable. Previous studies utilized 
human brains which were unenriched in 
57
Fe; this diminished the spectral quality greatly 
such that minor species, e.g. NHHS Fe
II
, could have gone undetected. That does not 
explain why intense features, like those originating from heme centers or the CD, would 
not have been observed. We suspect that blood would have been drained from 
postmortem human samples, explaining the absence of spectral features due to 
hemoglobin. Previous spectra were exclusively obtained on Fe-rich regions of the brain 
(e.g. the substantia nigra), which may be dominated by ferritin Fe. The averaged Fe 
content of the entire brain may not be dominated by ferritin to this extent. More 
speculatively, the human donors were generally at the end of their natural lifespan, and 
older brains may possibly contain more ferritin than younger and middle-aged ones, the 
age periods we have studied here (41). Finally, the concentration of Fe in the average 
human diet may be higher, relatively speaking, than in our mouse chow, which could 
translate into relatively more ferritin and less CD in the human brain. Further studies are 
required to examine each of these possibilities. 
 
Incorporation of Fe into the Brain 
In this study, we found that young mouse brains exchanged Fe rapidly during the 
rapid growth phase, including the export of Fe. This resulted in an overall decline in the 
concentration of Fe in the brain. During this period, the brain appears to grow faster than 
could be maintained by the rate of Fe import, such that ferritin stores were activated. 
With age, the dynamic exchange of Fe slows, brain growth slows, and the concentration 
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of Fe in the brain recovers. During the first month of life, the proportion of stored Fe 
declines while the proportion of mitochondrial Fe increases. As the animals become 
adults, the proportion of stored Fe increases again. In our study, the concentration of 
mitochondria did not decline noticeably up to 58 wks; we are currently investigating 
whether mitochondrial levels decline towards the end of the animal's natural lifespan, as 
has been reported (11).  
A decline of Fe concentration in the brain immediately after birth has been 
reported (42-44). Keen and Hurley measured age-dependent brain Fe concentrations in 
hybrid mice (45). At birth, Fe concentrations were 17.3 μg Fe/gm brain wet wt (which 
corresponds to 330 μM using the same density assumed here). By days 5–8, the brain 
contained 8.6 μg Fe/gm (160 μM). By day 60, [Fe] returned to newborn levels. 
 
 
Burst of Mitochondriogenesis 
In yeast cells, the Mössbauer CD and HS heme doublet, the g = 1.93 and 1.86 
EPR signals and the heme a, b, and c UV-vis signals arise primarily from the 
mitochondrial respiratory complexes (24), and so we have assigned the analogous 
features in brain spectra similarly. The intensity of these signals, considered collectively, 
undoubtedly reflects the concentration of mitochondria in the brain. The ferritin-like 
sextet in the Mössbauer spectrum reflects brain Fe that is stored. These assignments are 
supported by a recent study of the ironome of human Jurkat cells and their isolated 
mitochondria (46).  
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Our results show that most of the Fe in the brain of prenatal and newborn mice is 
stored, and that during the first month of life, the proportion of stored Fe declines while 
the proportion of mitochondrial Fe increases. As the animals move into adulthood, the 
proportion of stored Fe in the brain increases again. We did not detect an overall decline 
in the concentration of mitochondria with age up to 58 wks; further studies are underway 
to determine whether mitochondrial levels decline towards the end of the animal's 
natural lifespan. Mitochondrial levels have been reported to decline with age due to 
mitophagy (11).  
These results, in conjunction with those of the 
57
Fe incorporation study, suggest a 
connection between this burst of mitochondriogenesis and an increase in brain activity 
(Figure B5). Before birth and immediately thereafter, the level of brain activity is low 
and so might be the demand for energy. During this period, Fe is slowly imported into 
the brain where most of it is stored as ferritin or ferritin-like material. During the first 
few weeks of life, there is an increased level of brain activity as the animal's eyes open 
and they explore their environment. The increased brain activity increases the demand 
for more chemical energy, prompting a burst of mitochondriogenesis. This demand for 
Fe is beyond that at which Fe can be imported into the brain. Thus, the brain draws upon 
its Fe stores to build the requisite Fe/S clusters and heme centers. The scarcity of Fe is 
exacerbated by the rapid increase of brain volume during the same period, resulting in 
the overall decline in the Fe concentration in the brain. Eventually, the burst of 
mitochondriogenesis slows, as does the rate of brain growth. The brain replenishes its Fe  
 
 181 
 
 
 
 
Figure B5. Mössbauer spectra of brains isolated at different ages. a, -1 wk; b, 1 wk; 
c, 2 wks; d, 4 wks; e, 24 wks; f, 60 wks.  All samples were collected at 6 K, 0.05 T, and 
applied fields were parallel to the gamma radiation.  The vertical dashed line shows the 
position of the high-energy line of the central doublet. The arrow shows the position of 
the nonheme HS Fe
II
 feature. 
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stores, via the slow import of Fe from the blood, and it reestablishes a higher overall Fe 
concentration. 
This model is consistent with previous results. Pysh and co-workers used 
electron microscopy to determine the proportion of rat cell volume (in the inferior  
colliculus) due to mitochondria during different stages of development (47). The 
mitochondrial profile number was relatively low during the first few postnatal days but 
increased rapidly thereafter, leveling off at ca. 25 days postnatal. The mitochondrial 
volume fraction increased 6-fold, reaching 9% of tissue volume in adults. Interestingly, 
there was no correlation of mitochondria with synapse concentrations; rather, the rate of 
mitochondriogenesis correlated with increased levels of synaptic activity. 
 
Effect of Iron Deficiency 
Our results indicate that the regulation of brain Fe is sensitive to dietary changes. 
The brain responds to Fe deficiency by reducing levels of stored ferritin Fe while 
maintaining normal mitochondria levels. Ten-day old rats fed an Fe-deficient diet for 28 
days showed a 27% decline in non-heme brain Fe,(48) similar to the 25% decline that 
we observed. Interestingly, in our study, the concentration of mitochondria in Fe-
deficient brains was actually higherthan observed in Fe-sufficient animals at any 
developmental stage examined. Explaining this counterintuitive result will require 
further study, but Fe regulation in the brain is undoubtedly complex, and the brain is 
probably protected from organism-level Fe deficiencies. In other studies, levels of the 
brain Fe-containing proteins tyrosine hydroxlase, tryptophan hydroxylase, monoamine 
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oxidase, succinate hydroxylase and cytochrome c in Fe deficient animals were also 
normal (49). Mackler et al. (50) reported that the levels of cytochromes a and c were 
normal under Fe deficient conditions, and that the level of cytochrome b was only 
slightly reduced relative to that in Fe-sufficient mitochondria. Neurological problems 
may only arise if the Fe deficiency is so severe that all storage forms of Fe in the animal 
have been exhausted and the brain can no longer be protected from the deficiency. 
 
Mononuclear Nonheme High-spin Ferrous and Ferric Species 
Our results indicate the presence of substantial amounts of NHHS Fe
II
 in the 
mouse brain. NHHS Fe
II
 complexes are generally less tightly coordinated than LS 
complexes and they exhibit more rapid ligand-exchange. Such properties would be 
expected for trafficking Fe and for complexes that undergo Fenton chemistry. Three of 
our Mössbauer spectra clearly indicate the presence of substantial concentrations of 
NHHS Fe
II
 species in the brain (−1 wk, 3 wks, and Fe-deficient). In these cases, the 
concentration of all NHHS Fe
II
 species in the mouse brain was 20 μM. The NHHS 
Fe
II
 doublets were broad, suggesting that many NHHS Fe
II
 species contribute. The 
NHHS Fe
II
 doublet in the other brain Mössbauer spectra were present but less well 
resolved. 
The g = 4.3 EPR signal was present in every brain homogenate examined; this 
indicates the presence of HS Fe
III
 ions with rhombic symmetry in the brain. The 
quantified intensity of this signal indicates that these Fe
III
 species are present at a 
combined concentration of 100 nM. A portion of these species are undoubtedly 
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Fe
II
 and Fe
III
 ions bound tightly in the active site of enzymes in the brain; perhaps some 
is present as Fe
III
 transferrin (51). Another portion may be involved in trafficking and/or 
the Labile Iron Pool (LIP) (52-54). Such species have not been observed in previous 
Mössbauer and EPR studies of the brain (55).  
Other groups have reported the presence “chelatable”, “free”, “labile” or 
“loosely-bound” Fe in the brain. These pools of Fe are defined operationally, i.e. as the 
Fe in supernatant fractions of brain extracts treated with Fe chelators and then spun by 
centrifugation. Sohal et al. (56) measured bleomycin-chelated and ferrozine-chelated 
(called nonheme) Fe in the mouse brain, and observed an age-dependent increase of 
nonheme Fe but not bleomycin-chelatable Fe. Magaki et al. (57) measured “loosely 
bound iron” and “non-heme iron”, defined operationally, in 6, 12, and 24 week old 
mouse brains. They found that loosely bound Fe represented 20%–30% of non-heme Fe, 
with the latter type of Fe increasing with age and the former decreasing slightly or 
remaining constant. Using chelator induced calcein-quenching, Kaur et al. (58) found 
that an operationally defined LIP in mouse brain increased with age. Other LIPs are 
defined by staining the brain directly. Using high-resolution histological staining 
methods, Meguro et al. (21) reported substantial amounts of (again, operationally 
defined) nonheme Fe
II
 and Fe
III
 species distributed heterogeneously throughout the rat 
brain. They determined that the levels of these species increase with the age of the 
animal. 
All of these previously reported LIPs, defined by their chelation ability, differ 
fundamentally from the mononuclear HS Fe
II
 and Fe
III
 species observed here. The 
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species we observed are defined solely by their spectroscopic properties, not by their 
chelation properties. Comparing the two will require establishing the chelation properties 
of the species we observe and the spectroscopic properties of the chelatable Fe species 
reported previously. 
 
Spin Radical Species 
The radical species detected here may be physiologically relevant since samples 
were prepared in the absence of O2 which minimizes the possibility of generating 
artifactual radical signals during sample preparation. Transient radicals in the brain have 
been detected using spin-probes (59) but the radical detected here is fundamentally 
different because it is stable in the absence of such probes (radical probes trap unstable 
radicals). Radical species are cleared from the brain faster in young mice than in old, 
suggesting that the reducing capacity of the brain may decrease with age (60). These 
changes may be related to the age-dependent increase in the stable radical species that 
we observed by EPR. Most theories of aging involve the age-dependent accumulation of 
ROS (61), which could be responsible for the gradual build-up of the stable radical. 
 
Conclusions 
Our study provides new insights into Fe metabolism, trafficking and homeostasis 
in the brain. We have enriched mice with 
57
Fe and have used Mössbauer spectroscopy, 
along with EPR, UV-vis, and ICP-MS, as biophysical probes of the types of Fe centers 
contained in the mouse brain at different stages of development. We quantified the rates 
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of Fe incorporation into the brain, and found that Fe is imported slowly, relative to the 
rate of import into other organs. The slow rate of Fe incorporation into the brain is 
probably due to the tight regulation at the BBB. The rate of Fe incorporation is biphasic, 
with a rapid phase occurring in very young animals and a slower phase occurring in 
adult animals. During the rapid Fe-incorporation phase, the brain grows rapidly, and the 
level of brain activity increases. As such, ATP-generating mitochondria are being 
generated rapidly. This creates a high demand for Fe. This demand cannot be met solely 
with newly imported Fe. As a result, the concentration of Fe in the brain declines and 
some ferritin-stored Fe is released and used for mitochondriogenesis. As brain growth 
and mitochondriogenesis slow, the Fe import rate becomes sufficient to allow some of 
the imported Fe to be stored once again. 
The brain contains substantial concentrations of NHHS Fe
II
 and Fe
III
 species a 
portion of which may be used in trafficking and homeostasis. Iron in this category is 
known to undergo the Fenton reaction to generate reactive oxygen species which is 
associated with aging. Further studies are required to determine whether the detected Fe 
species actually participate in such reactions. We observed a stable organic radical EPR 
signal which increased with age, consistent with the ROS theory of aging. Only ferritin-
like Fe was observed in previous Mössbauer studies of the human brain, possibly 
because only Fe-rich regions were examined, and/or because of differences in the age 
and/or diets of the mice vs. human involved. We demonstrated that the Fe content of the 
brain is sensitive to diet, in that stored Fe was preferentially utilized when mice were Fe-
deficient. 
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The methods developed here are widely applicable, and could be applied to any 
and all mouse organs, including those found in transgenic animals with various Fe-
associated disorders. This approach may reveal differences in Fe metabolism, trafficking 
and/or regulatory homeostasis, and thus significantly impact the mechanistic study of 
Fe-related diseases. 
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APPENDIX C  
LOW-MOLECULAR-MASS METAL COMPLEXES IN THE MOUSE BRAIN
3
 
Abstract 
 The presence of labile low-molecular-mass (LMM, defined as < 10 kDa) metal 
complexes in cells and super-cellular structures such as the brain has been inferred from 
chelation studies, but direct evidence is lacking. To evaluate the presence of LMM metal 
complexes in the brain, supernatant fractions of fresh mouse brain homogenates were 
passed through a 10 kDa cutoff membrane and subjected to size-exclusion liquid 
chromatography under anaerobic refrigerated conditions. Fractions were monitored for 
Mn, Fe, Co, Cu, Zn, Mo, S and P using an on-line ICP-MS. At least 30 different LMM 
metal complexes were detected along with numerous P- and S- containing species. 
Reproducibility was assessed by performing the experiment 13 times, using different 
buffers, and by examining whether complexes changed with time. Co exhibited 11 LMM 
complexes with molecular masses < 4 kDa; Fe and Mn each exhibited 2 - 3 such 
complexes. Mo contained the molybdopterin cofactor and another LMM complex. No 
Cu or Zn complexes in this very low mass range were observed. These two metals were 
present in what appeared to be protein-bound complexes with masses ranging from 4 – 
20 kDa. Co was the only metal for which the “free” or aqueous complex was 
reproducibly observed. Aqueous Co may be sufficiently stable in this environment due 
                                                 
3
 McCormick, SP; Chakarabarti, M; Cockrell, AL; Park, J; Lindahl, LS; Lindahl, PA. (2013) Low-
molecular-mass metal complexes in the mouse brain. Metallomics 5, 232-241. http://pubs.rsc.org/en/ 
Content/ArticleLanding/2013/MT/c3mt00009e#!divAbstract.Reproduced by permission of The Royal 
Society of Chemistry. 
 189 
 
to its relatively slow water-exchange kinetics. Attempts were made to assign some of 
these complexes, but further efforts will be required to identify them unambiguously and 
to determine their functions. 
Introduction 
Transition metals such as iron, copper, manganese, molybdenum, and cobalt are 
critical components of cells and super-cellular structures like the brain. They tend to be 
redox-active and have excellent catalytic properties that render them common residents 
in the active-sites of enzymes. However, many of those same properties can be 
deleterious to the cell, especially when their ligands are coordinated weakly. Labile Fe
II
 
and Cu
I
 complexes in particular can react with H2O2 to generate •OH via the Fenton 
reaction (62, 63). Hydroxyl radicals and other reactive oxygen species (ROS) can 
damage DNA, proteins and membranes. Thus, trafficking newly-imported metal ions 
from the plasma membrane to various apo-protein targets requires chaperones that bind 
these metal ions weakly enough so that they can be transferred from one species to the 
next while simultaneously avoiding dangerous side-reactions. Substantial progress has 
been made in understanding how this happens in cells, but many molecular-level details, 
e.g. the specific metal trafficking species involved and their exact cellular functions, 
remain unknown (64). Nowhere is metal ion trafficking more important than in the brain, 
since many neurodegenerative diseases are associated with metal ion accumulation (65, 
66). 
The concentration of Fe in the brains of mice fed standard (50 mg Fe/kg) chow is 
ca. 350 µM, with ~ 50% present as ferritin, ~ 40% as Fe/S clusters and heme centers, 
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and 5% - 9% as mononuclear nonheme high-spin (NHHS) Fe
II
 and Fe
III
 species.(67) 
Ferritin is a protein complex that stores Fe in cells. Most Fe/S clusters and heme centers 
reside in mitochondrial respiratory complexes where they help provide chemical energy 
for the brain. Some NHHS Fe
II
 ions are found in the active sites of enzymes while others 
may be involved in trafficking. NHHS Fe
II
 complexes often have weakly-coordinating 
ligands and engage in Fenton chemistry.  Fe in the brain is heterogeneously 
distributed (21). The reasons for this are unknown, but spatially-dependent differences in 
traffic patterns or flows are implied. The concentration of Fe in the Substantia Nigra 
(SN) increases in Parkinson’s Disease (PD), in association with the loss of mitochondrial 
function and damage to dopaminergic neurons (68). 
Trafficking of metals involves protein chaperones that bind metal ions in one 
location of the cell and release them in another, e.g. to an apo-protein binding site during 
folding and maturation (69). Whether trafficking also involves low-molecular-mass 
(LMM) metal complexes is less certain. Such species may exist in aqueous regions of a 
cell, where they might interact with protein chaperones and/or pass through membrane-
bound transporters. For example, Mrs3p/Mrs4p are membrane-bound mitochondrial 
proteins that transport Fe from the cytosol to the mitochondrial matrix (70). Although 
the structures of these two proteins are unknown, homologous structures suggest that the 
channels that pass through them are too small to accommodate a protein (70). This 
suggests that LMM Fe complexes, consisting of the metal ion coordinated by small 
organic or inorganic ligands, and/or by waters, pass through these transporters.  
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If LMM metal complexes are involved in trafficking, they should have weakly 
coordinating ligands that can be displaced by strong chelating agents. However, this 
form of Fe is also likely to engage in Fenton chemistry. Pamp et al.(71) concluded that 
labile Fe constitutes 0.2 – 3% of overall cellular Fe. In human cells containing 400 µM 
Fe,(46) this corresponds to a collective labile Fe concentration of 1-10 M. Using 
fluorescence sensors, Petrat et al. found that the concentration of chelatable iron in the 
cytosol of intact hepatocytes was in the same range, namely 5.8 ± 2.6 µM.(54) 
According to Rauen et al. about 1% of cellular Fe exists in a pool that is not bound to 
ferritin or other proteins.(72) They estimate that the concentration of chelatable Fe in 
liver mitochondria and in the cytosol is 12 µM(73) and 6 µM(54), respectively. Using 
chelators of different Fe affinities had no effect on the estimated size of the 
mitochondrial chelatable Fe pool, suggesting that the determined pool concentration (16 
± 2 µM) represents its “true” size. These estimates are substantially less than the 
concentration of NHHS Fe
II
 ions present within respiring yeast mitochondria (ca. 150 
M), as quantified by Mössbauer spectroscopy.(74) Some Mössbauer-detectable NHHS 
Fe
II
 species may be protein-bound and not labile. Differences may also arise from the 
different organisms probed and/or different cellular metabolic growth modes. The 
Mössbauer-detected NHHS Fe
II
 ions are chelated by 1,10-phenantroline (Phen),(74) 
which attenuates Fe/S cluster synthesis,(75) strongly suggesting that these ions serve as 
feedstock for this process.   
In most cases, the exact roles of LMM Fe complexes in cells and the brain are 
unknown. However, patterns are emerging suggesting involvement in development, 
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aging and neurodegenerative diseases. Kaur et al.(58) found an increase in the labile iron 
pool (LIP) in the brains of older mice, suggesting that such ions might be involved in 
aging. Wypijewska et al.(76) found increased LIP in the SN of PD patients. Sohal et 
al.(56) and Magaki et al.(57) reported that 20% - 30% of nonheme Fe in the developing 
mouse brain was labile. Meguro et al.(21) found that chelatable nonheme Fe
II
 and Fe
III
 
species were distributed heterogeneously throughout the rat brain and that the 
concentration of these species increased with age. Huang et al.(77) reported that 
psychological stress (generated using electric shock) expands the LMM Fe
III
 and Fe
II
 
pools in the cerebral cortex, hippocampus and striatum, as detected by Perl’s and 
Turnbull’s stains, respectively. Nothing is known regarding the particular complexes 
involved in these effects.  
Zn is not formally a transition metal, but this redox-inactive divalent metal ion 
also plays critical roles in brain metabolism.(78) The concentration of Zn in the mouse 
brain is ca. 320 µM,(67) most of which is bound to metalloproteins. Metallothioneins are 
the primary intracellular Zn-buffering proteins. Metallothionein III in the brain has a 
molecular mass (MM) of ca. 7 kDa and contains 8-11 Zn binding sites.(79) Zn is also 
found in aggregated amyloid beta protein filaments in Alzheimer’s Disease (AD), and is 
associated with amyotrophic lateral sclerosis, epilepsy, strokes, depression, and 
schizophrenia.(80) Protein-based and non-protein-based fluorescent probes have been 
used to image mobile Zn ions in cells and tissues.(81, 82) Palmer and coworkers targeted 
protein-based FRET fluorescence sensors to the mitochondria, ER and Golgi of HeLa 
cells, and estimated the presence of such pools at low pM concentrations.(83, 84) The 
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detected concentration of cytosolic Zn was also extremely low, namely 80 pM. In 
contrast, high concentrations of Zn (estimated to be mM levels) are found in synaptic 
vesicles within neurons that use glutamate as a neurotransmitter.(85) The synaptic Zn 
pool has been detected by Zn-specific fluorescent dyes.(86, 87) These vesicles are 
located primarily in the cerebral cortex and limbic structures. Labile Zn ions enter these 
vesicles via the membrane-bound protein ZnT3 and are released upon synaptic 
activation.(88) This pool modulates the overall excitability of the brain, and is involved 
in signal transduction, memory and learning.  
Copper is present in the mouse brain at low concentrations (~ 5 µM)(67) but it is 
no less important than Fe or Zn. Cu plays essential roles in respiration, oxidative stress 
response, and other enzymatic activities.(89) Cu ions in the brain parenchyma are 
involved in the metabolism of neurotransmitters and myelination.(90)  
Numerous proteins are known to be involved in Cu trafficking. Ctr1 is a 
transporter on the plasma membrane that brings Cu into the cell.(91) Once in the cell, Cu 
can be stored in metallothionein, transported to mitochondria, incorporated into apo-
Cu/Zn SOD, or transported to the Golgi apparatus for export from the cell.(90) Cu-
containing ceruloplasmin helps distribute and metabolize Cu, and it may help Fe efflux 
from the brain.(92)  Cox17 is an 8.0 kDa protein that transfers cytosolic Cu to 
mitochondria for incorporation into apo-cytochrome c oxidase.(93) CCS1 is a trimer 
with 9 kDa subunits which functions to insert Cu into apo-Cu/Zn SOD.(94, 95) The 
concentration of CCS1 is sensitive to intracellular levels of Cu. Atx1 is an 8.2 kDa 
copper-binding chaperone that transports Cu to the Cu-ATPases in the trans-Golgi 
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network. These proteins, Atp7a and Atp7b, deliver Cu for incorporation into 
proteins.(96) When intracellular Cu concentration exceeds some setpoint value, they 
export Cu from the cell.  
The presence of a labile Cu pool is less certain than that for Fe or Zn. Using 
highly selective ratiometric fluorescent reporters for Cu
I
 ions, Domaille et al. found an 
ascorbate-induced increase in the labile Cu
I
 pool in HEK 293T cells.(97) Hirayama et al. 
used a fluorescent sensor to visualize labile Cu
I
 pools in mice.(98)  
The mouse brain contains ~14 µM Mn, ~ 400 nM Mo, and ~ 30 nM Co, 
respectively.(67) Some Mn is incorporated into mitochondrial superoxide dismutase 
(SOD2) which functions to diminish oxidative stress.(99) Mn levels in the brain are 
elevated in patients with AD and Prion disease.(100) Mo is coordinated to the 
molybdopterin cofactor in the active site of various molybdenum hydroxylases.(101) A 
deficiency of the molybdopterin cofactor causes seizures and death in newborns.(102, 
103) Cobalt metabolism in the brain includes lipid biosynthesis and one-carbon 
metabolism.(104, 105) Co is present in coenzyme B12 bound in methionine 
synthase.(106) This enzyme functions in methionine metabolism, which includes methyl 
group transfer reactions involving choline, folate and S-adenosyl-methionine.(107) 
In this study, we have evaluated the presence of LMM metal complexes in the 
mouse brain. Rather than using specific chelators to detect such species, we have 
detected them using anaerobic liquid chromatography with an on-line ICP-MS. We 
report here that the brain contains a limited number of LMM Fe, Co, Mn, Mo, Cu and Zn 
 195 
 
complexes. These complexes were enumerated and characterized in terms of 
concentration and approximate MM. A few species were tentatively assigned.  
  
Experimental Procedures 
Chemicals and Standards 
The water used was house-distilled, deionized using ion-exchange columns 
(Thermo Scientific 09-034-3), and then distilled again using a sub-boiling still (Savillex 
DST-1000). Cytochrome c (Saccharomyces cerevisiae), aprotinin (bovine lung), ATP, 
ADP, AMP, and cyanocobalamin were from Fisher Scientific (Pittsburgh, PA, USA). 
Inositol hexaphosphate (IP6), oxidized and reduced glutathione, sodium molybdate, and 
sodium phosphate were from Sigma Aldrich (St. Louis, Mo, USA). The molybdopterin 
cofactor was isolated as described(108) from xanthine oxidase. The sample buffer was 
20 mM Tris (Fisher) pH 7.4. 
 
Animal Care and Dissections 
 ICR (Imprinting Control Region) outbred mice were raised and manipulated in 
accordance with the TAMU Animal Care and Use committee (AUP 2010-226). Mice 
were housed in disposable plastic cages (Innovive Innocage Static Short) with all-plastic 
water bottles and plastic feeders with zinc electroplated reinforcements. Mice were fed 
Fe-deficient chow (Harlan Laboratories, Inc. Teklad ID TD.80396.PWD) supplemented 
with 50 mg/Kg of Fe citrate. Mice were euthanized by an intraperitoneal injection of 
ketamine and xylazine as described.(67) Immediately after breathing ceased and the 
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heart stopped beating, animals were imported into a refrigerated (5–10 °C) Ar-
atmosphere glove box (MBraun Labmaster) containing 2–20 ppm O2, as monitored by a 
Teledyne O2 analyzer (Model 310). From this point forward, all sample manipulations 
were performed in a glove box unless mentioned otherwise.  
 
Preparation of LMM Brain Extracts 
 Animals were perfused with heparinized Ringer's buffer at 1.0 mL/min for 0.5 
min/g mouse, and then dissected as described.(67) Immediately after isolation, 3 - 4 
brains were added to a known volume (2 – 3 mL) of degassed 20 mM Tris buffer (pH 
7.4). The solution was homogenized for 1 min using a plastic rotary knife inserted into a 
tissue grinder (Omni TH). The resulting homogenate was disrupted by nitrogen 
cavitation (model 4639, Parr Instruments) at 800 psi for 10 min. The resulting extract 
was treated with Triton X-100 and Sodium deoxycholate (final concentrations of 1% 
(v/v) and 1% (w/v), respectively) for 10 min. The sample was removed from the box in 
an O-ring-sealed centrifuge bottle and spun at 110,000×g for 30 min. The bottle was 
returned to the box and the resulting supernatant fraction (~ 3 mL) was transferred to a 
stirred cell concentrator (Amicon Model 8003, Millipore) fitted with a 10 kDa cutoff 
membrane (YM-10, Millipore). The supernatant was passed through the membrane with 
a head pressure of 90 psi Ar, and ~ 2 mL of the flow-through solution (FTS) was 
collected in a plastic screw-top tube. The tube was sealed with electrical tape, placed 
inside of a second container that was then sealed, removed from the box, and 
immediately imported into a second glovebox that contained the LC. In one experiment, 
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the FTS was split into two aliquots, one of which was spiked with 100 µL of 180 nM 
stock solutions (prepared in 20 mM Tris pH 7.4) of FeSO4, CuCl2, MnCl2, CoCl2, ZnCl2 
and Na2MoO4. After 3 hrs, aliquots were injected, one after the other, into the LC-ICP-
MS system.  
 
Elemental Concentrations in Flow-Through Solutions 
 Aliquots (150 µL) of the FTS for each run were placed into 15 mL plastic screw-
top tubes (BD Falcon) containing 100 µL of concentrated trace-metal-grade (TMG) 
nitric acid (6.4 M final concentration). After ~ 12 hr at 90 ºC, samples were diluted with 
9.75 mL of distilled-and-deionized water, affording a final acid concentration of 0.14 M. 
Calibration curves were prepared from standard solutions containing P, S, Co, Cu, Zn, 
Fe, Mn, and Mo (Inorganic Ventures, Christiansburg Virginia, USA)  at known 
concentrations, prepared in  trace-metal-grade nitric acid and diluted using distilled-and-
deionized water. Data were collected in He collision mode using ICP-MS (model 7700x, 
Agilent Technologies, Tokyo, Japan). Elemental concentrations were determined using 
the calibration curve. Values obtained were adjusted for dilution factors. 
 
Chromatography and Instrumentation 
 HPLC separations were carried out in a refrigerated Ar-atmosphere glove box 
(Labmaster, Mbraun USA) using an Agilent 1200 Bioinert LC composed of a metal-free 
Infinity 1260 Quaternary Pump equipped with a manual injection valve fitted with a 500 
µL PEEK injection loop. Two size-exclusion Superdex Peptide GL 10/300 columns (300 
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× 10 mm, GE Life Science, USA) were combined in series using a male-to-male union 
connector. The mobile phase was 20 mM Tris buffer (pH 7.4). Post-column eluent flow 
(0.35 mL/min) was mixed in real-time with a solution of 4% trace-metal-grade nitric 
acid plus 100 g/L 116In, diluting the eluent 2-fold. The resulting solution flowed into an 
on-line inductively coupled plasma mass spectrometer (ICP-MS) (7700x, Agilent 
Technologies, Tokyo Japan), and 
31
P, 
34
S , 
55
Mn, 
35
Cu, 
59
Co, 
65
Zn, 
95
Mo, 
56/57
Fe, and 
116
In  were detected. Indium was used as an internal standard to monitor plasma 
suppression. Other ICP-MS conditions: RF power, 1500 W; Ar flow rate, 15 L/min; 
collision cell He flow rate, 4.3 mL/min; sampling/skimmer cones, Pt, Pt; dwell time, 0.2 
sec; internal standard pump rate, 0.35 mL/min. 
 The column was cleaned after each run using 10 column volumes (CVs) of a 
chelator cocktail at a flow rate of 150 µL/min and then regenerated with the elution 
buffer (20 mM Tris, pH 7.4). The chelator cocktail was composed of 20 mM Tris pH 8.0 
plus 10 µM each of ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic 
acid, tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN), Phen and 2,2’-bipyridine.  
 
Molecular Mass Calibration 
 The MM associated with each chromatographic peak was calculated using a 
standard curve constructed from 14 known species (data not shown). Standard stock 
solutions were prepared in 20 mM Tris pH 7.4, affording concentrations ranging from 1 
- 200 µM. Each solution was injected individually onto the column. Elution volumes Ve 
were assigned based either on ICP-MS detector response or on UV-vis spectral intensity. 
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In cases where multiple forms were evident (GSH, GSSG, ATP, ADP, and AMP), the 
peak with the MM nearest to the known mass of the species was assigned to that species. 
Void volume V0 was determined using Blue Dextran (MM 2000 kDa). The logarithm of 
the MM was plotted vs. the ratio Ve/V0 (Data not shown). The best-fit linear regression 
curve was constructed through the data points. 
 
Results 
 The objective of this study was to determine whether the mouse brain contained 
LMM transition metal complexes detectable by LC-ICP-MS. We avoided oxidizing Fe
II
-
containing species due to concern that endogenous ligands might dissociate upon 
oxidation and be replaced by waters, rendering insoluble aqueous Fe
III
 ions that would 
adhere to the column. Once animals were euthanized, all procedures involving samples 
were performed in a refrigerated Ar-atmosphere glove box. In each experiment, isolated 
brains were homogenized and centrifuged, and then supernatants were passed through a 
10 kDa cut-off membrane. Because such complexes could potentially be highly dynamic 
and unstable, samples were prepared for the LC as fast as possible; FTSs were injected 
onto the LC column ca. 3 hrs after animals were euthanized. Experiments were 
performed 13 times to assess reproducibility.  
 Elemental concentrations in the FTSs were determined and corrected for dilution, 
affording estimates for the collective concentrations of all the LMM species for these 
elements in the brain. The results were  (in µM): Co, 0.06 ± 0.01; Mo, 0.3 ± 0.1; Mn, 0.8 
± 0.1; Cu, 4.2 ± 0.2; Fe, 18 ± 1; Zn, 44 ± 7; S, 1500 ± 70; and P, 11,000 ± 1000. 
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Assuming the total metal concentrations in the brain mentioned in the Introduction 
(except for Co, which was found in the current study to be present in the brain at 88 ± 5 
nM), the percentages of these elements in the brain that passed through the LMM 
membrane are: Co, 66 ± 10; Mo, 67 ± 25; Mn, 6 ± 1, Cu, 84 ± 12; Fe, 5 ± 0.4; Zn, 14 ± 
2; S, 9 ± 2; P, 12 ± 3. Thus, LMM species represent large percentages of total Co, Mo 
and Cu ions in the brain, but small percentages of Mn, Fe, Zn, S and P. For Fe in 
particular, the calculated percentage is comparable to previous chelation-based 
determinations in human cells (see Introduction).   
 Given the potential lability of these metal complexes, we evaluated the 
percentage of the metals that eluted from the column, normalized to the amount loaded. 
The averages of three runs were: Mo, 74 ± 12; Mn, 93 ± 4; Fe, 89 ± 7; Co, 93 ± 4; Cu, 
84 ± 6; Zn, 92 ± 3; P, 91 ± 3 and S, 92 ± 6, respectively. These values indicate that the 
majority of the metal-containing species in the FLSs eluted from the column. The small 
percentage of each metal that did not elute demonstrates the importance of washing the 
column extensively between runs.  
 A total of 13 runs were performed; of these, 11 were analyzed. The two excluded 
runs had peak linewidths 2 - 3 fold greater than the others (suggesting a problem with 
the column). Thus, our analyses were essentially free of subjective bias. Reproducibility 
was acceptable but there were noticeable variations. P and S chromatograms were the 
most reproducible, in that the same sets of peaks, with similar relative area-ratios, were 
observed in each run. The Ve associated with each peak were not perfectly matched from 
one chromatogram to another, and so small shifts in the volume dimension, 
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corresponding to no more than 0.24 mL, were allowed to align S and P peaks to the 
greatest extent possible. The identical alignment offsets were used for the corresponding 
Mo, Mn, Co, Fe, Cu and Zn chromatograms generated in the same run. In this way, the S 
and P chromatograms served as an internal calibration to align the metal-based 
chromatograms. Data sets were not adjusted further.  
 We considered that some peaks might arise from degradation products of the 
brain, despite using freshly prepared FTS and working quickly. To examine this, a FTS 
was left for 13 days in a refrigerated box prior to passage through the column. The 
resulting chromatograms, compared to those obtained using fresh FTS, revealed virtually 
no change in relative peak areas and distributions (data not shown). We conclude that 
our samples did not degrade on the time scale of the experiment.  
 We also considered that our results might depend on the FTS buffer employed. 
To examine this, the buffer was switched from Tris to HEPES (both 20 mM at pH 7.4). 
The resulting chromatograms revealed no significant differences (data not shown). 
Remaining run-to-run variations probably arose from animal-to-animal differences. To 
minimize these, mice were euthanized at approximately the same time of day (10 am – 
12 noon). Age and gender differences were considered as variational factors, but no 
correlations were obvious. In analyzing datasets, we assumed that any peak observed in 
> 50% of the metal-matched datasets represented a real species in the brain. Peaks 
observed in 25% - 50% of chromatograms were viewed as probably reflecting real 
species. Peaks observed in < 25% of chromatograms were considered artifacts and were 
not included in downstream analyses. Averages for peaks that were reproducibly present, 
 202 
 
according to these criteria, are summarized in Table 1.  MMs for each species were 
estimated from Ve and the best-fit linear regression standard-curve line.  
 Representative chromatograms of the FLS for each element, along with various 
standard compounds, are shown in Figures C1 – 9. The P chromatogram (Figure C1) 
exhibited two major regions of peaks. The high-molecular-mass (HMM) region 
corresponds to P-containing compounds with MMs between ca. 13 - 6 kDa (21 – 25 
mL). P-compounds with MMs between 4 - 0.2 kDa (27– 41 mL) are included in the low-
molecular-mass (LMM) region. The intermediate-molecular-mass (IMM) region 
between 4 – 6 kDa was effectively devoid of peaks. 
The ill-resolved shape of the HMM region suggested that multiple overlapping species 
contributed, and we did not attempt to decompose it. In contrast, the peaks in the LMM 
region were better resolved. These were simulated using the equation 
2
0
0 max
V V
VI I I e

 
 
    (1) 
where ɷ is the width of the peak and IV, I0, and Imax are the detector responses at any 
volume V, at volume V = 0, and at the volume corresponding to the peak maximum, 
respectively. We integrated the total area under the chromatogram along with the relative 
areas under the individual LMM peaks such that the percentage of the total eluent P due 
to each LMM peak (fcpd-i) could be determined. The concentration of each P-containing 
species represented by the LMM peaks in the brain ([Cpdi]) was calculated using the 
equation  
[ ] [ ]i cpd i ftsCpd f P FD    (2) 
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Figure C1. Phosphorus chromatograms of brain FTS and various phosphorus-
containing compounds. A, brain FTS; B, IP6; C, ATP; D, ADP; E, AMP, and F, HPO4
2-
. Red lines in Figures C1 - 8 are simulations representing the LMM species listed in 
Table C1. The blue line is the overall simulation. 
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Assigned Name Peak Center 
(mL) 
Peak Width 
(mL) 
Molecular Mass 
(Da) 
Area 
(%) 
[Metal]Brain 
(µM) 
Confidence 
(%) 
PHMM V < 18 mL N/A 24,000 – 48,000 43 ± 14 4600 ± 1500 100 
P2490 29.5 ± 0.3 0.6 ± 0.2 2490 ± 150 0.8 ± 0.5 90 ± 50 67 
P1950 30.7 ± 0.6 1.0 ± 0.5 1950 ± 240 1.2 ± 1 130 ± 110 92 
P1240 32.9 ± 0.4 0.7 ± 0.1 1240 ± 100 7 ± 3 760 ± 320 100 
P1060 33.7 ± 0.2 0.5 ± 0.1 1060 ± 40 4 ± 3 430 ± 320 41 
P900 34.5 ± 0.3 0.4 ± 0.1 900 ± 60 3 ± 2 320 ± 220 92 
P630 36.2 ± 0.2 0.5 ± 0.2 630 ± 30 19 ± 13 2000 ± 1400 83 
P570 36.7 ± 0.2 0.5 ± 0.2 570 ± 20 15 ± 11 1600 ± 1200 67 
P530 37.1 ± 0.1 0.5 ± 0.1 530 ± 10 14 ± 10 1500 ± 1100 50 
P490 37.5 ± 0.1 0.5 ± 0.2 490 ± 10 13 ± 13 1400 ± 1400 58 
       
SHMM V < 18 mL n/a 24,000 - 48,000 54 ± 10 800 ± 150 100 
S1540 31.8 ± 0.2 0.6 ±  0.1 1540 ± 76 2.4 ± 1 35 ± 15 100 
S940 34.3 ± 0.4 0.8 ±  0.4 940 ± 73 1.4 ± 1 21 ± 15 100 
S570 36.7 ± 0.1 0.4  ± 0.1 570 ± 5 22 ± 13 320 ± 190 92 
S520 37.1  ± 0.1 0.5 ± 0.1 520 ± 7 17 ± 11 250 ± 160 100 
S370 38.8 ± 0.2 0.7 ± 0.2 370 ± 14 5 ± 1 74 ± 74 100 
       
CoHMM V < 18 mL n/a 24,000 - 48,000 8 ± 7 0.005 ± 0.004 100 
Co1640
 31.5 ± 0.8 0.5 ± 0.1 1640 ± 250 38 ± 16 0.020 ±0.009 100 
Co1380 32.4 ± 0.3 0.8 ± 0.3 1380 ± 80 18 ± 8 0.010 ± 0.004 100 
Co1130 33.4 ± 0.6 0.9 ± 0.5 1130 ± 140 15 ± 11 0.009 ± 0.006 100 
Co920 34.4 ± 0.5 0.5 ± 0.2 920 ± 90 3 ± 2 0.002 ± 0.001 92 
Co900 34.5 ± 0.3 1 ± 1 900 ± 60 2 ± 1 0.001 ± 0.0005 50 
Co630 36.2 ± 0.3 1 ± 1 630 ± 40 5 ± 5 0.003 ± 0.003 75 
Co500 37.4 ± 0.3 1 ± 1 500 ± 30 3 ± 3 0.002 ± 0.002 75 
Co400 38.4 ± 0.3 0.7 ± 0.7 400 ± 20 2 ± 2 0.001 ± 0.001 58 
Co300 39.7 ± 0.5 0.8 ± 0.5 310 ± 30 1 ± 1 0.0008 ± 0.0004 75 
Co210 41.6 ± 0.5 1.1 ± 0.9 210 ± 20 2 ± 2 0.001 ± 0.001 85 
Coaq 43.9 ± 0.5 1.0 ± 1.3 < 200 3 ± 3 0.002 ± 0.002 50 
 
 
Table C1. Low-Molecular-Mass Metal Complexes in the Mouse Brain. Confidence 
was defined as the number of chromatograms for a given element in which the peak was 
present divided by the total number of chromatograms for that element, multiplied by 
100.   
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Assigned Name Peak Center  
(mL) 
Peak Width  
(mL) 
Molecular Mass  
(Da) 
Area  
(%) 
[Metal]Brain 
(µM) 
Confidence 
(%) 
CuHMM V < 19.4 mL n/a 24,000 – 48,000 60 ±16 2.6 ± 0.7 100 
Cu19390 19.5 ± 0.1 0.8 ± 0.6 19390 ± 440 23 ± 12 1.0 ± 0.5 100 
Cu15670 20 ± 0.2 0.6 ± 0.1 15670 ± 610 13 ± 5 0.6 ± 0.2 100 
Cu8650 23.4 ± 0.3 1.0 ± 0.2 8650 ± 500 2 ± 0.7 0.08 ± 0.03 100 
Cu5680 25.5 ± 0.2 0.6 ± 0.2 5680 ± 280 0.5 ± 0.3 0.02 ± 0.01 100 
Cu4230 26.9 ± 0.4 0.7 ± 0.3 4230 ± 350 0.5 ± 0.2 0.02 ± 0.01 100 
Cu1020 33.9 ± 0.7 0.4 ± 0.2 1020 ± 140 0.2 ± 0.6 0.01 ± 0.03 92 
Cu370 38.9 ± 0.2 0.6 ± 0.2 370 ± 20 0.8 ± 0.8 0.03 ± 0.03 100 
ZnHMM V < 18 mL n/a 24,000 – 48,000 86 ± 3 38 ± 1 100 
Zn19630 19.4 ± 0.4 0.6 ± 0.2 19630 ± 1610 8.5 ± 4 3.75 ± 2 100 
Zn16000 20.4 ± 0.5 0.8 ± 0.4 16000 ± 1640 5 ± 2 2.2 ± 0.9 92 
Zn1760 31.2 ± 0.5 0.6 ± 0.5 1760 ± 180 0.4 ± 0.2 0.18 ± 0.09 42 
Zn400 38.5 ± 0.1 0.4 ± 0.1 400 ± 8 0.2 ± 0.1 0.09 ± 0.04 67 
FeHMM V < 18 mL n/a 24,000 - 48,000 98 ± 2 17.4 ± 0.4 100 
Fe3320 28.1 ± 0.4 0.6 ± 0.5 3320 ± 270 1.4 ± 1.2 0.2 ± 0.2 58 
Fe1720 31.3 ± 0.1 0.6 ± 0.2 1720 ± 40 0.3 ± 0.2 0.05 ± 0.03 58 
Fe510 37.3 ± 0.3 0.6 ± 0.4 510 ± 30 0.5 ± 0.3 0.09 ± 0.05 75 
MnHMM V < 18 mL n/a 24,000 - 48,000 77 ± 22 0.6 ± 0.2 100 
Mn3810 27.4 ± 0.2 0.6 ±  0.1 3810 ± 190 3 ± 1 0.025 ± 0.008 50 
Mn2710 29.1 ± 0.5 0.7 ±  0.2 2710 ± 300 3 ± 2 0.025 ± 0.017 85 
Mn2040 30.5 ± 0.8 1.4 ± 0.9 2040 ± 320 11 ± 5 0.09 ± 0.04 58 
Mn1680 31.4  ± 0.3 0.7 ± 0.4 1680 ± 100 17 ± 9 0.14 ± 0.08 50 
Mn1270 32.8 ± 1.3 1 ± 1 1270 ± 340 8 ± 7 0.07 ± 0.06 50 
MoHMM V < 18 mL n/a 20,000 - 48,000 80 ± 10 0.22  ± 0.03 100 
Mo940 34.3 ± 0.5 0.5 ± 0.2 940 ± 100 2 ± 2 0.005 ± 0.004 50 
Mo410 38.4 ± 0.6 1.2 ± 0.7 410 ± 50 5 ± 3 0.01 ± 0.008 58 
Mo350 39.1 ± 0.7 0.9 ± 0.4 350 ± 50 9 ± 5 0.02 ± 0.013 67 
Mo240 41.0 ± 0.6 1.6 ± 0.7 240 ± 30 4 ± 3 0.01 ± 0.008 67 
 
Table C1.  Low-Molecular-Mass Metal Complexes in the Mouse Brain. Confidence 
was defined as the number of chromatograms for a given element in which the peak was 
present divided by the total number of chromatograms for that element, multiplied by 
100.   
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where [P]fts is the concentration of P in the FTS and FD is the fold-dilution used to 
prepare the FTS starting from the intact brain. Similar equations were used to estimate 
the concentrations of all LMM metal and S compounds. Equation [2] assumes that the 
same proportion of each P compound was retained by the column. Maximum and 
minimum concentrations for each compound (Table 1) were estimated by assuming that 
the P retained by the column was exclusively either the P species of interest, or other P-
containing species, respectively.   
 Eight species were used to simulate the LMM region of the P chromatogram 
(Figure C1, Table C1). Each was designated by the element followed by a subscript 
indicating its approximate MM. The dominant P peak (P490) comigrated with ADP and 
was assigned as such. Authentic ATP migrated at a slightly smaller Ve and its peak fit in 
the HMM shoulder of P490 as long as the linewidth was increased. Alternatively, the 
peak for ATP and another species could both fit into this shoulder if narrower linewidths 
were assumed. IP6 binds Fe in cells and is thought to be involved in trafficking.(109) 
However, no Fe peaks comigrated with Fe-bound IP6. The remaining P peaks were not 
assigned. Curiously, no peaks comigrated with AMP or orthophosphate.  
 Peaks in the representative S chromatogram (Figure C2) again segregated into 
HMM, IMM and LMM regions. Again, there were few, if any, S-containing species 
present in the IMM region. As with P, the S-containing species in the HMM region were 
poorly resolved and only the overall response in this region was determined by 
simulation. The LMM region contained 4 major resolved peaks. The dominant peak  
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Figure C2. Sulfur chromatograms of brain FTS and various S-containing 
compounds. A, brain FTS; B, glutathione, GSH; C, oxidized glutathione, GSSG. The 
authentic glutathione solution contained some GSSG, while the GSSG solution 
contained a contaminant. 
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(S570) comigrated with GSSG. However, its broad linewidth suggested that GSSG and 
another S species with a similar MM contributed. Another peak (S370) nearly comigrated 
with GSH, and was assigned as such. The remaining two species, S1540 and S940 were not 
assigned. The ratio of peak areas for the oxidized and reduced glutathione species was 
ca. 4:1 GSSG:GSH, assuming that one of the two species that contributed to S570 was 
GSSG. This suggests a molar ratio of ca. 2:1 which is reasonably close to previously 
reported molar ratios for brain samples.(110)  
 The Co chromatogram (Figure C3) displayed numerous species in the LMM 
region, some HMM peak intensity, and little if any peaks in the IMM region. Of all 
metals detected, Co exhibited the greatest number of LMM species. Cyanocobalamin 
migrated just slightly slower than the dominant Co peak (Co1640), suggesting that Co1640 
might arise from a related complex (e.g. adenosylcobalamin). Aqueous Co
II
 ions 
migrated as multiple species, consistent with rapid ligand/proton exchange reactions.  
 The representative Cu chromatogram (Figure C4) indicated a HMM region 
containing ca. 5 – 6 reasonably resolved peaks, with MMs between 19 and 48 kDa. The 
IMM region was devoid of peaks, and the LMM region contained only ca. 2 peaks. 
Although the trace in Figure C4 suggests a miniscule amount of aqueous Cu, this feature 
was not reliably present in other traces.  
 The Zn chromatogram (Figure C5) showed a well-resolved HMM region that 
included ca. 5 species. The IMM and LMM regions were virtually devoid of peaks.  
 The Fe chromatogram (Figure C6) showed a poorly resolved HMM region and 
an IMM region largely devoid of peaks. The LMM region included two significant peaks  
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Figure C3. Cobalt chromatograms of brain FTS and other Co species. A, brain FTS; 
B, cyanocobalamin; and C, aqueous Co. The three lowest MM simulations in the figure 
are considered a single species (Coaq) in Table C1. 
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Figure C4. Copper chromatograms of brain FTS and other Cu species. A, brain FTS 
×15; B, brain FTS ×1; C, Cu
II
(EDTA); and D, aqueous Cu. 
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Figure C5. Zinc chromatograms of brain FTS. A, brain FTS ×16; B, brain FTS ×1; C, 
Zn
II
(TPEN); and D, aqueous Zn. 
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(Fe1720 and Fe510), but these were only observed in 58% and 75% of the chromatograms, 
respectively. In general, there was more variability in the Fe (and Mn) chromatograms 
than in chromatograms from the other metals. In most traces, the ultra LMM region was 
devoid of features (the trace shown in Figure C6 shows such a feature, but it was not 
routinely observed). 
 The Mn chromatogram (Figure C7) included poorly resolved features in the 
HMM region, no features in the IMM region, and a few peaks in the LMM region. 
Mn1270 and the broad feature centered at ca. 28 mL were present in about half of the 
traces. The Mo chromatogram (Figure C8) exhibited peaks in the HMM and LMM 
regions, while the IMM region was largely devoid of peaks. The major LMM peak 
(Mo350) comigrated with molybdopterin isolated from xanthine oxidase, suggesting that 
these peaks arise from the same or a closely related species.    
 
Discussion and Conclusions 
 The objective of this study was to determine whether the mouse brain contains 
LMM metal complexes, defined as Mo, Mn, Fe, Co, Cu and Zn complexes possessing 
MMs < 10 kDa. Rather than using chelators, our approach was to detect such species 
directly, using ICP-MS to monitor metals eluting from our LMM size-exclusion 
chromatography column. We were careful to avoid oxidation of any redox-active 
complexes, by working in an inert-atmosphere glovebox. 
 We attempted to limit ligand substitution reactions by minimizing the time 
between euthanizing the animals and loading the LC column, and by running the column  
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Figure C6. Iron chromatograms of brain FTS. A, brain FTS ×15; B, brain FTS ×1; C, 
Fe
II
(ATP); and D, aqueous Fe. 
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Figure C7. Manganese chromatograms of brain FTS and other Mn species. A, brain 
FTS; B, Mn
II
(EDTA); and C, aqueous Mn. 
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Figure C8. Molybdenum chromatograms of brain FTS and molybdopterin extract 
from xanthine oxidase. A, brain FTS; and B, molybdopterin.  The intense peak in B 
with MM ~1.5 kDa was not assigned. 
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at low temperature. We distinguished “real” from artifactual complexes by repeating the 
experiment 13 times and assigning a confidence probability to each species in 
accordance with the proportion of runs in which the species was observed (Table 1). Our 
results were independent of buffer used. The vast majority of metal ions loaded on the 
column did not adhere to it.  
 By these criteria, our results indicate that there are 11 Co, 5 Cu, 5 Mn, 4 Mo, 3 
Fe, and 2 Zn LMM complexes in the mouse brain. Of these 30 LMM metal complexes, 
only 2 – 3 have masses suggesting protein ligation (Cu8650, Cu5680 and perhaps Cu4230). 
The rest have lower MMs which suggest either small peptides as ligands or perhaps 
organic/inorganic ligands.  
 Except for Cu, all of the metals displayed a significant gap between one edge of 
the HMM region (with MMs > ~ 20 kDa) and one edge of the LMM region (with MMs 
< 4 kDa). The absence of metal complexes between these two regions implies that the 
division into such groups is not arbitrary. Zhuang et al. reported that the shortest (non-
alternatively spliced) protein in the mouse genome is 38 residues, which corresponds to 
4.2 kDa.(111) This suggests that the complexes in the HMM region are exclusively 
protein-based and it raises the possibility that the metal complexes in the LMM region 
are either non-proteinaceous or have peptides arising from post-translational truncations. 
Large natural products and siderophores (e.g. actinomycin D, glycosylated antibiotics, 
pyoverdine) have MMs of ca. 1.5 kDa.  
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 Of the metals examined, Co exhibited the most LMM complexes and perhaps the 
least protein-based species. Cu and Zn displayed the opposite pattern, with numerous 
well-resolved metal-bound proteins and few non-proteinaceous complexes.  
 Our results impact the issue of whether cells contain “free” or aqueous metal 
ions. They indicate that there are significant concentrations of aqueous Co ions in the 
brain, but do not provide clear evidence of aqueous Cu, Zn, Mn, Mo or Fe ions. ICP-MS 
is quite sensitive, such that the concentration of aqueous metal ion would need to be < 10 
nM (ca. 10
3
 ions per cells; data not shown) to escape detection. In a seminal study 
published over a decade ago, O’Halloran and coworkers argued that there are no “free” 
or aqueous Cu ions in the cell, and that Cu trafficking exclusively involves transferring 
Cu ions from one protein chaperone to the next.(112) Their conclusion was based on 
ability of the Cu-loaded chaperone CCS to donate Cu into apo-SOD1 even in the 
presence of bathocurproine sulfate, a strong Cu
I
 chelator. Using thermodynamic binding 
constants, they estimated that there is < 1 aqueous Cu ion per cell. They rationalized that 
the intracellular milieu must have a large capacity for binding aqueous Cu ions, and that 
aqueous Cu would be dangerous to the cell, due to its tendency to engage in Fenton 
chemistry. To the limited extent that our results can detect aqueous Cu (down to ~ 300 
Cu ions/cell), they support the conclusion that there are no “free”/aqueous Cu ions in the 
mouse brain.   
 Similar thermodynamic calculations involving aqueous Zn ions in the cell yield 
concentrations of tens to hundreds of pM. Like Cu, this translates into < 1 aqueous Zn 
ion per cell assuming a cell volume of 10
-14
 L. Aqueous Zn ions also inhibit human 
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receptor protein-tyrosine phosphatase in accordance with KI = 21 ± 7 pM,(113) again 
suggesting very few if any intracellular aqueous Zn ions. Our results suggest the absence 
of aqueous Zn in the mouse brain and provide substantial evidence for protein-based Zn 
complexes. We propose that the Zn species released during the firing of synaptic 
vesicles have one or more non-aqueous ligands. The species released are almost 
certainly not “free”/aqueous Zn.  
 Aqueous metal ions rapidly exchange bound waters with the solvent, with rate-
constants that vary in the order Ni
II
 < Co
II
 < Fe
II
 < Mn
II
 < Zn
II
 < Cu
II
.(114) The waters 
on such complexes have average residence times ranging from 10
-4
 – 10-10 sec. At 
moments when a coordinated water dissociates, thousands of potential ligands in the 
cellular milieu could interact with the metal at the vacant coordination site. This would 
promote the formation of a new complex. In the likely event that the new ligand would 
coordinate stronger than water, the complex would become less dynamic. Even if no 
permanent complexes formed, the result of this dynamic exchange-reaction would be a 
population-distribution of closely related and rapidly interconverting species rather than 
a single entity. Indeed the broad structured peaks obtained from the chromatographic 
migration of aqueous metal ions in our study suggest such a population of species. Could 
such dynamical populations serve discrete physiological functions in a cell, or would 
they be deleterious, engaging in uncontrolled side reactions that produce toxic species? 
We suspect that cells could not survive the uncontrollable behavior of most aqueous 
transition metal ions. Moreover, the cell would be unable to regulate such ions since the 
coordinating ligands would not be under genetic control. Chaos would result. 
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 Accordingly, aqueous metal ions with the fastest water exchange-dynamics 
would seem to be the least likely to exist in a cell, while those with slower exchange-
dynamics might be sufficiently stable. Our detection of aqueous Co ions in FTSs 
supports this possibility, since, of the metals examined, aqueous Co
II
 exchanges water 
ligands slowest. To test this idea further, aqueous Ni
II
 ions, which exhibit even slower 
water exchange-dynamics, were added to a FTS prior to passage through the column. A 
single peak with the MM of aqueous Ni
II
 was detected. When other aqueous metal ions, 
including Fe, Cu, Zn and Mn were added to the FTS, the only aqueous ion detected in 
the resulting chromatograms was Co (data not shown).   
 The fast ligand exchange-dynamics inherent to metal ions are slowed with 
polydentate ligands. Polydentate metal complexes would likely exist as single 
autonomous entities that are not in a dynamic equilibrium with other potential ligands in 
the cell. Slower exchange dynamics would minimize toxic side reactions because they 
would not have dynamically-free sites. Moreover, such ligands would need to be 
synthesized and thus regulated by the cell. The shape of such large complexes would 
allow other cellular components (e.g. membrane-bound protein transporters) to 
recognize and distinguish one complex from another. All of these factors favor the 
occurrence in the cell of metal complexes with polydentate ligands. Undoubtedly all of 
the LMM metal complexes characterized in this study are of that type.  
 We are particularly interested in metal complexes involved in metal ion 
trafficking – assuming such complexes exist. For such complexes, the coordinating 
polydentate ligands must bind strong enough to avoid the problems mentioned above, 
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yet also allow the metal to be transferred to downstream acceptors. In some well-
documented cases, altering the redox state of the metal(115) or the pH(116) of the 
solution are sufficient to labilize the ligands. Binding to a protein or macromolecular 
complex might also labilize the ligands coordinating a metal.  
 Determining the physiological role of each LMM metal complex in the brain that 
we have described in this study will be a challenge that will require multiple 
“orthogonal” approaches. The LC-ICP-MS approach used here is complementary to that 
of treating cells or tissues with custom-designed chelators that react with and sense labile 
metal complexes.(72, 81, 82, 97) The advantage of the chelator-based method is the 
ability to detect labile metal ions in intact live cells. The disadvantages are that such 
chelators may react with multiple species in the cell, and that the process of detection 
destroys the complexes of interest. The advantage of the LC-ICP-MS approach is that 
individual metal complexes can be detected undisturbed (barring potential degradation 
reactions occurring during workup). The disadvantage is that the cell itself must be 
disrupted such that critical information regarding cellular compartmentalization is lost. 
Merging these approaches, e.g. using LC-ICP-MS to assess which particular complexes 
react with designer metal sensors, will undoubtedly yield the greatest insight into metal 
ion metabolism in cells and super-cellular structures such as the brain. 
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